<!DOCTYPE html>
<html lang="en"     class="pb-page"  data-request-id="07b6dc07-0b86-43a3-9ce9-15bca75f132c"  
><head data-pb-dropzone="head"><meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="pbContext" content=";issue:issue:doi\:10.1002/ajmg.a.v191.5;journal:journal:10968628;page:string:Article/Chapter View;ctype:string:Journal Content;website:website:pericles;requestedJournal:journal:15524833;article:article:doi\:10.1002/ajmg.a.63132;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text"/>
<script id="adobeDigitalData">window.adobeDataLayer = window.adobeDataLayer || [];
window.adobeDataLayer.push({"site":{"environment":"LIVE","hub":"pericles","locale":"en-US"},"user":{"login-status":"guest","identities":[{"type":"InstitutionUser","uuid":"d01f57db-9690-42e3-8c3e-11f3114bd187","customerRecords":[{"customerDomain":"ALM-CU","customerNumber":"CORE00000004012"}]},{"type":"RegionUser","uuid":"1e062694-1189-4932-91ab-dd78ca25a1ee"},{"type":"BasicGroup","uuid":"e623deab-c83b-41e3-84a2-d9f1d46c5f17"},{"type":"SmartGroupUser","uuid":"b7acda8c-ce18-451b-a68d-e14b72f9b5b8"},{"type":"RegionUser","uuid":"5da2ed7b-eccc-453b-a112-e569efaf7e1a"},{"type":"BasicGroup","uuid":"197fe835-5b5f-4f4e-b8e9-a74d68491a84"},{"type":"SmartGroupUser","uuid":"b2dbfe27-ecae-4bb6-bb0d-d75e5caa3762"},{"type":"SmartGroupUser","uuid":"da88d808-3f7b-4bde-9210-10862b6d121b"},{"type":"SmartGroupUser","uuid":"8c72a733-117a-4bc9-a682-13475f13e6a3"}]},"content":{"item":{"title":"Nosology of genetic skeletal disorders: 2023 revision","doi":"10.1002/ajmg.a.63132","access":"open","type":"article","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"Biotechnology (Life Sciences)","topicUri":"ls35"},{"taxonomyUri":"global-subject-codes","topicLabel":"Basic Medical Sciences","topicUri":"md10"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Genetics","topicUri":"ls60"},{"taxonomyUri":"global-subject-codes","topicLabel":"Human Genetics","topicUri":"ls61"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"ls63"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"md1a"},{"taxonomyUri":"open-access","topicLabel":"Open Access Content","topicUri":"open-access-content"},{"taxonomyUri":"fundref-funders","topicLabel":"The Wellcome Trust DBT India Alliance","topicUri":"501100009053"},{"taxonomyUri":"fundref-funders","topicLabel":"University of Lausanne","topicUri":"501100006390"},{"taxonomyUri":"fundref-funders","topicLabel":"Sigrid Jusélius Foundation","topicUri":"501100006306"},{"taxonomyUri":"fundref-funders","topicLabel":"Wellcome Trust","topicUri":"100010269"}],"published-date":"2023-02-13","access-denial":"no","format-available":["Abstract","Cited by","First page image","Full text","PDF","References","AM pdf"],"format-viewed":"full text"},"group":{"doi":"10.1002/ajmg.a.v191.5","access":"no","type":"issue","volume":"191","issue":"5","published-date":"2023-05-01","topics":[{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"Biotechnology (Life Sciences)","topicUri":"ls35"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Genetics","topicUri":"ls60"},{"taxonomyUri":"global-subject-codes","topicLabel":"Human Genetics","topicUri":"ls61"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"ls63"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"global-subject-codes","topicLabel":"Basic Medical Sciences","topicUri":"md10"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"md1a"}]},"series":{"title":"American Journal of Medical Genetics Part A","doi":"10.1002/(ISSN)1552-4833","access":"no","type":"journal","code":"15524833","eissn":"1552-4833","topics":[{"taxonomyUri":"gpt-sitename","topicLabel":"wly.genetics_000065","topicUri":"wly.genetics_000065"},{"taxonomyUri":"global-subject-codes","topicLabel":"MEDICAL SCIENCE","topicUri":"md"},{"taxonomyUri":"global-subject-codes","topicLabel":"Biotechnology (Life Sciences)","topicUri":"ls35"},{"taxonomyUri":"global-subject-codes","topicLabel":"LIFE SCIENCES","topicUri":"ls"},{"taxonomyUri":"global-subject-codes","topicLabel":"Genetics","topicUri":"ls60"},{"taxonomyUri":"global-subject-codes","topicLabel":"Human Genetics","topicUri":"ls61"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"ls63"},{"taxonomyUri":"global-subject-codes","topicLabel":"Cell \u0026 Molecular Biology","topicUri":"ls30"},{"taxonomyUri":"global-subject-codes","topicLabel":"Basic Medical Sciences","topicUri":"md10"},{"taxonomyUri":"global-subject-codes","topicLabel":"Medical Genetics","topicUri":"md1a"},{"taxonomyUri":"gpt-zonename","topicLabel":"aj-med-genetics_AJMG","topicUri":"aj-med-genetics_ajmg"}]}},"page":{"brand":"wol","type":"article","primary-section":"journal","secondary-section":"article","tertiary-section":"full"}});
</script><script src="https://assets.adobedtm.com/59640f9fa510/591d3f748997/launch-1ff1f800248b.min.js"></script>
<script type="text/javascript">var $DoubleClickZone = "aj-med-genetics_ajmg";var $DoubleClickSite =  "wly.genetics_000065";</script>







<meta charset="UTF-8">




<meta name="robots" content="noarchive"/>





    














    






    <meta property="og:title" content="Nosology of genetic skeletal disorders: 2023 revision"/>


    <meta property="og:type" content="Article"/>


    
        <meta property="og:url" content="https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.63132"/>
    
    


    
    
        
        

        
            <meta property="og:image" content="https://onlinelibrary.wiley.com/cms/asset/d4751376-a6e0-426b-b4c6-f4646d6d8072/ajmg.a.v191.5.cover.jpg?trick=1683261820153"/>
            <meta property="twitter:image" content="https://onlinelibrary.wiley.com/cms/asset/d4751376-a6e0-426b-b4c6-f4646d6d8072/ajmg.a.v191.5.cover.jpg?trick=1683261820153"/>
        
    


    <meta property="og:site_name" content="Wiley Online Library"/>


    
    

        

        <meta property="og:description" content="The “Nosology of genetic skeletal disorders” has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new disorders thank..."/>
    




    <meta name="viewport" content="width=device-width,initial-scale=1"/>



































<!-- OsanoScriptEnabled: true -->

<style>
/* Osano - Hide close and reject all buttons */
.osano-cm-denyAll,
.osano-cm-dialog__close {
    display: none
}
</style>
<script>
!function(e="v1"){let n=location.host.split(".").slice(-3).join(".");var o=document.cookie,a=new Date;a.setFullYear(a.getFullYear()+1),0>o.indexOf("lit_osano="+e)&&(document.cookie="lit_osano="+e+"; expires="+a+"; path=/; domain="+n+";",o.indexOf("osano_consentmanager_uuid=")>=0&&(document.cookie="osano_consentmanager_uuid=; expires=Thu, 01 Jan 1970 00:00:00 UTC; path=/; domain="+n+";"),o.indexOf("osano_consentmanager=")>=0&&(document.cookie="osano_consentmanager=; expires=Thu, 01 Jan 1970 00:00:00 UTC; path=/; domain="+n+";"),localStorage.removeItem("osano_consentmanager"),localStorage.removeItem("osano_consentmanager_tattles-cookie"),localStorage.removeItem("osano_consentmanager_tattles-iframe"),localStorage.removeItem("osano_consentmanager_tattles-ignore"),localStorage.removeItem("osano_consentmanager_tattles-script"),localStorage.removeItem("osano_consentmanager_uuid"),console.log("[OsanoDebug] lit_osano reset"));let t=["Du kan lukke dette banner for at forts\xe6tte med kun vigtige cookies.","Puede cerrar este banner para continuar con solo las cookies esenciales","Puoi chiudere questo banner per continuare con solo i cookie essenziali","Sie k\xf6nnen dieses Banner schlie\xdfen, um nur mit essenziellen Cookies fortzufahren.","Tento banner můžete zavř\xedt a pokračovat pouze se z\xe1kladn\xedmi soubory cookie.","U kunt deze banner sluiten om verder te gaan met alleen essenti\xeble cookies.","Voc\xea pode fechar este banner para continuar apenas com os cookies essenciais.","Voit sulkea t\xe4m\xe4n bannerin jatkaaksesi vain v\xe4ltt\xe4m\xe4tt\xf6mien ev\xe4steiden k\xe4ytt\xf6\xe4.","Vous pouvez fermer cette banni\xe8re pour continuer avec uniquement les cookies essentiels.","You may close this banner to continue with only essential cookies.","Μπορείτε να κλείσετε αυτό το banner για να συνεχίσετε μόνο με βασικά cookies","Можете да затворите този банер, за да продължите само с основните бисквитки."];var s,i="Osano",r="data";(s=window)[i]=s[i]||function(){s[i][r].push(arguments)},s[i][r]=s[i][r]||[],window.Osano("onUiChanged",(e,n)=>{if(console.log("[OsanoDebug] Event onUiChanged: ",e,", ",n),"dialog"===e&&"show"===n){let o=document.querySelector(".osano-cm-message");if(o){let a=o.textContent,s=t.find(e=>a.includes(e));o.textContent=a.replace(s,"")}}})}();
</script>

<link rel="preload" href="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js" as="script">
<script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/67a788d8-9344-4c9b-a3c2-89b5073ee231/osano.js"></script>





    

    <meta name="citation_doi" content="10.1002/ajmg.a.63132"/>

    <meta name="dc.identifier" content="10.1002/ajmg.a.63132"/>




<meta name="citation_journal_title" content="American Journal of Medical Genetics Part A"><meta name="citation_title" content="Nosology of genetic skeletal disorders: 2023 revision"><meta name="citation_volume" content="191"><meta name="citation_issue" content="5"><meta name="citation_firstpage" content="1164"><meta name="citation_lastpage" content="1209"><meta name="citation_publication_date" content="2023/05/01"><meta name="citation_online_date" content="2023/02/13"><meta name="citation_issn" content="1552-4833"><meta name="citation_language" content="en"><meta name="citation_author" content="Sheila Unger"><meta name="citation_author_institution" content="Division of Genetic Medicine Lausanne University Hospital and University of Lausanne Lausanne Switzerland"><meta name="citation_author" content="Carlos R. Ferreira"><meta name="citation_author_institution" content="Skeletal Genomics Unit, Metabolic Medicine Branch National Human Genome Research Institute, National Institutes of Health Bethesda Maryland USA"><meta name="citation_author" content="Geert R. Mortier"><meta name="citation_author_institution" content="Center for Human Genetics University Hospital Leuven and KU Leuven Leuven Belgium"><meta name="citation_author" content="Houda Ali"><meta name="citation_author_institution" content="INSERM, US14-Orphanet Paris France"><meta name="citation_author" content="D&#xe9;bora R. Bertola"><meta name="citation_author_institution" content="Unidade de Gen&#xe9;tica, Instituto da Crian&#xe7;a, Hospital das Cl&#xed;nicas da Faculdade de Medicina Universidade de S&#xe3;o Paulo S&#xe3;o Paulo Brazil"><meta name="citation_author_institution" content="Departamento de Gen&#xe9;tica e Biologia Evolutiva, Instituto de Bioci&#xea;ncias Universidade de S&#xe3;o Paulo S&#xe3;o Paulo Brazil"><meta name="citation_author" content="Alistair Calder"><meta name="citation_author_institution" content="Radiology Department Great Ormond Street Hospital for Children, NHS Foundation Trust London UK"><meta name="citation_author" content="Daniel H. Cohn"><meta name="citation_author_institution" content="Department of Molecular, Cell and Developmental Biology University of California, Los Angeles Los Angeles California USA"><meta name="citation_author_institution" content="Department of Orthopaedic Surgery University of California, Los Angeles Los Angeles California USA"><meta name="citation_author" content="Valerie Cormier-Daire"><meta name="citation_author_institution" content="Paris Cit&#xe9; University, Reference Center for Skeletal Dysplasia, INSERM UMR 1163, Imagine Institute Necker Enfants Malades Hospital (AP-HP) Paris France"><meta name="citation_author" content="Katta M. Girisha"><meta name="citation_author_institution" content="Department of Medical Genetics, Kasturba Medical College, Manipal Manipal Academy of Higher Education Manipal Karnataka India"><meta name="citation_author" content="Christine Hall"><meta name="citation_author_institution" content="Emerita Consultant Paediatric Radiologist at Great Ormond Street Childrens' Hospital London UK"><meta name="citation_author" content="Deborah Krakow"><meta name="citation_author_institution" content="Departments of Obstetrics and Gynecology, Orthopaedic Surgery and Human Genetics, David Geffen School of Medicine University of California, Los Angeles Los Angeles California USA"><meta name="citation_author" content="Outi Makitie"><meta name="citation_author_institution" content="Children's Hospital University of Helsinki and Helsinki University Hospital Helsinki Finland"><meta name="citation_author_institution" content="Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden"><meta name="citation_author" content="Stefan Mundlos"><meta name="citation_author_institution" content="Institut f&#xfc;r medizinische Genetik und Humangenetik Charit&#xe9; - Universit&#xe4;tsmedizin Berlin Berlin Germany"><meta name="citation_author" content="Gen Nishimura"><meta name="citation_author_institution" content="Department of Radiology Musashino-Yowakai Hospital Tokyo Japan"><meta name="citation_author" content="Stephen P. Robertson"><meta name="citation_author_institution" content="Department of Women's and Children's Health, Dunedin School of Medicine University of Otago Dunedin New Zealand"><meta name="citation_author" content="Ravi Savarirayan"><meta name="citation_author_institution" content="Murdoch Children's Research Institute and University of Melbourne Parkville Victoria Australia"><meta name="citation_author" content="David Sillence"><meta name="citation_author_institution" content="Specialities of Genomic Medicine and Paediatrics and Adolescent Health Sydney University Clinical School, Children's Hospital Westmead NSW Australia"><meta name="citation_author" content="Marleen Simon"><meta name="citation_author_institution" content="Department of Genetics University Medical Center Utrecht Utrecht The Netherlands"><meta name="citation_author" content="V. Reid Sutton"><meta name="citation_author_institution" content="Department of Molecular & Human Genetics Baylor College of Medicine & Texas Children's Hospital Houston Texas USA"><meta name="citation_author" content="Matthew L. Warman"><meta name="citation_author_institution" content="Department of Orthopedic Surgery, Boston Children's Hospital Harvard Medical School Boston Massachusetts USA"><meta name="citation_author_institution" content="Department of Genetics Harvard Medical School Boston Massachusetts USA"><meta name="citation_author" content="Andrea Superti-Furga"><meta name="citation_author_institution" content="Division of Genetic Medicine Lausanne University Hospital and University of Lausanne Lausanne Switzerland"><meta name="citation_abstract_html_url" content="https://onlinelibrary.wiley.com/doi/abs/10.1002/ajmg.a.63132"><meta name="citation_fulltext_html_url" content="https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.63132"><meta name="citation_pdf_url" content="https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.63132"><meta name="citation_publisher" content="John Wiley & Sons, Ltd"><meta name="citation_fulltext_world_readable" content=""/><meta name="article_references" content=" Unger, S.,  Ferreira, C. R.,  Mortier, G. R.,  Ali, H.,  Bertola, D. R.,  Calder, A.,  Cohn, D. H.,  Cormier-Daire, V.,  Girisha, K. M.,  Hall, C.,  Krakow, D.,  Makitie, O.,  Mundlos, S.,  Nishimura, G.,  Robertson, S. P.,  Savarirayan, R.,  Sillence, D.,  Simon, M.,  Sutton, V. R., &#x2026;  Superti-Furga, A. (2023).  Nosology of genetic skeletal disorders: 2023 revision. American Journal of Medical Genetics Part A,  191A: 1164&#x2013; 1209. https://doi.org/10.1002/ajmg.a.63132"><meta name="Description" content="Abstract The &#x201c;Nosology of genetic skeletal disorders&#x201d; has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new diso...">



<title>Nosology of genetic skeletal disorders: 2023 revision - Unger - 2023 - American Journal of Medical Genetics Part A - Wiley Online Library</title>









<link rel="stylesheet" type="text/css" href="/wro/m6hz~article-metrics-phase2.css">
            
<link rel="stylesheet" type="text/css" href="/wro/m6hz~product.css">

<link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/icomoon/icomoon.woff?6229abf71b6d1d24fb6f" as="font" type="font/woff" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/open-sans/open-sans-v15-latin-regular.woff2?6229abf71b6d1d24fb6f" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="preload" href="/products/acropolis/pericles/releasedAssets/fonts/source-serif-pro/source-serif-pro-v5-latin-regular.woff2?6229abf71b6d1d24fb6f" as="font" type="font/woff2" crossorigin="anonymous"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/build-6229abf71b6d1d24fb6f.css"/><link rel="stylesheet" href="/products/acropolis/pericles/releasedAssets/css/print-6229abf71b6d1d24fb6f.css" media="print"/>



<script async src="/pb-assets/catchpoint-1549680351760.js"></script>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="shortcut icon" href="/favicon.ico">


<link rel="stylesheet" type="text/css" href="/pb-assets/hub-assets/pericles/hub-1681996217510.css">


<link rel="stylesheet" type="text/css" href="/pb-assets/css/iucr-1510734465460.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/readcube-1510565373110.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/css/dr-overrides-1611780866727.css">
<!-- link rel="stylesheet" type="text/css" href="/pb-assets/css/temporary-1525702334993.css" -->

<style>
/* PERICLES-15842: 22.1 Feature: Save and Publish Button,
This fix is temporary and should be removed after ticket (LIT-503873) is done. */
.pb-changes-dialog.pb-save-dialog .modal-footer .btn.dropdown-toggle {
    display: none;
}
.pb-changes-dialog.pb-save-dialog .modal-footer .btn.btn-primary{
    border-radius: 4px;
    margin-right: 5px
}


/* PERICLES-7186: distorted cover images */
.journal-info-container .cover-image__image img {
    min-height: unset;
}

/* TEMPORARY CSS HACK TO FIX LIT-220590 */
.icon-icon-Rss::before {
    content: "\e629";
}

/* TEMPORARY CSS TO FIX ALIGNMENT OF TOP AD IN RIGHT RAIL */
.publication-cover-info {
    margin-bottom: 20px;
}

.article-row-right > .pb-ad {
    margin-left: 0;
    margin-bottom: 10px;
}

/* TEMPORARY HACK FOR PERICLES-6763 */
.table-of-content .issue-item h2 {
    font-size: 16px;
}

.table-of-content .issue-item h2 a.issue-item__title {
    display: inline;
}

/* TEMPORARY CSS FOR PERICLES-7445 */

input.saml__consent__yes {
    background: #005274;
    font-size: 12px;
    font-size: .75rem;
    padding: 12px 20px;
    border-radius: 0;
    margin-top: 20px;
    margin-right: 10px;
    width: 100px;
}

input.saml__consent__yes:hover {
    background: #003951;
}

/* PERICLES-2166: Site-wide maintenance message */

.admin-message {
    background-color: #005274;
    color: white;
}

/* TEMPORARY CSS FOR STAY-CONNECTED SOCIAL MEDIA ICONS */
.stay-connected ul  {
    list-style: none;
    margin: 0;
    padding: 0;
}

.stay-connected i {
    margin-right: 10px;
    font-size: 25px;
    line-height: 55px;
}

.stay-connected i.icon-hubs-rg-icon,
.stay-connected i.icon-hubs-soundcloud-icon {
    font-size: 41px;
}

.stay-connected .icon-hubs-pinterest-icon:before {
    color: white;
}

.stay-connected .icon-hubs-pinterest-icon {
    background-color: #BD081C;
    border: solid #BD081C;
    border-width: 8px;
}

/* PERICLES-5833: TEMPORARY CSS TO ADJUST POSITION OF ADS */
.article-mpu-bottom .pb-ad {
    margin: 0 0 0 195px;
}


.article-mpu-top .pb-ad {
    padding-top: 20px;
    margin: 0 0 -35px 0;
}

.banner-wrapper .pb-ad {
    padding: 0;
}

/* TEMPORARY CSS FOR THE SOCIETY MEMBER LOGIN PAGE */
.society-member-login .widget__header,
.society-member-login .show-registration,
.society-member-login .show-request-reset-password {
    display: none;
}

.society-member-login .login-form {
    margin-top: 20px;
}

.society-member-login .widget__body .input-group+.input-group {
    margin-top: 15px;
}


/* TEMPORARY CSS TO HIDE FPI IN TOP CONTENT ACTION WIDGET */
.top-content .firstPageImage {
	display: none;
}


.custom-page-pericles .main-content :target:before {
	content: "";
	display: block;
	height: 140px;
	margin: -140px 0 0;
}

/* PERICLES-4777: TEMPORARY CSS TO HIDE OPTIONS IN THE SIDEBAR ON MRW PAGES */
.journal-resources li#TableofContents,
.journal-resources li#Topics,
.journal-resources li#ArticleTitlesAZ {
	display: none;
}

/* TEMPORARY FIX FOR UNWANTED MARGIN BELOW COVER IMAGES ON BOOK SERIES PAGES */
.remove-margin .cover-image {
	margin: 0;
}

/* TEMPORARY FIX TO MAKE IT POSSIBLE TO EDIT RICH TEXT WIDGETS IN SLIDESHOWS */
.bs .modal-backdrop {
	display: none;
}

/* TEMPORARY FIX FOR MENU POSITION */
.hubpage-menu nav {
	padding-bottom: 0;
	position: relative;
}

/* TEMPORARY FOR MARGIN AROUND ADS */
.advert.advert-leaderboard {
	margin: 15px 0;
}

.banner-wrapper {
	box-shadow: none;
}

/* TEMPORARY TO FIX OVERFLOW FOR P IN JOURNAL-NEWS SLIDESHOWS */
.journal-news .slide-item p {
	overflow: unset;
}

/* EDITOR HIGHLIGHTS CSS */
div.ancillary-content.relateditem div.content {
	height: 10em;
}
div.ancillary-content.listitem div.content {
	height: 4em;
}

/* TEMPORARY Fix heading on Topical Index widget for MRWs */
.topical-index h2 {
    margin: 15px 0;
    font-size: 1.75rem;
    line-height: 28px;
    color: #1c1d1e;
    font-family: Source Serif Pro,serif;
    font-weight: normal;
}

/* PERICLES-7288 */
.issue-supplementary-files, .cover-image__virtual-issue {
    margin-bottom: 15px;
}

/* PERICLES-8875 */
.journal-news .slide-item img {
    float: left;
    margin-right: 10px;
}

/* DO NOT REMOVE */
li[heading="Restore Points"].ng-isolate-scope,
li[heading="Disable Widgets"].ng-isolate-scope {
    display: none!important;
}

.modal-header .widgetOrigin {
    display: none;
}

/* PERICLES-10090 */
.cover-image__image img {
    max-width: 150px;
    max-height: 150px;
}

/* LIT-282003 */
.journal-info-container span.info_value:after {
    content: '\003B';
}

.journal-info-container span.info_value:last-child:after {
    content: '';
}

/* LIT-299510 */
h1.citation__title {
    font-size: 22px;
    font-size: 1.375rem;
}

@media (max-width: 991px) {
    h1.citation__title {
        font-size: 18px;
        font-size: 1.125rem;
    }
    h1.citation__title:after {
        content: "";
    }
}

/* LIT-295816 */
.search__item .item__body .meta__details a.publication_meta_serial:after {
    content: "";
    margin: 0;
}
.search__item .item__body .meta__details a.publication_meta_volume_issue:before {
    content: "|";
    margin-left: 4px;
    margin-right: 4px;
}

/* PPV */
.cart-indicator__wrapper {
    padding: 0;
}

/* TrendMD Test */
#article__content #trendmd-suggestions{
    margin-top: 40px !important;
    border-top: 1px solid #ddd;

}
body #article__content .trendmd-widget-container {
    margin-top: 20px !important;
}

body #article__content .trendmd-widget-header__heading{
    font-size: 20px !important;
    margin-bottom: 30px !important
}
body #article__content .trendmd-widget-list-item__link, body #article__content .trendmd-widget-list-item__meta{
    font-family:'Open Sans', arial, sans-serif !important;
}
body #article__content .trendmd-widget{
	font-size:16px !important;
}
body #article__content .trendmd-widget-list-item{
	margin-bottom:24px !important;
}
body #article__content .trendmd-widget-list-item__link{
	color: #005293 !important;
}
body #article__content .trendmd-widget-list-item__meta{
	color: #5d5d5d !important;
	font-size:14px !important;
	margin-top:3px !important;
}
body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
	width: 47% !important;
}

@media (max-width: 450px) {
	body #article__content .trendmd-widget_horizontal .trendmd-widget-section{
		width: 95% !important;
	}
}

#pane-pcw-related .trendmd-widget-header__heading{
	font-size: 18px !important;
	font-family:'Open Sans', arial, sans-serif !important;
}
#pane-pcw-related .trendmd-widget-container{
	padding:0 20px !important;
}
#pane-pcw-related .trendmd-widget-list-item__link{
	 font-family:'Open Sans', arial, sans-serif !important;
	 font-size:14px !important;
	 color: #005293 !important;
	 display:block;
	 margin-bottom: 5px !important;
}
#pane-pcw-related .trendmd-widget-list-item__meta{
	font-family:'Open Sans', arial, sans-serif !important;
	color:#666 !important;
}
#pane-pcw-related .trendmd-widget-list-item{
	margin-bottom:20px !important;
}
</style>

<!-- Google Search Console verification -->
<meta name="google-site-verification" content="ffz4i4DxIJCdGpRXe0XN6KG6o4FYI-nnFW9I_dg8piM" />



<!-- Grapeshot Implementation -->
<script>
	var gs_channels = 'default';
</script>

<script src="//wiley.grapeshot.co.uk/main/channels.cgi?url=https://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.63132" async></script>

<!-- DoubleClick Implementation -->
<script type="text/javascript">
	var $WileyGooglePublisherID = 2215;

	if (!$DoubleClickSite) {
		switch("pericles") {
	  		case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickSite = "wly.agriculture_000018";
				break;
			case "afspubs":
				var $DoubleClickSite = "wly.aqua.fish_000017";
				break;
			case "aasldpubs":
  				var $DoubleClickSite = "wly.gastro.hep_000059";
  				break;
			case "headachejournal":
  				var $DoubleClickSite = "wly.neurology_000086";
  				break;
  			case "wildlife":
				var $DoubleClickSite = "wly.zoology_000120";
				break;
			default:
				var $DoubleClickSite = "undefined-site";
		};
  	};

	if (!$DoubleClickZone) {
		switch("pericles") {
			case "acsess.onlinelibrary.wiley.com":
				var $DoubleClickZone = "Agriculture_ACSESS_Hub";
				break;
			case "afspubs":
				var $DoubleClickZone = "AFS_HUB";
				break;
			case "aasldpubs":
				var $DoubleClickZone = "AASLD-pubs_HUB";
				break;
			case "headachejournal":
				var $DoubleClickZone = "headache_HUB";
				break;
			case "wildlife":
				var $DoubleClickZone = "tws_HUB";
				break;
			default:
				var $DoubleClickZone = "undefined-zone";
		};
	};

	var $GooglePublisherCategory = "/" + $WileyGooglePublisherID + "/" + $DoubleClickSite + "/" + $DoubleClickZone;
</script>

<script>
	var googletag = googletag || {};

	googletag.cmd = googletag.cmd || [];

	( function () {

		var gads = document.createElement ( 'script' ) ,
		node = document.getElementsByTagName ( 'script' ) [ 0 ] ;

		gads.async = true;
		gads.src = document.location.protocol + '//www.googletagservices.com/tag/js/gpt.js';

		node.parentNode.insertBefore ( gads , node );

	}) ();
</script>

<script>
	googletag.cmd.push ( function () {

		var sizes = {
			leaderboard : googletag.sizeMapping ()
				.addSize ([ 300 , 100 ] , [ 300 , 50 ])
				.addSize ([ 740 , 100 ] , [ 728 , 90 ])
				.addSize ([ 0 , 0 ] , 'fluid')
				.build () ,
			rail : googletag.sizeMapping ()
				.addSize ([ 0 , 0 ] , [ 300 , 250 ])
				.build (),
			interstitial : googletag.sizeMapping ()
							.addSize ([ 0 , 0 ] , [ 640 , 480 ])
							.build ()

		};


		gptPage = window.digitalData && digitalData.page && digitalData.page.page ? digitalData.page.page : "blank";
		gptSubPage = window.digitalData && digitalData.page && digitalData.page.subPage ? digitalData.page.subPage : "blank";


		function gptClean(gptText){
			if(typeof(gptText)=="string"){
				gptText = gptText.replace(/\&/g,'%26');


				return gptText.replace(/\^|\*|#|\$|\"|\'|\=|\,|\!|\+|\~|\;|\(|\)|\<|\>|\[|\]|\?|\%|\:|\@|\;|\&|\||\{|\}|\\|/g,'');

			}
			return "blank";
		}


		googletag.pubads ()
			.setTargeting ( 'property' 	, 'value-of-property' 	) 	// Change and duplicate this line for as many additional keywords to send
			.setTargeting ( 'doi' , gptClean('10.1002/ajmg.a.63132')) // Publication DOI
			.setTargeting ( 'gs_cat' 	, gs_channels 		) 	// Grapeshot
			.setTargeting ( 'pbPage', gptClean(gptPage) )
			.setTargeting ( 'pbSubPage', gptClean(gptSubPage) )
			.setTargeting ( 'urlpath', gptClean(document.location.pathname));

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-leaderboard' )
			.defineSizeMapping ( sizes.leaderboard )
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-1' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-1')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-rail-2' )
			.defineSizeMapping ( sizes.rail )
			.setTargeting ( 'Position', 'advert-rail-2')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );

		googletag.defineSlot ( $GooglePublisherCategory, 'fluid', 'advert-video' )
			.defineSizeMapping ( sizes.interstitial )
			.setTargeting ( 'Position', 'advert-video')
			.addService ( googletag.pubads ())
			.setCollapseEmptyDiv ( true );


		googletag.pubads ().enableSingleRequest ();
		googletag.enableServices ();
	});
	//]]>
</script>

<script type="text/javascript">
    var utmParamsEnabled = true;
</script>

<script type="text/javascript">
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?953dddc9c7bea72022e3bd3ba7782e7b";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

<script>
// Temporary fix related to: PERICLES-16131
function handleNoSharingOptions(){
    $('.share-access__ctrl').on('click', function(){
        
    var count = 0; 
    let intervalId =  setInterval(function(){

        if(count++ == 20){
            clearInterval(intervalId);
        }

        if($.trim($('.share__block').text()) === ''){

            const message = '<p style="text-transform: none">No sharing options available</p>';
            $('.share__block').html(message);
            $('.share-access__ctrl').unbind('click');
            
            clearInterval(intervalId);
        }
    }, 300);
});
}

document.addEventListener("DOMContentLoaded", handleNoSharingOptions);
</script>






    <!-- Get whether TNSI is in live or test mode -->
    
    <!-- Get the configured TNSI Javascript version number -->
    
    <!-- Get the configured TNSI MerchantID -->
    
    <!-- Add "TEST" to beginning of merchant ID when running in test mode -->
    

    










    
    

    
    
    
    
    <!-- loading Javascript for using the persistence Service -->
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        function getParameter(parameterName) {
            let result = null,
                tmp = [];
            location.search
                .substr(1)
                .split("&")
                .forEach(function (item) {
                    tmp = item.split("=");
                    if (tmp[0] === parameterName) result = tmp[1];
                });
            return result;
        }

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            queryParamsDelimiter: encodeURIComponent('?'),

            getWAYFLessUrl: function (entityId) {
                let redirectURL = getParameter('redirectUri');
                if(redirectURL == null){
                    redirectURL = encodeURIComponent(this.returnURL);
                }
                if(redirectURL.indexOf('saml_referrer') < 0){
                    redirectURL += encodeURIComponent(((redirectURL.indexOf(this.queryParamsDelimiter) !== -1) ? '&' : '?') + 'saml_referrer');
                }
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + redirectURL;
            },
            retrieveEntity: function () {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve, reject) {
                    ps.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var ps = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    ps.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId, entityTitle) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId, entityTitle: entityTitle, eventGroupKey: 'f3709139-0e36-40cb-a26b-86935a3534e6'}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (let i in allSsoInstitutions) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID, ssoInstitution.entity.title)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>


<script type="text/javascript">
        (function() {
            function riskifiedBeaconLoad() {
                var store_domain = 'https://onlinelibrary.wiley.com';
                var session_id = '60EA4DBEB3B95ADC7D725B270C460B84';
                var url = ('https:' == document.location.protocol ? 'https://' : 'http://')
                    + "beacon.riskified.com?shop=" + store_domain + "&sid=" + session_id;
                var s = document.createElement('script');
                s.type = 'text/javascript';
                s.async = true;
                s.src = url;
                var x = document.getElementsByTagName('script')[0];
                x.parentNode.insertBefore(s, x);
            }
            if (window.attachEvent)
                window.attachEvent('onload', riskifiedBeaconLoad)
            else
                window.addEventListener('load', riskifiedBeaconLoad, false);
        })();
    </script>
</head>
<body class="pb-ui"><div class="skip-links">
    <ul class="rlist">
        <li><a href="#article__content" tabindex="1">Skip to Article Content</a></li>
                <li><a href="#pane-pcw-detailscon" tabindex="1">Skip to Article Information</a></li>
            </ul>
</div>







    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










    
    
        <div data-widget-def="pageHeader" data-widget-id="62175478-b98a-43d5-90f2-1f2045ac1a7e" class="pageHeader">
        



        
        <header class="page-header">
    <div data-pb-dropzone="main">
    



        
        










    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="bb5b5e2c-d3d6-4015-b586-eeade38f59d4" class="admin-message">
        



        
        <div class="container"><div class="row"><div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div></div></div>

        </div>
    





        
        <div class="container"><div class="row"><div class="contents col-sm-12 col-md-12">



        
        <div class="pull-left">









    
    
        <div data-widget-def="ux3-general-image" data-widget-id="ff262197-0fb8-4973-aaa2-2fceba4b5a61" class="logo-container hidden-xs hidden-sm hidden-md">
        



        
        <a href="/" title="Wiley Online Library"><img id="mainLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png"/></a>

        </div>
    











    
    
        <div data-widget-def="ux3-general-image" data-widget-id="9a75b789-224c-4745-833a-930cf6c36f35" class="logo-container-mobile hidden-lg hidden-md hidden-sm">
        



        
        <a href="/" title="Wiley Online Library"><img id="mobileLogo" alt="Wiley Online Library" src="/pb-assets/hub-assets/pericles/mobilehublogo-1518781861020.png"/></a>

        </div>
    

</div><div class="pull-right">









    
    
        <div data-widget-def="UX3QuickSearchWidget" data-widget-id="48175bb0-0f70-46e6-bb89-7e2781fdb8e4" class="header-quicksearch">
        



        
        <div class="quick-search-wrapper"><a href="#" title="search" aria-label="Search" class="quick-search__item"><i aria-hidden="true" class="icon-search"></i><span class="quick-search__item__arrow"></span></a><div data-linkto-page="true" class="quick-search quickSearchFormContainer"><div class="main-search-field-wrapper"><div class="tab clearfix"><input type="search" placeholder="Search" value="" tabindex="13" aria-label="Search" class="fakeQSInput quickSearchFilter"/><label for="search-within" class="sr-only">Search within</label><select name="search-within" id="search-within" tabindex="10" class="search-within"><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c0" data-url="thisCategory" data-value="15524833">This Journal</option><option value="#pane-67065c09-4a88-49cd-934c-ac707951d35c1" data-url="https://onlinelibrary.wiley.com">Anywhere</option></select><ul role="tablist" class="rlist tab__content"><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c0" role="tab" class="tab__pane quick-search-pane__anywhere active"><form action="/action/doSearch" name="thisJournalQuickSearch" method="get" title="Quick Search"><div class="input-group option-0"><label for="searchField0" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField0" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><input type="hidden" name="SeriesKey" value="15524833"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced?publication=15524833" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced?publication=15524833#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li><li id="pane-67065c09-4a88-49cd-934c-ac707951d35c1" role="tab" class="tab__pane quick-search-pane__anywhere"><form action="https://onlinelibrary.wiley.com/action/doSearch" name="defaultQuickSearch" method="get" title="Quick Search"><div class="input-group option-1"><label for="searchField1" class="hiddenLabel">Search term</label><input type="search" name="AllField" id="searchField1" placeholder="Search" onfocus="this.value = this.value;" data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" tabindex="9" class="autocomplete actualQSInput quickSearchFilter"/><div class="search-options-wrapper quickSearchFilter"><a href="https://onlinelibrary.wiley.com/search/advanced" title="" tabindex="12" class="advanced">  Advanced Search</a><a href="https://onlinelibrary.wiley.com/search/advanced#citation" title="" tabindex="12" class="citation">  Citation Search</a></div></div><button type="submit" title="Search" tabindex="11" aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form></li></ul></div></div></div></div>

        </div>
    











    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="5ef13ed1-f4ac-4b62-a426-07ec9576a586" class="cart-indicator__wrapper">
        



        
        <div class="pull-left">









    
    
        <div data-widget-def="eCommerceCartIndicatorWidget" data-widget-id="4a9f7c04-a273-4a25-91fb-8e7bd9970288" class="cart-indicator__wrapper">
        



        
        















<div class="eCommerceCartIndicatorWidget">
    
        
        
            
        
    
</div>

        </div>
    

</div><div class="pull-right">









    
    
        <div data-widget-def="literatumNavigationLoginBar" data-widget-id="d384ca92-7137-45d6-b3c2-78c9c0a98c2b" class="login-bar-container">
        



        
        




    








    
    
        




    









    <div class="loginBar login-open">
        <a href="/action/showLogin?role=button&amp;uri=%2Fdoi%2F10.1002%2Fajmg.a.63132&amp;aria-label=Log+in+or+Register" class="show-login" role="button" uri="/doi/10.1002/ajmg.a.63132" aria-label="Log in or Register">
            <span class="icon-profile_empty"></span>
            <span class="sign-in-label">Login / Register</span>
        </a>
            
    </div>


    



        </div>
    

</div>

        </div>
    

</div>
</div></div></div>
    </div>
</header>


        </div>
    











    
    
        <div data-widget-def="pageBody" data-widget-id="72100436-7a82-49fc-933b-c6c9d8c42914" class="pageBody article-page-tablet body-text">
        



        
        <main id="main-content" tabindex="-1">
    <!--begin pagefulltext-->
    <div class="page-body pagefulltext">
        <div data-pb-dropzone="main">
        



        
        <div>









    
    
        <div data-widget-def="literatumAd" data-widget-id="0220a30b-90c0-4b51-8637-141edf12f86a" class="banner-wrapper">
        



        
        



    
        <div class="pb-ad">
            <aside role="complementary">
		<div id="advert-leaderboard" class="advert advert-leaderboard">
			<script>
				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-leaderboard' );
				});
			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1013&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D728x90%26amp%3Btile%3D1%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fajmg.a.63132&pubId=80516423&placeholderId=1015&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=728x90&amp;tile=1&amp;c=$random">
				</a>
			</noscript>
		</div>
	</aside>
        </div>
        
    

    

    



        </div>
    





        
        <style type="text/css">li.menu-item[data-menu-label="Accepted Articles"] {
  display: none;
}</style>










    
    
        <section data-widget-def="ux3-layout-widget" data-widget-id="9e8ee65a-2e18-4c00-9474-5ac10e16ecfe" class="journal-page-header card">
        



        
        <div class="container"><div class="row"><div class="journal-info-container col-md-8"><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div><div class="hidden-xs hidden-sm hidden-md col-md-4"><div class="pb-dropzone" data-pb-dropzone="col-1" title="col-1"></div></div></div></div>

        </section>
    











    
    
        <div data-widget-def="menuWidget" data-widget-id="998218b4-f988-4a0c-8c4f-b2d3875e1770" class="scrollThenFix stickybar pages-nav hidden-xs hidden-sm hidden-md">
        



        
        <div class="stickybar__wrapper"><div class="main-nav"><a href="#undefined" data-toggle="nav" title="menu drawer"><i aria-hidden="true" class="icon-menu2"></i><i aria-hidden="true" class="icon-close_thin"></i></a><nav role="navigation" data-ctrl-res="never" aria-label="Journal navigation" class="drawer__nav container gutterless hidden-sm hidden-xs"><h2 class="is-accessible">Navigation Bar</h2><section><h3 class="is-accessible">Menu</h3><a href="/" class="menu-header hidden-md hidden-lg">Home</a><ul id="menubar" role="menubar" class="menubar rlist--inline"><li id="menu-item-undefined-0" role="presentation" data-menu-label="Home" class="menu-item"><a href="/journal/15524833" role="menuitem" tabindex="0" class="sub-menu-item"><span>Home</span></a></li><li id="menu-item-undefined-1" role="presentation" data-menu-label="About" class="dropdown menu-parent"><a href="#" data-target="About-1-dropdown" id="About-1" data-toggle="dropdown" role="menuitem" aria-haspopup="true" aria-expanded="false" tabindex="-1" class="dropdown__toggle"><span>About</span><i aria-hidden="true" class="icon-arrow_r pull-right hidden-md hidden-lg"></i><i aria-hidden="true" class="icon-section_arrow_d pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="About-1" role="menu" id="About-1-dropdown" class="rlist dropdown__menu"><li role="presentation" data-menu-label="Overview" class="menu-item"><a href="/page/journal/15524833/homepage/productinformation.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Overview</span></a></li><li role="presentation" data-menu-label="Contact" class="menu-item"><a href="/page/journal/15524833/homepage/contact.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Contact</span></a></li><li role="presentation" data-menu-label="Editorial Board" class="menu-item"><a href="/page/journal/15524833/homepage/editorialboard.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Editorial Board</span></a></li><li role="presentation" data-menu-label="OA Advantages" class="menu-item"><a href="/page/journal/15524833/homepage/oa-advantages" role="menuitem" tabindex="-1" class="sub-menu-item"><span>OA Advantages</span></a></li><li role="presentation" data-menu-label="Advertise" class="menu-item"><a href="/page/journal/15524833/homepage/advertise.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Advertise</span></a></li><li role="presentation" data-menu-label="Permissions" class="menu-item"><a href="/page/journal/15524833/homepage/permissions.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Permissions</span></a></li></ul></li><li id="menu-item-undefined-2" role="presentation" data-menu-label="Contribute" class="dropdown menu-parent"><a href="#" data-target="Contribute-2-dropdown" id="Contribute-2" data-toggle="dropdown" role="menuitem" aria-haspopup="true" aria-expanded="false" tabindex="-1" class="dropdown__toggle"><span>Contribute</span><i aria-hidden="true" class="icon-arrow_r pull-right hidden-md hidden-lg"></i><i aria-hidden="true" class="icon-section_arrow_d pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="Contribute-2" role="menu" id="Contribute-2-dropdown" class="rlist dropdown__menu"><li role="presentation" data-menu-label="Author Guidelines" class="menu-item"><a href="/page/journal/15524833/homepage/forauthors.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Author Guidelines</span></a></li><li role="presentation" data-menu-label="Open Access" class="menu-item"><a href="/page/journal/15524833/homepage/nihcompliance.htm" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Open Access</span></a></li><li role="presentation" data-menu-label="Submit a Manuscript" class="menu-item"><a href="/page/journal/15524833/homepage/forauthors.html?" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Submit a Manuscript</span></a></li><li role="presentation" data-menu-label="For Referees" class="menu-item"><a href="/page/journal/15524833/homepage/forreferees.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>For Referees</span></a></li></ul></li><li id="menu-item-undefined-3" role="presentation" data-menu-label="Browse" class="dropdown menu-parent"><a href="#" data-target="Browse-3-dropdown" id="Browse-3" data-toggle="dropdown" role="menuitem" aria-haspopup="true" aria-expanded="false" tabindex="-1" class="dropdown__toggle"><span>Browse</span><i aria-hidden="true" class="icon-arrow_r pull-right hidden-md hidden-lg"></i><i aria-hidden="true" class="icon-section_arrow_d pull-right hidden-sm hidden-xs"></i></a><ul aria-labelledby="Browse-3" role="menu" id="Browse-3-dropdown" class="rlist dropdown__menu"><li role="presentation" data-menu-label="Accepted Articles" class="menu-item"><a href="/toc/15524833/0/ja" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Accepted Articles</span></a></li><li role="presentation" data-menu-label="Early View" class="menu-item"><a href="/toc/15524833/0/0" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Early View</span></a></li><li role="presentation" data-menu-label="Current Issue" class="menu-item"><a href="/toc/15524833/current" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Current Issue</span></a></li><li role="presentation" data-menu-label="All Issues" class="menu-item"><a href="/loi/15524833" role="menuitem" tabindex="-1" class="sub-menu-item"><span>All Issues</span></a></li><li role="presentation" data-menu-label="Cover Gallery" class="menu-item"><a href="/index/15524833?ContentItemCategory=COVER%20IMAGE" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Cover Gallery</span></a></li><li role="presentation" data-menu-label="Most Accessed" class="menu-item"><a href="/page/journal/15524833/homepage/mostaccessed.html" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Most Accessed</span></a></li><li role="presentation" data-menu-label="Virtual Issues" class="menu-item"><a href="/topic/vi-categories-15524833/virtual-issues/15524833" role="menuitem" tabindex="-1" class="sub-menu-item"><span>Virtual Issues</span></a></li></ul></li></ul></section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="30bbd914-6ff8-451e-849a-401c3cc8a85a" class="social-links">
        



        
        <div class="social-media">
  <h2 class="side-section-header hiddenLabel--lg hiddenLabel--md">Follow journal</h2>
  <ul class="rlist--inline">
    <li><a title="Alert" href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=15524833" id="alert-link"><i class="icon-alert"></i><span class="label hiddenLabel--lg hiddenLabel--md">Alert</span></a></li>
    <li><a title="Twitter channel" href="#" id="twitter-link"><i class="icon-twitter-round"></i><span class="label hiddenLabel--lg">Twitter channel</span></a></li>
    <li><a title="Facebook page" href="#" id="facebook-link"><i class="icon-facebook-round"></i><span class="label hiddenLabel--lg">Facebook page</span></a></li>
    <li><a title="RSS channel" href="#" id="rss-link"><i class="icon-icon-Rss"></i><span class="label hiddenLabel--lg hiddenLabel--md">RSS channel</span></a></li>
  </ul>
</div>

        </div>
    

</nav></div></div><div class="header__dropzone"></div>

        </div>
    

</div>










    
    
        <section data-widget-def="ux3-layout-widget" data-widget-id="0f7bccba-8328-4dbd-a1fa-e84c526dd9ab">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">



        
        <div>



        
        <article data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fajmg.a.63132&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fajmg.a.v191.5%3Bjournal%3Ajournal%3A10968628%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3BrequestedJournal%3Ajournal%3A15524833%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fajmg.a.63132%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2" data-related="/action/ajaxShowRecommended?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fajmg.a.63132&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fajmg.a.v191.5%3Bjournal%3Ajournal%3A10968628%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3BrequestedJournal%3Ajournal%3A15524833%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fajmg.a.63132%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata&amp;downloadCountPopupHtml=%3Cp%3E%3Csmall%3EUsage+represents+full+text+views+on+Wiley+Online+Library+since+January+4%3Csup%3Eth%3C%2Fsup%3E+2022.%3C%2Fsmall%3E%3C%2Fp%3E%3Cp%3E%3Csmall%3EFor+articles+published+or+journals+transferred+to+Wiley+%3Cstrong%3Eafter%3C%2Fstrong%3E+this+date%2C+usage+represents+views+since+the+article%2Fchapter+was+first+published+on+Wiley+Online+Library.%3C%2Fsmall%3E%3C%2Fp%3E" data-details="/action/ajaxShowPubInfo?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1002%2Fajmg.a.63132&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fajmg.a.v191.5%3Bjournal%3Ajournal%3A10968628%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3BrequestedJournal%3Ajournal%3A15524833%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fajmg.a.63132%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata&amp;downloadCountPopupHtml=%3Cp%3E%3Csmall%3EUsage+represents+full+text+views+on+Wiley+Online+Library+since+January+4%3Csup%3Eth%3C%2Fsup%3E+2022.%3C%2Fsmall%3E%3C%2Fp%3E%3Cp%3E%3Csmall%3EFor+articles+published+or+journals+transferred+to+Wiley+%3Cstrong%3Eafter%3C%2Fstrong%3E+this+date%2C+usage+represents+views+since+the+article%2Fchapter+was+first+published+on+Wiley+Online+Library.%3C%2Fsmall%3E%3C%2Fp%3E" data-mathjax="https://cdnjs.cloudflare.com/ajax/libs/mathjax/3.2.0/es5/tex-mml-chtml.min.js?config=TeX-MML-CHTML" data-getFTR-enabled="data-getFTR-enabled" data-getFTR-url="/references/links/10.1002/ajmg.a.63132?linkSource=FULL_TEXT" data-getFTR-count='10' class="heelo"><div class="row article-row"><div id="article__content" tabindex="-1" class="col-sm-12 col-md-8 col-lg-8 article__content article-row-left"><div data-pb-dropzone="mrwBannerDropZone" class="mrw-banner-dropzone">



        
        
</div><div class="article-citation"><div class="citation">
   <div class="pb-dropzone" data-pb-dropzone="publicaitonContent-series-title"><div id="journal-banner-text" class="journal-banner-text"><a href="/journal/15524833" title="American Journal of Medical Genetics Part A homepage">American Journal of Medical Genetics Part A</a></div><a href="/toc/15524833/2023/191/5" class="volume-issue">Volume 191, Issue 5</a><span class="citation__page-range"> p. 1164-1209</span><a href="/journal/15524833" title="American Journal of Medical Genetics Part A homepage" class="citation--logo"><img id="journal-banner-image" test="test-value" alt="American Journal of Medical Genetics Part A" src="/pb-assets/journal-banners/15524833-1501384744747.jpg" class="journal-banner-image"></a><script>var image = new Image();

image.onerror = function() {
  // if the image does not exist
  //document.getElementById("journal-banner-text").style.marginBottom = "15px";
  document.getElementById("journal-banner-text").style.fontSize = "22px";
  document.getElementById("journal-banner-image").style.display = "none";
}

image.src = "/pb-assets/journal-banners/15524833-1501384744747.jpg";</script></div>
   <div class="doi-access-container clearfix"><span class="primary-heading"><span class="primary-heading">ORIGINAL ARTICLE</span></span><div class="doi-access-wrapper"><div class="open-access access-type"><i aria-hidden="true" class="icon-icon-lock_open"></i><div class="doi-access">Open Access</div></div></div><div class="doi-access-wrapper"><a target="_blank" class="access-icon-wrapper" aria-label="Creative Commons license information" href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><span aria-hidden="true" class="access-icon icon-cc"></span><span aria-hidden="true" class="access-icon icon-by"></span><span aria-hidden="true" class="access-icon icon-nd"></span><span aria-hidden="true" class="access-icon icon-nc"></span></a></div>
   </div>
   <h1 class="citation__title">Nosology of genetic skeletal disorders: 2023 revision</h1>
   <div class="pb-dropzone" data-pb-dropzone="publicaitonContent-versions"><!-- Empty dropzone --></div>
   <div class="loa comma visible-xs mobile-authors loa-authors-trunc">
      <div class="comma__list"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Unger/Sheila" class="author-name accordion-tabbed__control" data-id="am1" data-db-target-for="am1" aria-controls="am1" aria-haspopup="true" id="am1_Ctrl" role="button"><span>Sheila Unger</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am1" aria-labelledby="am1_Ctrl" role="region" id="am1">
               <p class="author-name">Sheila Unger</p>
               <p>Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Unger/Sheila">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Ferreira/Carlos+R." class="author-name accordion-tabbed__control" data-id="am2" data-db-target-for="am2" aria-controls="am2" aria-haspopup="true" id="am2_Ctrl" role="button"><span>Carlos R. Ferreira</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am2" aria-labelledby="am2_Ctrl" role="region" id="am2">
               <p class="author-name">Carlos R. Ferreira</p>
               <p>Skeletal Genomics Unit, Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Ferreira/Carlos+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Mortier/Geert+R." class="author-name accordion-tabbed__control" data-id="am3" data-db-target-for="am3" aria-controls="am3" aria-haspopup="true" id="am3_Ctrl" role="button"><span>Geert R. Mortier</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am3" aria-labelledby="am3_Ctrl" role="region" id="am3">
               <p class="author-name">Geert R. Mortier</p>
               <p>Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Mortier/Geert+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Ali/Houda" class="author-name accordion-tabbed__control" data-id="am4" data-db-target-for="am4" aria-controls="am4" aria-haspopup="true" id="am4_Ctrl" role="button"><span>Houda Ali</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am4" aria-labelledby="am4_Ctrl" role="region" id="am4">
               <p class="author-name">Houda Ali</p>
               <p>INSERM, US14-Orphanet, Paris, France</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Ali/Houda">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Bertola/D%C3%A9bora+R." class="author-name accordion-tabbed__control" data-id="am5" data-db-target-for="am5" aria-controls="am5" aria-haspopup="true" id="am5_Ctrl" role="button"><span>Débora R. Bertola</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am5" aria-labelledby="am5_Ctrl" role="region" id="am5">
               <p class="author-name">Débora R. Bertola</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-4701-6777"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-4701-6777</span></a></li>
               </ul>
               <p>Unidade de Genética, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil</p>
               <p>Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Bertola/D%C3%A9bora+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Calder/Alistair" class="author-name accordion-tabbed__control" data-id="am6" data-db-target-for="am6" aria-controls="am6" aria-haspopup="true" id="am6_Ctrl" role="button"><span>Alistair Calder</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am6" aria-labelledby="am6_Ctrl" role="region" id="am6">
               <p class="author-name">Alistair Calder</p>
               <p>Radiology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Calder/Alistair">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Cohn/Daniel+H." class="author-name accordion-tabbed__control" data-id="am7" data-db-target-for="am7" aria-controls="am7" aria-haspopup="true" id="am7_Ctrl" role="button"><span>Daniel H. Cohn</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am7" aria-labelledby="am7_Ctrl" role="region" id="am7">
               <p class="author-name">Daniel H. Cohn</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0003-0388-4457"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0003-0388-4457</span></a></li>
               </ul>
               <p>Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, California, USA</p>
               <p>Department of Orthopaedic Surgery, University of California, Los Angeles, Los Angeles, California, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Cohn/Daniel+H.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Cormier%E2%80%90Daire/Valerie" class="author-name accordion-tabbed__control" data-id="am8" data-db-target-for="am8" aria-controls="am8" aria-haspopup="true" id="am8_Ctrl" role="button"><span>Valerie Cormier-Daire</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am8" aria-labelledby="am8_Ctrl" role="region" id="am8">
               <p class="author-name">Valerie Cormier-Daire</p>
               <p>Paris Cité University, Reference Center for Skeletal Dysplasia, INSERM UMR 1163, Imagine Institute, Necker Enfants Malades Hospital (AP-HP), Paris, France</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Cormier%E2%80%90Daire/Valerie">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Girisha/Katta+M." class="author-name accordion-tabbed__control" data-id="am9" data-db-target-for="am9" aria-controls="am9" aria-haspopup="true" id="am9_Ctrl" role="button"><span>Katta M. Girisha</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am9" aria-labelledby="am9_Ctrl" role="region" id="am9">
               <p class="author-name">Katta M. Girisha</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-0139-8239"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-0139-8239</span></a></li>
               </ul>
               <p>Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Girisha/Katta+M.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Hall/Christine" class="author-name accordion-tabbed__control" data-id="am10" data-db-target-for="am10" aria-controls="am10" aria-haspopup="true" id="am10_Ctrl" role="button"><span>Christine Hall</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am10" aria-labelledby="am10_Ctrl" role="region" id="am10">
               <p class="author-name">Christine Hall</p>
               <p>Emerita Consultant Paediatric Radiologist at Great Ormond Street Childrens' Hospital, London, UK</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Hall/Christine">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Krakow/Deborah" class="author-name accordion-tabbed__control" data-id="am11" data-db-target-for="am11" aria-controls="am11" aria-haspopup="true" id="am11_Ctrl" role="button"><span>Deborah Krakow</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am11" aria-labelledby="am11_Ctrl" role="region" id="am11">
               <p class="author-name">Deborah Krakow</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0001-9906-4968"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0001-9906-4968</span></a></li>
               </ul>
               <p>Departments of Obstetrics and Gynecology, Orthopaedic Surgery and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Krakow/Deborah">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Makitie/Outi" class="author-name accordion-tabbed__control" data-id="am12" data-db-target-for="am12" aria-controls="am12" aria-haspopup="true" id="am12_Ctrl" role="button"><span>Outi Makitie</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am12" aria-labelledby="am12_Ctrl" role="region" id="am12">
               <p class="author-name">Outi Makitie</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-4547-001X"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-4547-001X</span></a></li>
               </ul>
               <p>Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</p>
               <p>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Makitie/Outi">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Mundlos/Stefan" class="author-name accordion-tabbed__control" data-id="am13" data-db-target-for="am13" aria-controls="am13" aria-haspopup="true" id="am13_Ctrl" role="button"><span>Stefan Mundlos</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am13" aria-labelledby="am13_Ctrl" role="region" id="am13">
               <p class="author-name">Stefan Mundlos</p>
               <p>Institut für medizinische Genetik und Humangenetik, Charité - Universitätsmedizin Berlin, Berlin, Germany</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Mundlos/Stefan">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Nishimura/Gen" class="author-name accordion-tabbed__control" data-id="am14" data-db-target-for="am14" aria-controls="am14" aria-haspopup="true" id="am14_Ctrl" role="button"><span>Gen Nishimura</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am14" aria-labelledby="am14_Ctrl" role="region" id="am14">
               <p class="author-name">Gen Nishimura</p>
               <p>Department of Radiology, Musashino-Yowakai Hospital, Tokyo, Japan</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Nishimura/Gen">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Robertson/Stephen+P." class="author-name accordion-tabbed__control" data-id="am15" data-db-target-for="am15" aria-controls="am15" aria-haspopup="true" id="am15_Ctrl" role="button"><span>Stephen P. Robertson</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am15" aria-labelledby="am15_Ctrl" role="region" id="am15">
               <p class="author-name">Stephen P. Robertson</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-5181-7809"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-5181-7809</span></a></li>
               </ul>
               <p>Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Robertson/Stephen+P.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Savarirayan/Ravi" class="author-name accordion-tabbed__control" data-id="am16" data-db-target-for="am16" aria-controls="am16" aria-haspopup="true" id="am16_Ctrl" role="button"><span>Ravi Savarirayan</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am16" aria-labelledby="am16_Ctrl" role="region" id="am16">
               <p class="author-name">Ravi Savarirayan</p>
               <p>Murdoch Children's Research Institute and University of Melbourne, Parkville, Victoria, Australia</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Savarirayan/Ravi">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Sillence/David" class="author-name accordion-tabbed__control" data-id="am17" data-db-target-for="am17" aria-controls="am17" aria-haspopup="true" id="am17_Ctrl" role="button"><span>David Sillence</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am17" aria-labelledby="am17_Ctrl" role="region" id="am17">
               <p class="author-name">David Sillence</p>
               <p>Specialities of Genomic Medicine and Paediatrics and Adolescent Health, Sydney University Clinical School, Children's Hospital, Westmead, NSW, Australia</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Sillence/David">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Simon/Marleen" class="author-name accordion-tabbed__control" data-id="am18" data-db-target-for="am18" aria-controls="am18" aria-haspopup="true" id="am18_Ctrl" role="button"><span>Marleen Simon</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am18" aria-labelledby="am18_Ctrl" role="region" id="am18">
               <p class="author-name">Marleen Simon</p>
               <p>Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Simon/Marleen">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Sutton/V.+Reid" class="author-name accordion-tabbed__control" data-id="am19" data-db-target-for="am19" aria-controls="am19" aria-haspopup="true" id="am19_Ctrl" role="button"><span>V. Reid Sutton</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am19" aria-labelledby="am19_Ctrl" role="region" id="am19">
               <p class="author-name">V. Reid Sutton</p>
               <p>Department of Molecular & Human Genetics, Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Sutton/V.+Reid">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Warman/Matthew+L." class="author-name accordion-tabbed__control" data-id="am20" data-db-target-for="am20" aria-controls="am20" aria-haspopup="true" id="am20_Ctrl" role="button"><span>Matthew L. Warman</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am20" aria-labelledby="am20_Ctrl" role="region" id="am20">
               <p class="author-name">Matthew L. Warman</p>
               <p>Department of Orthopedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA</p>
               <p>Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Warman/Matthew+L.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Superti%E2%80%90Furga/Andrea" class="author-name accordion-tabbed__control" data-id="am21" data-db-target-for="am21" aria-controls="am21" aria-haspopup="true" id="am21_Ctrl" role="button"><span>Andrea Superti-Furga<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="am21" aria-labelledby="am21_Ctrl" role="region" id="am21">
               <p class="author-type mb-1">Corresponding Author</p>
               <p class="author-name">Andrea Superti-Furga</p>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="/cdn-cgi/l/email-protection#e18092949184939588a1948f888dcf8289"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span><span class="__cf_email__" data-cfemail="17766462677265637e5762797e7b39747f">[email&#160;protected]</span></span></a></li>
               </ul>
               <ul class="rlist sm-account">
                  <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-3543-7531"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-3543-7531</span></a></li>
               </ul>
               <p>Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland</p>
               <p><b>Correspondence</b></p>
               <p>Andrea Superti-Furga, Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.</p>
               <p>Email: <a class="corr-email" title="Link to email address" href="/cdn-cgi/l/email-protection#71100204011403051831041f181d5f1219"><span><span class="__cf_email__" data-cfemail="c0a1b3b5b0a5b2b4a980b5aea9aceea3a8">[email&#160;protected]</span></span></a></p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Superti%E2%80%90Furga/Andrea">Search for more papers by this author</a></div></span></div>
   </div>
   <div class="loa-wrapper loa-authors hidden-xs desktop-authors">
      <div id="sb-1" class="accordion">
         <div class="comma__list">
            <div class="accordion-tabbed"><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Unger/Sheila" class="author-name accordion-tabbed__control" data-id="a1" data-db-target-for="a1" aria-controls="a1" aria-haspopup="true" id="a1_Ctrl" role="button"><span>Sheila Unger</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a1" aria-labelledby="a1_Ctrl" role="region" id="a1">
                     <p class="author-name">Sheila Unger</p>
                     <p>Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Unger/Sheila">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Ferreira/Carlos+R." class="author-name accordion-tabbed__control" data-id="a2" data-db-target-for="a2" aria-controls="a2" aria-haspopup="true" id="a2_Ctrl" role="button"><span>Carlos R. Ferreira</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a2" aria-labelledby="a2_Ctrl" role="region" id="a2">
                     <p class="author-name">Carlos R. Ferreira</p>
                     <p>Skeletal Genomics Unit, Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Ferreira/Carlos+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Mortier/Geert+R." class="author-name accordion-tabbed__control" data-id="a3" data-db-target-for="a3" aria-controls="a3" aria-haspopup="true" id="a3_Ctrl" role="button"><span>Geert R. Mortier</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a3" aria-labelledby="a3_Ctrl" role="region" id="a3">
                     <p class="author-name">Geert R. Mortier</p>
                     <p>Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Mortier/Geert+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Ali/Houda" class="author-name accordion-tabbed__control" data-id="a4" data-db-target-for="a4" aria-controls="a4" aria-haspopup="true" id="a4_Ctrl" role="button"><span>Houda Ali</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a4" aria-labelledby="a4_Ctrl" role="region" id="a4">
                     <p class="author-name">Houda Ali</p>
                     <p>INSERM, US14-Orphanet, Paris, France</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Ali/Houda">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Bertola/D%C3%A9bora+R." class="author-name accordion-tabbed__control" data-id="a5" data-db-target-for="a5" aria-controls="a5" aria-haspopup="true" id="a5_Ctrl" role="button"><span>Débora R. Bertola</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a5" aria-labelledby="a5_Ctrl" role="region" id="a5">
                     <p class="author-name">Débora R. Bertola</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-4701-6777"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-4701-6777</span></a></li>
                     </ul>
                     <p>Unidade de Genética, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil</p>
                     <p>Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Bertola/D%C3%A9bora+R.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Calder/Alistair" class="author-name accordion-tabbed__control" data-id="a6" data-db-target-for="a6" aria-controls="a6" aria-haspopup="true" id="a6_Ctrl" role="button"><span>Alistair Calder</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a6" aria-labelledby="a6_Ctrl" role="region" id="a6">
                     <p class="author-name">Alistair Calder</p>
                     <p>Radiology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, UK</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Calder/Alistair">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Cohn/Daniel+H." class="author-name accordion-tabbed__control" data-id="a7" data-db-target-for="a7" aria-controls="a7" aria-haspopup="true" id="a7_Ctrl" role="button"><span>Daniel H. Cohn</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a7" aria-labelledby="a7_Ctrl" role="region" id="a7">
                     <p class="author-name">Daniel H. Cohn</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0003-0388-4457"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0003-0388-4457</span></a></li>
                     </ul>
                     <p>Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, California, USA</p>
                     <p>Department of Orthopaedic Surgery, University of California, Los Angeles, Los Angeles, California, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Cohn/Daniel+H.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Cormier%E2%80%90Daire/Valerie" class="author-name accordion-tabbed__control" data-id="a8" data-db-target-for="a8" aria-controls="a8" aria-haspopup="true" id="a8_Ctrl" role="button"><span>Valerie Cormier-Daire</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a8" aria-labelledby="a8_Ctrl" role="region" id="a8">
                     <p class="author-name">Valerie Cormier-Daire</p>
                     <p>Paris Cité University, Reference Center for Skeletal Dysplasia, INSERM UMR 1163, Imagine Institute, Necker Enfants Malades Hospital (AP-HP), Paris, France</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Cormier%E2%80%90Daire/Valerie">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Girisha/Katta+M." class="author-name accordion-tabbed__control" data-id="a9" data-db-target-for="a9" aria-controls="a9" aria-haspopup="true" id="a9_Ctrl" role="button"><span>Katta M. Girisha</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a9" aria-labelledby="a9_Ctrl" role="region" id="a9">
                     <p class="author-name">Katta M. Girisha</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-0139-8239"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-0139-8239</span></a></li>
                     </ul>
                     <p>Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Girisha/Katta+M.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Hall/Christine" class="author-name accordion-tabbed__control" data-id="a10" data-db-target-for="a10" aria-controls="a10" aria-haspopup="true" id="a10_Ctrl" role="button"><span>Christine Hall</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a10" aria-labelledby="a10_Ctrl" role="region" id="a10">
                     <p class="author-name">Christine Hall</p>
                     <p>Emerita Consultant Paediatric Radiologist at Great Ormond Street Childrens' Hospital, London, UK</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Hall/Christine">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Krakow/Deborah" class="author-name accordion-tabbed__control" data-id="a11" data-db-target-for="a11" aria-controls="a11" aria-haspopup="true" id="a11_Ctrl" role="button"><span>Deborah Krakow</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a11" aria-labelledby="a11_Ctrl" role="region" id="a11">
                     <p class="author-name">Deborah Krakow</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0001-9906-4968"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0001-9906-4968</span></a></li>
                     </ul>
                     <p>Departments of Obstetrics and Gynecology, Orthopaedic Surgery and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Krakow/Deborah">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Makitie/Outi" class="author-name accordion-tabbed__control" data-id="a12" data-db-target-for="a12" aria-controls="a12" aria-haspopup="true" id="a12_Ctrl" role="button"><span>Outi Makitie</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a12" aria-labelledby="a12_Ctrl" role="region" id="a12">
                     <p class="author-name">Outi Makitie</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-4547-001X"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-4547-001X</span></a></li>
                     </ul>
                     <p>Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland</p>
                     <p>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Makitie/Outi">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Mundlos/Stefan" class="author-name accordion-tabbed__control" data-id="a13" data-db-target-for="a13" aria-controls="a13" aria-haspopup="true" id="a13_Ctrl" role="button"><span>Stefan Mundlos</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a13" aria-labelledby="a13_Ctrl" role="region" id="a13">
                     <p class="author-name">Stefan Mundlos</p>
                     <p>Institut für medizinische Genetik und Humangenetik, Charité - Universitätsmedizin Berlin, Berlin, Germany</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Mundlos/Stefan">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Nishimura/Gen" class="author-name accordion-tabbed__control" data-id="a14" data-db-target-for="a14" aria-controls="a14" aria-haspopup="true" id="a14_Ctrl" role="button"><span>Gen Nishimura</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a14" aria-labelledby="a14_Ctrl" role="region" id="a14">
                     <p class="author-name">Gen Nishimura</p>
                     <p>Department of Radiology, Musashino-Yowakai Hospital, Tokyo, Japan</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Nishimura/Gen">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Robertson/Stephen+P." class="author-name accordion-tabbed__control" data-id="a15" data-db-target-for="a15" aria-controls="a15" aria-haspopup="true" id="a15_Ctrl" role="button"><span>Stephen P. Robertson</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a15" aria-labelledby="a15_Ctrl" role="region" id="a15">
                     <p class="author-name">Stephen P. Robertson</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-5181-7809"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-5181-7809</span></a></li>
                     </ul>
                     <p>Department of Women's and Children's Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Robertson/Stephen+P.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Savarirayan/Ravi" class="author-name accordion-tabbed__control" data-id="a16" data-db-target-for="a16" aria-controls="a16" aria-haspopup="true" id="a16_Ctrl" role="button"><span>Ravi Savarirayan</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a16" aria-labelledby="a16_Ctrl" role="region" id="a16">
                     <p class="author-name">Ravi Savarirayan</p>
                     <p>Murdoch Children's Research Institute and University of Melbourne, Parkville, Victoria, Australia</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Savarirayan/Ravi">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Sillence/David" class="author-name accordion-tabbed__control" data-id="a17" data-db-target-for="a17" aria-controls="a17" aria-haspopup="true" id="a17_Ctrl" role="button"><span>David Sillence</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a17" aria-labelledby="a17_Ctrl" role="region" id="a17">
                     <p class="author-name">David Sillence</p>
                     <p>Specialities of Genomic Medicine and Paediatrics and Adolescent Health, Sydney University Clinical School, Children's Hospital, Westmead, NSW, Australia</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Sillence/David">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Simon/Marleen" class="author-name accordion-tabbed__control" data-id="a18" data-db-target-for="a18" aria-controls="a18" aria-haspopup="true" id="a18_Ctrl" role="button"><span>Marleen Simon</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a18" aria-labelledby="a18_Ctrl" role="region" id="a18">
                     <p class="author-name">Marleen Simon</p>
                     <p>Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Simon/Marleen">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Sutton/V.+Reid" class="author-name accordion-tabbed__control" data-id="a19" data-db-target-for="a19" aria-controls="a19" aria-haspopup="true" id="a19_Ctrl" role="button"><span>V. Reid Sutton</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a19" aria-labelledby="a19_Ctrl" role="region" id="a19">
                     <p class="author-name">V. Reid Sutton</p>
                     <p>Department of Molecular & Human Genetics, Baylor College of Medicine & Texas Children's Hospital, Houston, Texas, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Sutton/V.+Reid">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Warman/Matthew+L." class="author-name accordion-tabbed__control" data-id="a20" data-db-target-for="a20" aria-controls="a20" aria-haspopup="true" id="a20_Ctrl" role="button"><span>Matthew L. Warman</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a20" aria-labelledby="a20_Ctrl" role="region" id="a20">
                     <p class="author-name">Matthew L. Warman</p>
                     <p>Department of Orthopedic Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA</p>
                     <p>Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA</p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Warman/Matthew+L.">Search for more papers by this author</a></div></span><span class="accordion-tabbed__tab-mobile  accordion__closed"><a href="/authored-by/ContribAuthorRaw/Superti%E2%80%90Furga/Andrea" class="author-name accordion-tabbed__control" data-id="a21" data-db-target-for="a21" aria-controls="a21" aria-haspopup="true" id="a21_Ctrl" role="button"><span>Andrea Superti-Furga<i aria-hidden="true" class="icon-mail_outline"></i></span><i aria-hidden="true" class="icon-section_arrow_d"></i></a><span class="comma-separator">,&nbsp;</span><div class="author-info accordion-tabbed__content" data-db-target-of="a21" aria-labelledby="a21_Ctrl" role="region" id="a21">
                     <p class="author-type mb-1">Corresponding Author</p>
                     <p class="author-name">Andrea Superti-Furga</p>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a class="sm-account__link" title="Link to email address" href="/cdn-cgi/l/email-protection#79180a0c091c0b0d10390c171015571a11"><i aria-hidden="true" class="icon-ic_mail_solid"></i><span><span class="__cf_email__" data-cfemail="accddfd9dcc9ded8c5ecd9c2c5c082cfc4">[email&#160;protected]</span></span></a></li>
                     </ul>
                     <ul class="rlist sm-account">
                        <li class="sm-account__item"><a target="_blank" class="sm-account__link" href="https://orcid.org/0000-0002-3543-7531"><i aria-hidden="true" class="icon-orcid"></i><span>orcid.org/0000-0002-3543-7531</span></a></li>
                     </ul>
                     <p>Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland</p>
                     <p><b>Correspondence</b></p>
                     <p>Andrea Superti-Furga, Division of Genetic Medicine, Lausanne University Hospital, Lausanne, Switzerland.</p>
                     <p>Email: <a class="corr-email" title="Link to email address" href="/cdn-cgi/l/email-protection#4f2e3c3a3f2a3d3b260f3a212623612c27"><span><span class="__cf_email__" data-cfemail="65041610150017110c25100b0c094b060d">[email&#160;protected]</span></span></a></p><a class="moreInfoLink" href="/authored-by/ContribAuthorRaw/Superti%E2%80%90Furga/Andrea">Search for more papers by this author</a></div></span></div>
         </div>
      </div>
   </div>
   <div class="epub-sections"><div class="epub-section"><span class="epub-state">First published: </span><span class="epub-date">13 February 2023</span></div>
      <div class="epub-section"><a class="epub-doi" aria-label="Digital Object Identifier" href="https://doi.org/10.1002/ajmg.a.63132">https://doi.org/10.1002/ajmg.a.63132</a></div><div class="epub-section cited-by-count"><span>Citations: <a href="#citedby-section">2</a></span></div></div>
   <div class="epub-sections">
      <div class="article-header__references-container no-truncate" id="ajmga63132-note-0001" tabindex="0">
         <div class="header-note-content">
            <p>Equal contributions from Sheila Unger and Carlos R. Ferreira.</p>
         </div>
      </div>
   </div>
</div></div><div class="fixedCoolBar"><nav aria-label="Article navigation and tools" class="coolBar stickybar"><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><div class="coolBar__section"><a href="javascript:void(0)" data-db-target-for="article" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="article_Pop" role="button" id="article_Ctrl" class="coolBar__ctrl hidden-lg"><i class="icon-abstract"></i><span>About</span></a><div data-db-target-of="article" aria-labelledby="article_Ctrl" id="article_Pop" class="coolBar__drop fixed rlist dropBlock__holder"><div data-target=".article-row-right .tab__nav, .coolBar--download" data-remove="false" data-targetClass="hidden-xs hidden-sm" data-toggle="transplant" data-direction="from" data-transplant="self" class="transplant showit"></div></div></div><div class="coolBar__section coolBar--sections"><a id="sections_Ctrl" href="javascript:void(0)" data-db-target-for="sections" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="sections_Pop" role="button" class="coolBar__ctrl"><i class="icon-list-unordered"></i><span>Sections</span></a><div data-db-target-of="sections" aria-labelledby="sections_Ctrl" id="sections_Pop" class="coolBar__drop dropBlock__holder rlist fixed"></div></div></div><div class="coolBar__second rlist"><div class="coolBar__section coolBar--download PdfLink"><a href="/doi/epdf/10.1002/ajmg.a.63132" title="ePDF" class="coolBar__ctrl pdf-download"><img src="/specs/products/acropolis/pericles/releasedAssets/images/pdf-icon-169a2eb30e52100e76dfa5f4b66998e6.png" alt="PDF"/>PDF</a></div>



        
        <div class="relative"><a href="#" data-db-target-for="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" role="button" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" aria-label="Tools" class="article-tools__ctrl"><i aria-hidden="true" class="icon-Icon_Tools"></i><span>Tools</span></a><div data-db-target-of="0e406ce9-5c43-4e2d-b741-e0b43d1f1865" aria-labelledby="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl" id="0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop" class="article-tools__block fixed dropBlock__holder"><ul role="menu" class="rlist w-slide--list"><li role="presentation" class="article-tool"><a href="https://onlinelibrary.wiley.com/action/rightsLink?doi=10.1002%2Fajmg.a.63132&amp;mode=" role="menuitem" target="_blank"><i aria-hidden="true" class="icon-permissions-key"></i><span>Request permission</span></a></li><li role="presentation" class="article-tool"><a href="/action/showCitFormats?doi=10.1002%2Fajmg.a.63132" role="menuitem" target="_self"><i aria-hidden="true" class="icon-export-icon"></i><span>Export citation</span></a></li><li role="presentation" class="article-tool"><a href="/personalize/addFavoritePublication?doi=10.1002%2Fajmg.a.63132" role="menuitem" target="_self"><i aria-hidden="true" class="icon-favorites"></i><span>Add to favorites</span></a></li><li role="presentation" class="article-tool"><a href="/action/addCitationAlert?doi=10.1002%2Fajmg.a.63132" role="menuitem" target="_self"><i aria-hidden="true" class="icon-Icon_Track-citations"></i><span>Track citation</span></a></li></ul></div></div>




        
        <!-- Go to www.addthis.com/dashboard to customize your tools --><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" defer="defer" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-51225be51b56b4c4"></script><div class="relative"><a id="share-access__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" aria-label="Share" class="share-access__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><a id="share__ctrl" href="#" data-db-target-for="dff42abe-4b17-4fe9-a9c5-625405cd1007" data-db-switch="icon-close_thin" aria-haspopup="true" aria-controls="share_Pop" role="button" class="share__ctrl hidden"><i aria-hidden="true" class="icon-Icon_Share"></i><span>Share</span></a><div data-db-target-of="dff42abe-4b17-4fe9-a9c5-625405cd1007" aria-labelledby="share-access__ctrl" id="share_Pop" class="share__block dropBlock__holder fixed">



        
        <div data-share-access="/action/authorizeSharing?doi=10.1002/ajmg.a.63132&amp;shareType=P2P&amp;format=PDF" class="share-access hidden"><p>Give access</p><a href="#" data-toggle="modal" data-target="#shareAccess" class="share-access__link"><i class="icon-users"></i>Share full text access</a></div><div class="ux-modal-container share-access__modal"><div id="shareAccess" class="modal"><div class="modal__dialog"><div class="modal__header"><button type="button" data-dismiss="modal" class="close"><i aria-hidden="true" class="icon-close_thin"></i></button><p>Share full-text access</p></div><div class="modal__body"><form method="post"><fieldset><legend>Please review our <a href="https://onlinelibrary.wiley.com/termsAndConditions" target="_blank">Terms and Conditions of Use</a> and check box below to share full-text version of article.</legend><div class="input-group"><label for="terms-and-conditions" class="checkbox--primary"><input id="terms-and-conditions" type="checkbox" value="yes" required="" name="terms-and-conditions" data-ajax-link="/action/generateShareUrl?doi=10.1002/ajmg.a.63132&amp;shareType=P2P&amp;format=PDF" data-shareable-link=""/><span class="label-txt">I have read and accept the Wiley Online Library Terms and Conditions of Use</span></label></div></fieldset><hr class="separator"/><div class="shareable"><label>Shareable Link</label><p>Use the link below to share a full-text version of this article with your friends and colleagues. <a href="https://onlinelibrary.wiley.com/researchers/tools-resources/sharing" target="_blank" class="emphasis">Learn more.</a></p><div class="shareable__box"><div class="shareable__text"><div class="shareable__field"><span id="shareable__text"></span><textarea tabindex="-1" class="shareable__text-area"></textarea></div></div><button type="submit" disabled="" class="btn shareable__btn">Copy URL</button></div><div class="error shareable__error hidden"></div></div></form></div></div></div></div>
</div></div>
</div></div></nav></div><div id="accessDenialslot" class="accessDenialslot"></div><div class="article__body "><article>
   
   <div class="abstract-group ">
      <section class="article-section article-section__abstract" lang="en" data-lang="en" id="section-1-en">
         <h2 id="d7369478" class="article-section__header section__title main abstractlang_en main">Abstract</h2>
         <div class="article-section__content en main">
            
            <p>The “Nosology of genetic skeletal disorders” has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new disorders thanks to advances in DNA sequencing technology. The most significant change as compared to previous versions is the adoption of the dyadic naming system, systematically associating a phenotypic entity with the gene it arises from. We consider this a significant step forward as dyadic naming is more informative and less prone to errors than the traditional use of list numberings and eponyms. Despite the adoption of dyadic naming, efforts have been made to maintain strong ties to the MIM catalog and its historical data. As with the previous versions, the list of disorders and genes in the Nosology may be useful in considering the differential diagnosis in the clinic, directing bioinformatic analysis of next-generation sequencing results, and providing a basis for novel advances in biology and medicine.</p>
            </div>
      </section>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="below-abstract-group"><!-- Empty dropzone --></div>
   
   <section class="article-section article-section__full">
      <section class="article-section__content" id="ajmga63132-sec-0001">
         
         <p>When the first “Nosology” was compiled and published in 1970, few would have predicted that it would gain such an important role in genetics clinics and research to motivate an 11th revision 52 years later&nbsp;(Table&nbsp;<a class="tableLink scrollableLink" title="Link to table" href="#ajmga63132-tbl-0001">1</a>). Yet, the reasons that stimulated the first Nosology are the same that uphold the present new revision: coping with the wealth of novel information on the growing number and variety of skeletal phenotypes with a genetic basis and trying to assure a common naming system to facilitate diagnosis and communication.</p>
         
         <div class="article-table-content" id="ajmga63132-tbl-0001">
            
            
            
            
            <header class="article-table-caption"><span class="table-caption__label">TABLE 1.
                </span>The nosology of genetic skeletal disorders: 2023 revision.</header>
            
            
            
            <div class="article-table-content-wrapper">
               <table class="table article-section__table">
                  
                  
                  
                  
                  
                  
                  
                  <thead>
                     
                     <tr>
                        
                        <th class="bottom-bordered-cell right-bordered-cell left-aligned">Group number/number of disorder</th>
                        
                        <th class="bottom-bordered-cell left-aligned">Name of group/name of disorder</th>
                        
                        <th class="bottom-bordered-cell left-aligned">Inheritance</th>
                        
                        <th class="bottom-bordered-cell left-aligned">Gene or locus</th>
                        
                        <th class="bottom-bordered-cell left-aligned">MIM No.</th>
                        
                        <th class="bottom-bordered-cell left-aligned">Notes</th>
                        </tr>
                     </thead>
                  
                  <tbody>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 1</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>FGFR3 chondrodysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 01-0010</td>
                        
                        <td class="left-aligned">Thanatophoric dysplasia (type 1), FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">187600</td>
                        
                        <td class="left-aligned">Includes previous “platyspondylyic dysplasia type San Diego”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 01-0020</td>
                        
                        <td class="left-aligned">Thanatophoric dysplasia (type 2), FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">187601</td>
                        
                        <td class="left-aligned">Radiographic differences between types 1 and 2 are correlated to specific <i>FGFR3</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 01-0030</td>
                        
                        <td class="left-aligned">Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN), FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">616482</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 01-0040</td>
                        
                        <td class="left-aligned">Achondroplasia, FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">100800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 01-0050</td>
                        
                        <td class="left-aligned">Hypochondroplasia, FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">146000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also group 33 for craniosynostosis syndromes linked to <i>FGFR3</i> variants, as well as CATSHL in group 30 and LADD syndrome in group 40 for other <i>FGFR3</i>-related phenotypes; rare <i>FGFR3</i> missense variants have been reported in idiopathic short stature but a causal link is not yet established and their significance remains unclear</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 2</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Type 2 collagen disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0010</td>
                        
                        <td class="left-aligned">Achondrogenesis, COL2A1-related (formerly type 2, type Langer-Saldino)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">200610</td>
                        
                        <td class="left-aligned">Achondrogenesis type 2 and hypochondrogenesis form one phenotypic continuum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0020</td>
                        
                        <td class="left-aligned">Hypochondrogenesis, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">200610</td>
                        
                        <td class="left-aligned">Achondrogenesis type 2 and hypochondrogenesis form one phenotypic continuum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0030</td>
                        
                        <td class="left-aligned">Platyspondylic dysplasia, type Torrance, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">151210</td>
                        
                        <td class="left-aligned">Often variants in the C-propeptide of collagen 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0040</td>
                        
                        <td class="left-aligned">Spondyloepiphyseal dysplasia congenita (SEDC), COL2A1-related</td>
                        
                        <td class="left-aligned">AD, AR*</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">183900, 604864</td>
                        
                        <td class="left-aligned">Includes mild SED with premature onset arthrosis, also known as osteoarthrosis with mild chondrodysplasia; includes Namaqualand type hip dysplasia. Mild SED cases may resemble MED (see note). AR*: very rare SED cases with biallelic <i>COL2A1</i> variants have been reported</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0050</td>
                        
                        <td class="left-aligned">Spondyloepimetaphyseal dysplasia, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">184250, 184253, 184255, 616583</td>
                        
                        <td class="left-aligned">Also known as “SED with marked metaphyseal changes”. Includes SEMD type Strudwick, SMD type Algerian, SED type Stanescu, dysspondyloenchondromatosis, and some cases of SMD “corner fracture” type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0060</td>
                        
                        <td class="left-aligned">Kniest dysplasia, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">156550</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0070</td>
                        
                        <td class="left-aligned">Spondyloperipheral dysplasia, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">271700</td>
                        
                        <td class="left-aligned">Like Torrance dysplasia, often variants in the C-propeptide of collagen 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0080</td>
                        
                        <td class="left-aligned">SED with metatarsal shortening, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">609162</td>
                        
                        <td class="left-aligned">Often associated with the p.R275C variant; formerly “Czech dysplasia”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0090</td>
                        
                        <td class="left-aligned">Stickler syndrome, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">108300</td>
                        
                        <td class="left-aligned">Monoallelic loss-of-function variants; see also <i>COL11A1</i>, <i>COL11A2</i>, <i>COL9A1</i>, <i>COL9A2</i>, <i>COL9A3</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 02-0100</td>
                        
                        <td class="left-aligned">Dysplasia of the proximal femoral epiphyses, COL2A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL2A1</i></td>
                        
                        <td class="left-aligned">150600, 608805</td>
                        
                        <td class="left-aligned">Heterogeneous condition, not all cases are due to COL2A1 variants (usually p.G393S; p.G717S; p.G1170S). The condition called “Meyer dysplasia of the hip” is not associated with <i>COL2A1</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also the pseudoachondroplasia-multiple epiphyseal dysplasia group for recessively inherited variants of Stickler syndrome as well as for overlapping phenotypes with normal stature and premature onset arthrosis; as well as spondylometaphyseal dysplasia Sutcliffe (or “corner fractures” type), <i>FN1</i>-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 3</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Type 11 collagen disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0010</td>
                        
                        <td class="left-aligned">Stickler syndrome, COL11A1-related</td>
                        
                        <td class="left-aligned">AD, MOS</td>
                        
                        <td class="left-aligned"><i>COL11A1</i></td>
                        
                        <td class="left-aligned">604841</td>
                        
                        <td class="left-aligned">Can also result from somatic mosaicism for a <i>COL11A1</i> variant</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0020</td>
                        
                        <td class="left-aligned">Marshall syndrome, COL11A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL11A1</i></td>
                        
                        <td class="left-aligned">154780</td>
                        
                        <td class="left-aligned">One report with homozygous p.G901E variant in two affected sibs (PMID 22499343)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0030</td>
                        
                        <td class="left-aligned">Stickler syndrome, COL11A2-related (non-ocular type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL11A2</i></td>
                        
                        <td class="left-aligned">184840</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0040</td>
                        
                        <td class="left-aligned">Fibrochondrogenesis, COL11A1-related</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>COL11A1</i></td>
                        
                        <td class="left-aligned">228520</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0050</td>
                        
                        <td class="left-aligned">Fibrochondrogenesis, COL11A2-related</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>COL11A2</i></td>
                        
                        <td class="left-aligned">614524</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0060</td>
                        
                        <td class="left-aligned">Otospondylomegaepiphyseal dysplasia (OSMED), recessive type, COL11A2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COL11A2</i></td>
                        
                        <td class="left-aligned">215150</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 03-0070</td>
                        
                        <td class="left-aligned">Otospondylomegaepiphyseal dysplasia (OSMED), dominant type, COL11A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL11A2</i></td>
                        
                        <td class="left-aligned">184840</td>
                        
                        <td class="left-aligned">Formerly Weissenbacher-Zweymüller syndrome and Stickler syndrome type 3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Stickler syndrome type 1 in collagen 2 group (Group 2) as well as recessive forms of Stickler syndrome in the pseudoachondroplasia-multiple epiphyseal dysplasia group (Group 9)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 4</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Sulfation disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0010</td>
                        
                        <td class="left-aligned">Achondrogenesis, SLC26A2-related (formerly achondrogenesis type 1B, or type Fraccaro)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC26A2</i></td>
                        
                        <td class="left-aligned">600972</td>
                        
                        <td class="left-aligned">Formerly known as achondrogenesis, type Fraccaro</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0020</td>
                        
                        <td class="left-aligned">Atelosteogenesis, SLC26A2-related (formerly atelosteogenesis type 2)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC26A2</i></td>
                        
                        <td class="left-aligned">256050</td>
                        
                        <td class="left-aligned">Includes former entities de la Chapelle dysplasia, McAlister dysplasia, and neonatal osseous dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0030</td>
                        
                        <td class="left-aligned">Diastrophic dysplasia, SLC26A2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC26A2</i></td>
                        
                        <td class="left-aligned">222600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0040</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, SLC26A2-related (autosomal recessive type, rMED)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC26A2</i></td>
                        
                        <td class="left-aligned">226900</td>
                        
                        <td class="left-aligned">See also multiple epiphyseal dysplasias and pseudoachondroplasia group (group 9)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0050</td>
                        
                        <td class="left-aligned">Spondylo-epi-metaphyseal dysplasia, PAPSS2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PAPSS2</i></td>
                        
                        <td class="left-aligned">612847</td>
                        
                        <td class="left-aligned">Formerly “SEMD Pakistani type”; includes the former “recessive brachyolmia, recessive type” as well as the older entities “Toledo brachyolmia” and “Hobaek brachyolmia”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0060</td>
                        
                        <td class="left-aligned">Chondrodysplasia with congenital joint dislocations, IMPAD1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IMPAD1</i></td>
                        
                        <td class="left-aligned">614078</td>
                        
                        <td class="left-aligned">Some features similar to Catel-Manzke syndrome, <i>TGDS</i>-related, as well as to Desbuquois syndrome, <i>CANT1</i>-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0070</td>
                        
                        <td class="left-aligned">Chondrodysplasia with congenital joint dislocations, CHST3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CHST3</i></td>
                        
                        <td class="left-aligned">143095</td>
                        
                        <td class="left-aligned">Includes recessive Larsen syndrome, humero-spinal dysostosis, and SED type Omani</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0080</td>
                        
                        <td class="left-aligned">Chondrodysplasia with hypomyelinating leucodystrophy, SLC35B2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC35B2</i></td>
                        
                        <td class="left-aligned">See 610788</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0090</td>
                        
                        <td class="left-aligned">Ehlers-Danlos syndrome, musculocontractural type, CHST14-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CHST14</i></td>
                        
                        <td class="left-aligned">601776</td>
                        
                        <td class="left-aligned">Includes adducted thumb-clubfoot syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0100</td>
                        
                        <td class="left-aligned">Ehlers-Danlos syndrome, musculocontractural type, DSE-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DSE</i></td>
                        
                        <td class="left-aligned">615539</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0110</td>
                        
                        <td class="left-aligned">Osteochondrodysplasia, brachydactyly, and overlapping malformed digits (OCBMD), CHST11-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CHST11</i></td>
                        
                        <td class="left-aligned">618167</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 04-0120</td>
                        
                        <td class="left-aligned">Developmental delay with corpus callosum, skeletal, and renal abnormalities, HS2ST1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HS2ST1</i></td>
                        
                        <td class="left-aligned">619194</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also filamin disorders (Group 6) and dysplasias with multiple joint dislocations (Group 5) for other conditions with dislocations, as well as brachydactyly, <i>CHSY1</i>-related, for phalangeal changes reminiscent of the sulfation disorders.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 5</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Dysplasias with multiple joint dislocations</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0010</td>
                        
                        <td class="left-aligned">Baratela-Scott syndrome, XYLT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>XYLT1</i></td>
                        
                        <td class="left-aligned">615777</td>
                        
                        <td class="left-aligned">May have intellectual disability; formerly Desbuquois dysplasia type 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0020</td>
                        
                        <td class="left-aligned">Desbuquois dysplasia (with accessory ossification center in digit 2), CANT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CANT1</i></td>
                        
                        <td class="left-aligned">251450</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0030</td>
                        
                        <td class="left-aligned">Desbuquois dysplasia (with short metacarpals and elongated phalanges, Kim type), CANT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CANT1</i></td>
                        
                        <td class="left-aligned">251450</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0040</td>
                        
                        <td class="left-aligned">SEMD with joint laxity (Hall type or leptodactylic type), KIF22-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>KIF22</i></td>
                        
                        <td class="left-aligned">603546</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0050</td>
                        
                        <td class="left-aligned">SEMD with joint laxity, EXOC6B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EXOC6B</i></td>
                        
                        <td class="left-aligned">618395</td>
                        
                        <td class="left-aligned">Phenotype resembles SEMD-JL leptodactylic or type Hall (preceding line)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0060</td>
                        
                        <td class="left-aligned">SEMD with joint laxity (Beighton type), B3GALT6-related (Ehlers-Danlos syndrome, spondylodysplastic type 2, EDSSPD2)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>B3GALT6</i></td>
                        
                        <td class="left-aligned">271640</td>
                        
                        <td class="left-aligned">Includes MIM 609465—Al-Gazali syndrome as neonatal form</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0070</td>
                        
                        <td class="left-aligned">Ehlers-Danlos syndrome, spondylodysplastic type 1 (EDSSPD1), B4GALT7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>B4GALT7</i></td>
                        
                        <td class="left-aligned">130070</td>
                        
                        <td class="left-aligned">Formerly known as “EDS, progeroid form”; includes Larsen syndrome, La Reunion type; see also <i>B3GALT6</i> deficiency above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0080</td>
                        
                        <td class="left-aligned">Multiple joint dislocations, short stature, craniofacial dysmorphisms, and skeletal dysplasia, with or without heart defects, B3GAT3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>B3GAT3</i></td>
                        
                        <td class="left-aligned">245600</td>
                        
                        <td class="left-aligned">The phenotype is very variable and has been reported also as “Larsen-like” or as “pseudodiastrophic dysplasia”. Intellectual disability and severe osteopenia with fractures have been observed. The OMIM entry includes older descriptions that are probably unrelated.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0090</td>
                        
                        <td class="left-aligned">Skeletal dysplasia with joint laxity and advanced bone age (SDJLABA), CSGALNACT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CSGALNACT1</i></td>
                        
                        <td class="left-aligned">618870</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 05-0100</td>
                        
                        <td class="left-aligned">Skeletal dysplasia with joint dislocations and amelogenesis imperfecta, SLC10A7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC10A7</i></td>
                        
                        <td class="left-aligned">618363</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: remarkably, this group contains several disorders of glycosaminoglycan synthesis. In spite of this group being named after a clinical feature (dysplasias with joint dislocations), the phenotypes in this group are related to those of the preceding Group 4 (sulfation disorders) and of the following Group 6 (filamin disorders) justifying its placement here. See also: Temtamy type brachydactyly, <i>CHSY1</i>-related, as well as SEMD with microcephaly, retinal dystrophy and hearing loss, <i>PISD</i>-related (Liberfarb syndrome), for other conditions with congenital dislocations, as well as EDSSPD3, <i>SLC39A13</i>-related, in the SEMD group.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 6</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Filamins and related disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0010</td>
                        
                        <td class="left-aligned">Frontometaphyseal dysplasia, FLNA-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FLNA</i></td>
                        
                        <td class="left-aligned">305620</td>
                        
                        <td class="left-aligned"><i>FLNA</i> gene also associated with MIM 300049, MIM 300321, MIM 314400, MIM 300048, MIM 300049 (see) and conditions below in this group</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0020</td>
                        
                        <td class="left-aligned">Frontometaphyseal dysplasia, MAP3K7-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MAP3K7</i></td>
                        
                        <td class="left-aligned">617137</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0030</td>
                        
                        <td class="left-aligned">Frontometaphyseal dysplasia, TAB2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TAB2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">No MIM entry yet; <i>TAB2</i> gene also associated with MIM 614980—congenital heart defects, nonsyndromic, 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0040</td>
                        
                        <td class="left-aligned">Cardiospondylocarpofacial syndrome, MAP3K7-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MAP3K7</i></td>
                        
                        <td class="left-aligned">157800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0050</td>
                        
                        <td class="left-aligned">Melnick-Needles syndrome, FLNA-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FLNA</i></td>
                        
                        <td class="left-aligned">309350</td>
                        
                        <td class="left-aligned">Includes osteodysplasty</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0060</td>
                        
                        <td class="left-aligned">Otopalatodigital syndrome type 1 (OPD1), FLNA-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FLNA</i></td>
                        
                        <td class="left-aligned">311300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0070</td>
                        
                        <td class="left-aligned">Otopalatodigital syndrome type 2 (OPD2), FLNA-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FLNA</i></td>
                        
                        <td class="left-aligned">304120</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0080</td>
                        
                        <td class="left-aligned">Terminal osseous dysplasia (TOD), FLNA-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FLNA</i></td>
                        
                        <td class="left-aligned">300244</td>
                        
                        <td class="left-aligned">Includes digitocutaneous dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0090</td>
                        
                        <td class="left-aligned">Larsen syndrome, FLNB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FLNB</i></td>
                        
                        <td class="left-aligned">150250</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0100</td>
                        
                        <td class="left-aligned">Atelosteogenesis type 1, FLNB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FLNB</i></td>
                        
                        <td class="left-aligned">108720, 112310</td>
                        
                        <td class="left-aligned">Includes Boomerang dysplasia, Piepkorn dysplasia, and spondylohumerofemoral (giant cell) dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0110</td>
                        
                        <td class="left-aligned">Atelosteogenesis type 3, FLNB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FLNB</i></td>
                        
                        <td class="left-aligned">108721</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0120</td>
                        
                        <td class="left-aligned">Spondylocarpotarsal synostosis syndrome, FLNB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FLNB</i></td>
                        
                        <td class="left-aligned">272460</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0130</td>
                        
                        <td class="left-aligned">Spondylocarpotarsal synostosis syndrome, RFLNA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RFLNA</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Entity proven, no MIM entry yet</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0140</td>
                        
                        <td class="left-aligned">Spondyocarpotarsal synostosis syndrome with contractures and pterygia, MYH3-related</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>MYH3</i></td>
                        
                        <td class="left-aligned">178110, 618469</td>
                        
                        <td class="left-aligned">frequently biallelic loss of function variants; monoallelic missense variants in the <i>MYH3</i> gene associated with MIM 193700-Arthrogryposis 2A, and MIM 618436-Arthrogryposis 2B3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 06-0150</td>
                        
                        <td class="left-aligned">Frank-ter Haar syndrome, SH3PXD2B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SH3PXD2B</i></td>
                        
                        <td class="left-aligned">249420</td>
                        
                        <td class="left-aligned">Includes previous Borrone dermatocardioskeletal syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also chondrodysplasia with congenital joint dislocations, <i>CHST3</i>-related (“recessive Larsen syndrome”) and the group of dysplasias with multiple dislocations, above (Group 5)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 7</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Proteoglycan core proteins disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0010</td>
                        
                        <td class="left-aligned">Dyssegmental dysplasia, HSPG2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HSPG2</i></td>
                        
                        <td class="left-aligned">224410, 224400</td>
                        
                        <td class="left-aligned">Variable severity; Includes both former Silverman-Handmaker and Rolland-Desbuquois types</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0020</td>
                        
                        <td class="left-aligned">Myotonic chondrodystrophy, HSPG2-related (Schwartz-Jampel syndrome)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HSPG2</i></td>
                        
                        <td class="left-aligned">255800</td>
                        
                        <td class="left-aligned">Variable severity; includes previous Burton dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0030</td>
                        
                        <td class="left-aligned">Spondylo-epiphyseal dysplasia, ACAN-related (dominant, Kimberley type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ACAN</i></td>
                        
                        <td class="left-aligned">608361</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0040</td>
                        
                        <td class="left-aligned">Spondylo-epi-metaphyseal dysplasia, ACAN-related (recessive, aggrecan type)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ACAN</i></td>
                        
                        <td class="left-aligned">612813</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0050</td>
                        
                        <td class="left-aligned">Short stature with advanced bone age, ACAN-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ACAN</i></td>
                        
                        <td class="left-aligned">165800</td>
                        
                        <td class="left-aligned">Sometimes with osteochondritis dissecans; other cases short stature with no skeletal features and normal bone age</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 07-0060</td>
                        
                        <td class="left-aligned">SEMD, BGN-related (Camera type)</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>BGN</i></td>
                        
                        <td class="left-aligned">300106</td>
                        
                        <td class="left-aligned">The <i>BGN</i> gene is also associated with a connective tissue- arterial aneurysms disorder (Meester-Loeys syndrome, MIM300989)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 8</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>TRPV4 disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 08-0010</td>
                        
                        <td class="left-aligned">Metatropic dysplasia, TRPV4-related</td>
                        
                        <td class="left-aligned">AD, MOS</td>
                        
                        <td class="left-aligned"><i>TRPV4</i></td>
                        
                        <td class="left-aligned">156530</td>
                        
                        <td class="left-aligned">Includes so-called “hyperplastic”, lethal, and non-lethal forms. Can also result from somatic mosaicism for a <i>TRPV4</i> variant.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 08-0020</td>
                        
                        <td class="left-aligned">Spondyloepimetaphyseal dysplasia, TRPV4-related (Maroteaux type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPV4</i></td>
                        
                        <td class="left-aligned">184095</td>
                        
                        <td class="left-aligned">Previously known as “pseudo-Morquio syndrome type 2”. Includes the obsolete MIM 168400-parastremmatic dwarfism entry, a phenotypic variant.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 08-0030</td>
                        
                        <td class="left-aligned">Spondyloepiphyseal dysplasia, Kozlowski type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPV4</i></td>
                        
                        <td class="left-aligned">184252</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 08-0040</td>
                        
                        <td class="left-aligned">Brachyolmia, TRPV4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPV4</i></td>
                        
                        <td class="left-aligned">113500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 08-0050</td>
                        
                        <td class="left-aligned">Familial digital arthropathy with brachydactyly, TRPV4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPV4</i></td>
                        
                        <td class="left-aligned">606835</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Missense variants in the <i>TRPV4</i> gene can be responsible for different types of peripheral neuropathies (see under MIM 605427). The <i>TRPV4</i> skeletal phenotypes can sometimes be associated with neuropathy.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 9</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Pseudoachondroplasia and the multiple epiphyseal dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0010</td>
                        
                        <td class="left-aligned">Pseudoachondroplasia, COMP-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COMP</i></td>
                        
                        <td class="left-aligned">177170</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0020</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, COMP-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COMP</i></td>
                        
                        <td class="left-aligned">132400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0030</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, MATN3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MATN3</i></td>
                        
                        <td class="left-aligned">607078</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0040</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, CANT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CANT1</i></td>
                        
                        <td class="left-aligned">617719</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0050</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, COL9A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL9A1</i></td>
                        
                        <td class="left-aligned">614135</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0060</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, COL9A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL9A2</i></td>
                        
                        <td class="left-aligned">600204</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0070</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia, COL9A3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL9A3</i></td>
                        
                        <td class="left-aligned">600969</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0080</td>
                        
                        <td class="left-aligned">Stickler syndrome, recessive type, COL9A1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COL9A1</i></td>
                        
                        <td class="left-aligned">614134</td>
                        
                        <td class="left-aligned">See also Groups 2 and 3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0090</td>
                        
                        <td class="left-aligned">Stickler syndrome, recessive type, COL9A2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COL9A2</i></td>
                        
                        <td class="left-aligned">614284</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0100</td>
                        
                        <td class="left-aligned">Stickler syndrome, recessive type, COL9A3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COL9A3</i></td>
                        
                        <td class="left-aligned">120270</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 09-0110</td>
                        
                        <td class="left-aligned">Multiple epiphyseal dysplasia with microcephaly and nystagmus (Lowry-Wood syndrome), RNU4ATAC-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RNU4ATAC</i></td>
                        
                        <td class="left-aligned">226960</td>
                        
                        <td class="left-aligned">See also Microcephalic osteodysplastic primordial dwarfism, <i>RNU4ATAC</i>-related, as well as Roifman syndrome, <i>RNU4ATAC</i>-related, both in the primordial dwarfism group (Group 21), for conditions with different severity from the <i>RNU4ATAC</i> gene</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also multiple epiphyseal dysplasia, recessive type, <i>SLC26A2</i>-related, as well as ASPED. Some <i>COL2A1</i> variants can make a MED-like phenotype. Some MED or MED-like phenotypes remain genetically unclear.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 10</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Skeletal disorders caused by abnormalities of cilia or ciliary signaling</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0010</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), DYNC2H1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYNC2H1</i></td>
                        
                        <td class="left-aligned">613091, 263520</td>
                        
                        <td class="left-aligned">There is significant clinical and radiological overlap between SRP1/3 and ATD. Some forms of both remain unlinked to the known genes. This gene can also be responsible for chondroectodermal dysplasia (Ellis-van Creveld), see below.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0020</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), IFT80-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT80</i></td>
                        
                        <td class="left-aligned">611263</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0030</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), IFT81-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT81</i></td>
                        
                        <td class="left-aligned">617895</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0040</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), WDR34-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR34</i></td>
                        
                        <td class="left-aligned">615633</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0050</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), WDR60-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR60</i></td>
                        
                        <td class="left-aligned">615503</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0060</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), DYNC2LI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYNC2LI1</i></td>
                        
                        <td class="left-aligned">617088</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0070</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), NEK1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NEK1</i></td>
                        
                        <td class="left-aligned">263520</td>
                        
                        <td class="left-aligned">Possibly also digenic inheritance combining <i>NEK1</i> with <i>DYNC2H1</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0080</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), IFT122-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT122</i></td>
                        
                        <td class="left-aligned">269860</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0090</td>
                        
                        <td class="left-aligned">Short rib–polydactyly syndrome (SRPS), WDR19-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR19</i></td>
                        
                        <td class="left-aligned">614091</td>
                        
                        <td class="left-aligned"><i>WDR19</i> is associated with MIM 614091, 614376, 614378, 615633 as well as with nephronopthisis (MIM 614377), Senior-Loken syndrome (MIM 616307) and Mainzer-Saldino syndrome (see below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0100</td>
                        
                        <td class="left-aligned">Short rib-polydactyly syndrome (SRPS), INTU-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>INTU</i></td>
                        
                        <td class="left-aligned">617925</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0110</td>
                        
                        <td class="left-aligned">Short rib-polydactyly syndrome (SRPS), TRAF3IP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRAF3IP1</i></td>
                        
                        <td class="left-aligned">See 607380</td>
                        
                        <td class="left-aligned"><i>TRAF3IP1</i> also known as <i>IFT154</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0120</td>
                        
                        <td class="left-aligned">Endocrine-cerebro-osteo dysplasia (ECO), CILK1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CILK1</i></td>
                        
                        <td class="left-aligned">612651</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0130</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), DYNC2H1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYNC2H1</i></td>
                        
                        <td class="left-aligned">613091</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0140</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), DYNC2LI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYNC2LI1</i></td>
                        
                        <td class="left-aligned">See 617088</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0150</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), WDR34-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR34</i></td>
                        
                        <td class="left-aligned">See 615633</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0160</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), TCTEX1D2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TCTEX1D2</i></td>
                        
                        <td class="left-aligned">617405</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0170</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), WDR60-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR60</i></td>
                        
                        <td class="left-aligned">See 615503</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0180</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), WDR19-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR19</i></td>
                        
                        <td class="left-aligned">614376</td>
                        
                        <td class="left-aligned"><i>WDR19</i> is associated with MIM 614091, 614376, 614378, 615633 as well as with nephronopthisis (MIM 614377), Senior-Loken syndrome (MIM 616307) and Mainzer-Saldino syndrome (see below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0190</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT140-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT140</i></td>
                        
                        <td class="left-aligned">266920</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0200</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), TTC21B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TTC21B</i></td>
                        
                        <td class="left-aligned">613819</td>
                        
                        <td class="left-aligned">Gene also known for nephronophthisis (MIM 613820)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0210</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT122-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT122</i></td>
                        
                        <td class="left-aligned">See 269860</td>
                        
                        <td class="left-aligned">Subsumed under SRPS (MIM 269860)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0220</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), WDR35-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR35</i></td>
                        
                        <td class="left-aligned">614091</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0230</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT43-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT43</i></td>
                        
                        <td class="left-aligned">617866</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0240</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT80-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT80</i></td>
                        
                        <td class="left-aligned">611623</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0250</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT172-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT172</i></td>
                        
                        <td class="left-aligned">615630</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0260</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT81-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT81</i></td>
                        
                        <td class="left-aligned">617895</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0270</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), IFT52-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT52</i></td>
                        
                        <td class="left-aligned">617102</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0280</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), CFAP410-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CFAP410</i></td>
                        
                        <td class="left-aligned">602271</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0290</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), CEP120-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CEP120</i></td>
                        
                        <td class="left-aligned">616300</td>
                        
                        <td class="left-aligned">Described in severe cases resembling SRPS; the <i>CEP120</i> gene is also associated with Joubert syndrome (MIM 617761)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0300</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), KIAA0586-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KIAA0586</i></td>
                        
                        <td class="left-aligned">616546</td>
                        
                        <td class="left-aligned">Gene also associated with Joubert syndrome (MIM 616490)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0310</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), GRK2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GRK2</i></td>
                        
                        <td class="left-aligned">See 109635</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0320</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), TRAF3IP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRAF3IP1</i></td>
                        
                        <td class="left-aligned">See 607380</td>
                        
                        <td class="left-aligned"><i>TRAF3IP1</i> also known as <i>IFT154</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0330</td>
                        
                        <td class="left-aligned">Short-rib thoracic dysplasia (formerly asphyxiating thoracic dysplasia—Jeune syndrome), KIAA0753-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KIAA0753</i></td>
                        
                        <td class="left-aligned">619479</td>
                        
                        <td class="left-aligned"><i>KIAA0753</i> variants also associated with orofaciodigital syndrome (MIM 617127) and with Joubert syndrome (MIM 619476)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0340</td>
                        
                        <td class="left-aligned">Axial spondylometaphyseal dysplasia, CFAP410-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CFAP410</i></td>
                        
                        <td class="left-aligned">602271</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0350</td>
                        
                        <td class="left-aligned">Axial spondylometaphyseal dysplasia, NEK1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NEK1</i></td>
                        
                        <td class="left-aligned">See 252100</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0360</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), EVC1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EVC1</i></td>
                        
                        <td class="left-aligned">225500</td>
                        
                        <td class="left-aligned">See also Weyers acrofacial (acrodental) dysostosis (MIM 193530)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0370</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), EVC2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EVC2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0380</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), WDR35-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR35</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0390</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), DYNC2LI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYNC2LI1</i></td>
                        
                        <td class="left-aligned"><i>See 617088</i></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0400</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), GLI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GLI1</i></td>
                        
                        <td class="left-aligned">See 165220</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0410</td>
                        
                        <td class="left-aligned">Chondroectodermal dysplasia (Ellis-van Creveld), SMO-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SMO</i></td>
                        
                        <td class="left-aligned">See</td>
                        
                        <td class="left-aligned">A single case with compound heterozygosity missense variants reported</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0420</td>
                        
                        <td class="left-aligned">Orofaciodigital syndrome type 4 (Mohr-Majewski), TCTN3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TCTN3</i></td>
                        
                        <td class="left-aligned">258860</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0430</td>
                        
                        <td class="left-aligned">Orofaciodigital syndrome type 2 (Mohr syndrome), NEK1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NEK1</i></td>
                        
                        <td class="left-aligned">252100</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0440</td>
                        
                        <td class="left-aligned">Cranioectodermal dysplasia (Levin-Sensenbrenner), IFT122-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT122</i></td>
                        
                        <td class="left-aligned">218330</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0450</td>
                        
                        <td class="left-aligned">Cranioectodermal dysplasia (Levin-Sensenbrenner), WDR35-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR35</i></td>
                        
                        <td class="left-aligned">613610</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0460</td>
                        
                        <td class="left-aligned">Cranioectodermal dysplasia (Levin-Sensenbrenner), WDR19-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR19</i></td>
                        
                        <td class="left-aligned">614378</td>
                        
                        <td class="left-aligned"><i>WDR19</i> is associated with MIM 614091, 614376, 614378, 615633 as well as with nephronopthisis (MIM 614377), Senior-Loken syndrome (MIM 616307) and Mainzer-Saldino syndrome (see below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0470</td>
                        
                        <td class="left-aligned">Cranioectodermal dysplasia (Levin-Sensenbrenner), IFT40-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT40</i></td>
                        
                        <td class="left-aligned">see 614620</td>
                        
                        <td class="left-aligned">see short rib thoracic dysplasia, <i>IFT140-</i>associated, above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0480</td>
                        
                        <td class="left-aligned">Cranioectodermal dysplasia (Levin-Sensenbrenner), IFT43-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT43</i></td>
                        
                        <td class="left-aligned">614009</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0490</td>
                        
                        <td class="left-aligned">Joubert syndrome with short-rib thoracic dysplasia, CSPP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CSPP1</i></td>
                        
                        <td class="left-aligned">615636</td>
                        
                        <td class="left-aligned">In OMIM as “Joubert syndrome type 21”; not all cases have thoracic dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0500</td>
                        
                        <td class="left-aligned">Atrial defects-polydactyly-multiple congenital malformation syndrome, PRKACA-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PRKACA</i></td>
                        
                        <td class="left-aligned">619142</td>
                        
                        <td class="left-aligned">OMIM created the name of “Cardioacrofacial syndrome 1”.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0510</td>
                        
                        <td class="left-aligned">Atrial defects-polydactyly-multiple congenital malformation syndrome, PRKACB-related</td>
                        
                        <td class="left-aligned">AD, MOS</td>
                        
                        <td class="left-aligned"><i>PRKACB</i></td>
                        
                        <td class="left-aligned">619143</td>
                        
                        <td class="left-aligned">OMIM created the name of “Cardioacrofacial syndrome 2”; one published patient later reclassified as “Ellis-van Creveld syndrome”.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0520</td>
                        
                        <td class="left-aligned">Mainzer-Saldino syndrome, IFT140-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT140</i></td>
                        
                        <td class="left-aligned">266920</td>
                        
                        <td class="left-aligned"><i>IFT140</i> also associated with isolated retinitis pigmentosa (MIM 617781)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0530</td>
                        
                        <td class="left-aligned">Mainzer-Saldino syndrome, IFT172-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IFT172</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"><i>IFT172</i> also associated with Bardet-Biedl syndrome (MIM 619471) and isolated retinitis pigmentosa (616394)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0540</td>
                        
                        <td class="left-aligned">Mainzer-Saldino syndrome, WDR19-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WDR19</i></td>
                        
                        <td class="left-aligned">See 614376</td>
                        
                        <td class="left-aligned"><i>WDR19</i> is also associated with MIM 614091, 614376, 614378, 615633 as well as with nephronopthisis (MIM 614377), and Senior-Loken syndrome (MIM 616307)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0550</td>
                        
                        <td class="left-aligned">Meckel syndrome, MKS1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MKS1</i></td>
                        
                        <td class="left-aligned">249000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0560</td>
                        
                        <td class="left-aligned">Meckel syndrome, TMEM216-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMEM216</i></td>
                        
                        <td class="left-aligned">603194</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0570</td>
                        
                        <td class="left-aligned">Meckel syndrome, TMEM67-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMEM67</i></td>
                        
                        <td class="left-aligned">607361</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0580</td>
                        
                        <td class="left-aligned">Meckel syndrome, CEP290-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CEP290</i></td>
                        
                        <td class="left-aligned">611134</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0590</td>
                        
                        <td class="left-aligned">Meckel syndrome, RPGRIP1L-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RPGRIP1L</i></td>
                        
                        <td class="left-aligned">611561</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0600</td>
                        
                        <td class="left-aligned">Meckel syndrome, CC2D2A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CC2D2A</i></td>
                        
                        <td class="left-aligned">612284</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 10-0610</td>
                        
                        <td class="left-aligned">Thoracolaryngopelvic dysplasia (Barnes)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">187760</td>
                        
                        <td class="left-aligned">Dominant transmission reported, but diagnostic criteria not stringent. The existence pf this entity is disputed.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Given the common genetic basis of several entries in this group and the absence (so far) of clear genotype-phenotype correlations, the distinction between chondroectodermal dysplasia, asphyxiating thoracic dystrophy (see below for name change), short rib-polydactyly syndromes and related conditions is historical and restricted to the clinical phenotypes. We have followed MIM and used the term “short-rib thoracic dysplasia” instead of “asphyxiating thoracic dysplasia”, to avoid the negative connotation and inaccuracy of “asphyxiating”. See also paternal UPD14 and Cerebro-costo-mandibular syndrome (rib gap syndrome), <i>SNRPB</i>-related, both in Group 36. The Bardet-Biedl syndrome with its large phenotypic spectrum has not been included in spite of minor skeletal involvement, as the predominant clinical features are non-skeletal.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 11</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Metaphyseal dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0010</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia Schmid (MCS), COL10A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL10A1</i></td>
                        
                        <td class="left-aligned">156500</td>
                        
                        <td class="left-aligned">Pathogenic variants are typically located in the C-terminal domain of the protein.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0020</td>
                        
                        <td class="left-aligned">Cartilage-hair hypoplasia (CHH; metaphyseal dysplasia, McKusick type), RMRP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RMRP</i></td>
                        
                        <td class="left-aligned">250250</td>
                        
                        <td class="left-aligned">The phenotype of CHH is variable and includes MIM 607095-anauxetic dysplasia as well as MIM 250460-metaphyseal dysplasia without hypotrichosis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0030</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with short stature (CHH-like), POP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POP1</i></td>
                        
                        <td class="left-aligned">617396</td>
                        
                        <td class="left-aligned">The clinical spectrum is variable. The denomination of “anauxetic dysplasia 2” in MIM is confusing as anauxetic dysplasia is a variant of Cartilage-Hair Hypoplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0040</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with short stature (CHH-like), NEPRO-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NEPRO</i></td>
                        
                        <td class="left-aligned">618853</td>
                        
                        <td class="left-aligned">Facial features and hypotrichosis reminiscent of Cartilage-Hair Hypoplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0050</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with pancreatic insufficiency and cyclic neutropenia (Shwachman-Bodian-Diamond syndrome), SBDS-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SBDS</i></td>
                        
                        <td class="left-aligned">260400</td>
                        
                        <td class="left-aligned">See also severe spondylodysplastic dysplasia, Sedaghatian-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0060</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with pancreatic insufficiency and cyclic neutropenia (SBDS type 2), EFL1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EFL1</i></td>
                        
                        <td class="left-aligned">617941</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0070</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with pancreatic insufficiency and cyclic neutropenia, DNAJC21-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DNAJC21</i></td>
                        
                        <td class="left-aligned">617052</td>
                        
                        <td class="left-aligned">Known in OMIM as Bone Marrow Failure Syndrome 3; BMFS3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0080</td>
                        
                        <td class="left-aligned">Shwachman-Diamond like syndrome, SRP54-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SRP54</i></td>
                        
                        <td class="left-aligned">618752</td>
                        
                        <td class="left-aligned">Known in OMIM as Neutropenia, severe congenital, 8</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0090</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia Spahr, MMP13-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MMP13</i></td>
                        
                        <td class="left-aligned">250400</td>
                        
                        <td class="left-aligned">Recessive, biallelic variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0100</td>
                        
                        <td class="left-aligned">Metaphyseal anadysplasia, MMP13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MMP13</i></td>
                        
                        <td class="left-aligned">602111</td>
                        
                        <td class="left-aligned">Dominant, monoallelic type; includes SEMD Missouri type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0110</td>
                        
                        <td class="left-aligned">Metaphyseal anadysplasia, MMP9-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MMP9</i></td>
                        
                        <td class="left-aligned">613073</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 11-0120</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia with maxillary hypoplasia, RUNX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RUNX2</i></td>
                        
                        <td class="left-aligned">156510</td>
                        
                        <td class="left-aligned">Frequently associated with intragenic duplication of exons 3 to 5 or 3 to 6. See also Cleidocranial dysplasia, RUNX2-related (below; MIM 119600), as well as non-syndromic midline craniosynostosis, RUNX2-related, below</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See Rhizomelic spondylo-metaphyseal dysplasia with remission, LBR-related (Group 13), for another anadysplasia-like disorder</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 12</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Spondylometaphyseal dysplasias (SMD)</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0010</td>
                        
                        <td class="left-aligned">Spondyloenchondrodysplasia with immune dysregulation (SPENCD), ACP5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ACP5</i></td>
                        
                        <td class="left-aligned">607944</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0020</td>
                        
                        <td class="left-aligned">Odontochondrodysplasia (ODCD), TRIP11-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRIP11</i></td>
                        
                        <td class="left-aligned">184260</td>
                        
                        <td class="left-aligned">See also Achondrogenesis, TRIP11-related (formerly type 1A)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0030</td>
                        
                        <td class="left-aligned">Spondylometaphyseal dysplasia Sutcliffe (or “corner fractures” type), FN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FN1</i></td>
                        
                        <td class="left-aligned">184255</td>
                        
                        <td class="left-aligned">Some cases are linked to <i>COL2A1</i> but not the original family</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0040</td>
                        
                        <td class="left-aligned">Spondylometaphyseal dysplasia with cone-rod dystrophy, PCYT1A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PCYT1A</i></td>
                        
                        <td class="left-aligned">608940</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0050</td>
                        
                        <td class="left-aligned">Spondylometaphyseal dysplasia with corneal dystrophy, PLCB3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PLCB3</i></td>
                        
                        <td class="left-aligned">618961</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 12-0060</td>
                        
                        <td class="left-aligned">Chondrodysplasia-pseudohermaphroditism syndrome, HHAT-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HHAT</i></td>
                        
                        <td class="left-aligned">600092</td>
                        
                        <td class="left-aligned">Also known as Nivelon-Nivelon-Mabille syndrome (<i>sic</i>)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also SMD Kozlowski, TRPV4-related, Severe spondylometaphyseal dysplasia (Sedaghatian type), <i>GPX4</i>-related, as well as Axial spondylometaphyseal dysplasia, <i>CFAP410</i>-related and Axial spondylometaphyseal dysplasia, <i>NEK1</i>-related. In addition, there are many reports of sporadic patients with unclassified SMD variants.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 13</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Spondyloepi(meta)physeal dysplasias (SE(M)D)</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0010</td>
                        
                        <td class="left-aligned">SED tarda, X-linked (SED-XL), TRAPPC2-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>TRAPPC2</i></td>
                        
                        <td class="left-aligned">313400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0020</td>
                        
                        <td class="left-aligned">SED with diabetes mellitus (Wolcott-Rallison syndrome), EIF2AK3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EIF2AK3</i></td>
                        
                        <td class="left-aligned">226980</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0030</td>
                        
                        <td class="left-aligned">Dyggve-Melchior-Clausen dysplasia, DYM-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYM</i></td>
                        
                        <td class="left-aligned">223800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0040</td>
                        
                        <td class="left-aligned">Smith-McCort dysplasia, DYM-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DYM</i></td>
                        
                        <td class="left-aligned">607326</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0050</td>
                        
                        <td class="left-aligned">Smith-McCort dysplasia, RAB33B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RAB33B</i></td>
                        
                        <td class="left-aligned">615222</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0060</td>
                        
                        <td class="left-aligned">SEMD, BNIP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BNIP1</i></td>
                        
                        <td class="left-aligned">see 603291</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0070</td>
                        
                        <td class="left-aligned">SEMD, MATN3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MATN3</i></td>
                        
                        <td class="left-aligned">608728</td>
                        
                        <td class="left-aligned">See also <i>MATN3-</i>related MED in Group 9</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0080</td>
                        
                        <td class="left-aligned">SEMD, DDRGK1-related (Shohat type)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DDRGK1</i></td>
                        
                        <td class="left-aligned">602557</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0090</td>
                        
                        <td class="left-aligned">SEMD with leucodystrophy, AIFM1-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>AIFM1</i></td>
                        
                        <td class="left-aligned">300232</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0100</td>
                        
                        <td class="left-aligned">SEMD, RSPRY1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RSPRY1</i></td>
                        
                        <td class="left-aligned">616723</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0110</td>
                        
                        <td class="left-aligned">SEMD, TMEM165-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMEM165</i></td>
                        
                        <td class="left-aligned">614727</td>
                        
                        <td class="left-aligned">Congenital disorder of glycosylation type IIk</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0120</td>
                        
                        <td class="left-aligned">SEMD with microcephaly, retinal dystrophy and hearing loss, PISD-related (Liberfarb syndrome)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PISD</i></td>
                        
                        <td class="left-aligned">618889</td>
                        
                        <td class="left-aligned">Phenotypically variable; in some affected individuals hearing and vision may be unaffected</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0130</td>
                        
                        <td class="left-aligned">SEMD, UFSP2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>UFSP2</i></td>
                        
                        <td class="left-aligned">142669, 617974</td>
                        
                        <td class="left-aligned">Includes Familial hip dysplasia (Beukes)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0140</td>
                        
                        <td class="left-aligned">SEMD, short limb–abnormal calcification type, DDR2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DDR2</i></td>
                        
                        <td class="left-aligned">271665</td>
                        
                        <td class="left-aligned">See also other dysplasias with stippling</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0150</td>
                        
                        <td class="left-aligned">Immuno-osseous dysplasia, SMARCAL1-related (Schimke type)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SMARCAL1</i></td>
                        
                        <td class="left-aligned">242900</td>
                        
                        <td class="left-aligned">Nephrotic syndrome is an important manifestation; see also EXTL3 deficiency, below</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0160</td>
                        
                        <td class="left-aligned">SEMD with immune deficiency and intellectual disability, EXTL3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EXTL3</i></td>
                        
                        <td class="left-aligned">617425</td>
                        
                        <td class="left-aligned">Also known as “Immunoskeletal dysplasia with developmental abnormalities”; includes Omenn syndrome with chondrodysplasia; see also <i>SMARCAL1</i>, above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0170</td>
                        
                        <td class="left-aligned">SEMD with immune deficiency, PGM3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PGM3</i></td>
                        
                        <td class="left-aligned">615816</td>
                        
                        <td class="left-aligned">Known in OMIM as “immunodeficiency 23”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0180</td>
                        
                        <td class="left-aligned">SEMD with intellectual disability, NANS-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NANS</i></td>
                        
                        <td class="left-aligned">610442</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0190</td>
                        
                        <td class="left-aligned">SEMD with severe short stature, RPL13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RPL13</i></td>
                        
                        <td class="left-aligned">618728</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0200</td>
                        
                        <td class="left-aligned">SEMD with elevated lysosomal enzymes, MBTPS1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MBTPS1</i></td>
                        
                        <td class="left-aligned">618392</td>
                        
                        <td class="left-aligned">only two unrelated individuals known so far; in OMIM as “Kondo-Fu type”; possible role of lysosomal dysfunction in pathogenesis is unclear</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0210</td>
                        
                        <td class="left-aligned">Short stature, skeletal dysplasia, liver failure, optic nerve atrophy and Pelger-Huet anomaly, NBAS-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NBAS</i></td>
                        
                        <td class="left-aligned">616483</td>
                        
                        <td class="left-aligned">Combination of clinical features is variable; also known as infantile liver failure syndrome type 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0220</td>
                        
                        <td class="left-aligned">Short stature, skeletal dysplasia and liver failure, RINT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RINT1</i></td>
                        
                        <td class="left-aligned">618641</td>
                        
                        <td class="left-aligned">Combination of clinical features is variable; also known as infantile liver failure syndrome type 3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0230</td>
                        
                        <td class="left-aligned">Spondylodysplastic Ehlers-Danlos syndrome (SDEDSS type 3), SLC39A13-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC39A13</i></td>
                        
                        <td class="left-aligned">612350</td>
                        
                        <td class="left-aligned"><i>SLC39A13</i>/ZIP13 zinc transporter</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0240</td>
                        
                        <td class="left-aligned">Spondylar and nasal alterations with striated metaphyses (SPONASTRIME dysplasia), TONSL-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TONSL</i></td>
                        
                        <td class="left-aligned">271510</td>
                        
                        <td class="left-aligned">Possibly genetically heterogeneous</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0250</td>
                        
                        <td class="left-aligned">Spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and Leber congenital amaurosis (SHILCA) syndrome, NMNAT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NMNAT1</i></td>
                        
                        <td class="left-aligned">619260</td>
                        
                        <td class="left-aligned">Nonsyndromic Leber congenital amaurosis (LCA9; MIM 608553) is also caused by biallelic <i>NMNAT1</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0260</td>
                        
                        <td class="left-aligned">Platyspondyly (brachyolmia) with amelogenesis imperfecta, LTBP3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LTBP3</i></td>
                        
                        <td class="left-aligned">601216</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0270</td>
                        
                        <td class="left-aligned">Cerebral, ocular, dental, auricular, and skeletal anomalies (CODAS syndrome), LONP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LONP1</i></td>
                        
                        <td class="left-aligned">600373</td>
                        
                        <td class="left-aligned">Mitochondrial chaperonopathy</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0280</td>
                        
                        <td class="left-aligned">Epiphyseal and vertebral dysplasia, microtia, flat nose plus associated malformation (EVEN-PLUS syndrome), HSPA9-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HSPA9</i></td>
                        
                        <td class="left-aligned">616854</td>
                        
                        <td class="left-aligned">Mitochondrial chaperonopathy</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0290</td>
                        
                        <td class="left-aligned">Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia (CAGSSS syndrome), IARS2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IARS2</i></td>
                        
                        <td class="left-aligned">616007</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0300</td>
                        
                        <td class="left-aligned">Steel syndrome, COL27A1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COL27A1</i></td>
                        
                        <td class="left-aligned">615155</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0310</td>
                        
                        <td class="left-aligned">Rhizomelic spondylo-metaphyseal dysplasia with remission, LBR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LBR</i></td>
                        
                        <td class="left-aligned">618019</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 13-0320</td>
                        
                        <td class="left-aligned">Rhizomelic spondylo-epi-metaphyseal dysplasia, GNPNAT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GNPNAT1</i></td>
                        
                        <td class="left-aligned">619598</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also: Opsismodysplasia, <i>INPPL1</i>-related; Mucopolysaccharidosis type 4, <i>GALNS</i>-related (type 4A; Morquio disease), as well as Progressive pseudorheumatoid dysplasia (PPRD), <i>WISP3</i>-related. See also the non-genetic SEMD phenocopy, “Chondrodysplasia and growth failure following early hematopoietic stem cell transplantation”, ***<a href="https://doi.org/10.1002/ajmg.a.62021" class="linkBehavior">https://doi.org/10.1002/ajmg.a.62021</a>, PMID: 33398909.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 14</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Severe spondylodysplastic dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0010</td>
                        
                        <td class="left-aligned">Achondrogenesis, TRIP11-related (formerly type 1A)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRIP11</i></td>
                        
                        <td class="left-aligned">200600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0020</td>
                        
                        <td class="left-aligned">Schneckenbecken dysplasia, SLC35D1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC35D1</i></td>
                        
                        <td class="left-aligned">269250</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0030</td>
                        
                        <td class="left-aligned">Severe spondylometaphyseal dysplasia (Sedaghatian type), GPX4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GPX4</i></td>
                        
                        <td class="left-aligned">250220</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0040</td>
                        
                        <td class="left-aligned">Severe spondylometaphyseal dysplasia (SMD Sedaghatian-like), SBDS-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SBDS</i></td>
                        
                        <td class="left-aligned">260400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0050</td>
                        
                        <td class="left-aligned">Opsismodysplasia, INPPL1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>INPPL1</i></td>
                        
                        <td class="left-aligned">258480</td>
                        
                        <td class="left-aligned">Includes lethal and milder cases</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0060</td>
                        
                        <td class="left-aligned">Spondylometaphyseal dysplasia, PAM16- related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PAM16</i></td>
                        
                        <td class="left-aligned">613320</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 14-0070</td>
                        
                        <td class="left-aligned">Carbohydrate deficient glycoprotein syndrome, ALG9-related (ALG9-CDG; Gillessen-Kaesbach-Nishimura syndrome)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ALG9</i></td>
                        
                        <td class="left-aligned">263210, 608776</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Thanatophoric dysplasia, <i>FGFR3</i>-related; achondrogenesis and Torrance dysplasia, <i>COL2A1</i>-related; Fibrochondrogenesis, <i>COL11A1</i>-related; Achondrogenesis, <i>SLC26A2</i>-related; and Metatropic Dysplasia, <i>TRPV4</i>-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 15</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Mesomelic and rhizo-mesomelic dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0010</td>
                        
                        <td class="left-aligned">Dyschondrosteosis (Leri-Weill), SHOX-related</td>
                        
                        <td class="left-aligned">Pseudo-AD</td>
                        
                        <td class="left-aligned"><i>SHOX</i></td>
                        
                        <td class="left-aligned">127300</td>
                        
                        <td class="left-aligned">Includes Reinhardt-Pfeiffer dysplasia, MIM 191400. Clinical continuum with Idiopathic short stature (MIM 300582)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0020</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia (Langer type), SHOX-related</td>
                        
                        <td class="left-aligned">Pseudo-AR</td>
                        
                        <td class="left-aligned"><i>SHOX</i></td>
                        
                        <td class="left-aligned">249700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0030</td>
                        
                        <td class="left-aligned">Omodysplasia, recessive type, GPC6-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GPC6</i></td>
                        
                        <td class="left-aligned">258315</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0040</td>
                        
                        <td class="left-aligned">Omodysplasia, dominant type, FZD2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FZD2</i></td>
                        
                        <td class="left-aligned">164745</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0050</td>
                        
                        <td class="left-aligned">Robinow syndrome, WNT5A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>WNT5A</i></td>
                        
                        <td class="left-aligned">180700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0060</td>
                        
                        <td class="left-aligned">Robinow syndrome, DVL1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DVL1</i></td>
                        
                        <td class="left-aligned">616331</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0070</td>
                        
                        <td class="left-aligned">Robinow syndrome, DVL3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DVL3</i></td>
                        
                        <td class="left-aligned">616894</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0080</td>
                        
                        <td class="left-aligned">Robinow syndrome, FZD2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FZD2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0090</td>
                        
                        <td class="left-aligned">Robinow syndrome, recessive type, ROR2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ROR2</i></td>
                        
                        <td class="left-aligned">268310</td>
                        
                        <td class="left-aligned">Includes previous COVESDEM (costo-vertebral segmentation defect with mesomelia); see also brachydactyly type B</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0100</td>
                        
                        <td class="left-aligned">Robinow syndrome, recessive type, NXN-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NXN</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0110</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia, HOXD-related (Kim or Korean type, Kantaputra type, Fryns type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXD</i></td>
                        
                        <td class="left-aligned">156232</td>
                        
                        <td class="left-aligned">Duplications at HOXD gene cluster locus; phenotypes is variable also within families</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0120</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia, Nievergelt type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">163400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0130</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia, Kozlowski-Reardon type</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">249710</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0140</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia with acral synostoses (Verloes-David-Pfeiffer type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SULF1, SLCO5A1</i></td>
                        
                        <td class="left-aligned">600383</td>
                        
                        <td class="left-aligned">Microdeletion syndrome involving two adjacent genes</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0150</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia (Savarirayan type), ID4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ID4</i></td>
                        
                        <td class="left-aligned">605274</td>
                        
                        <td class="left-aligned">Microdeletions on 6p22.3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0160</td>
                        
                        <td class="left-aligned">Mesomelic dysplasia with digital anomalies and intellectual disability (KINSSHIP syndrome), AFF3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>AFF3</i></td>
                        
                        <td class="left-aligned">619297</td>
                        
                        <td class="left-aligned">In spite of the acronym, this condition is quite different from both Nievergelt and Savarirayan mesomelic dysplasias</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 15-0170</td>
                        
                        <td class="left-aligned">Oculo-skeletal syndrome with rhizomelic shortening, MAB21L2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MAB21L2</i></td>
                        
                        <td class="left-aligned">615877</td>
                        
                        <td class="left-aligned">In OMIM as “Microphthalmia/Coloboma and skeletal dysplasia syndrome”. Skeletal involvement not in all individuals. Two brothers with biallelic variants (AR?) had ocular but no skeletal involvement.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Tibial hemimelia-polysyndactyly-triphalangeal thumb, <i>ZRS</i>-related, also consider: mesomelic dysplasia, Camera type (MIM#611886), the status of which remains unconfirmed</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 16</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Acromesomelic dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0010</td>
                        
                        <td class="left-aligned">Acromesomelic dysplasia (type Maroteaux), NPR2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NPR2</i></td>
                        
                        <td class="left-aligned">602875</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0020</td>
                        
                        <td class="left-aligned">Acromesomelic dysplasia, PRKG2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PRKG2</i></td>
                        
                        <td class="left-aligned">619636, 619638</td>
                        
                        <td class="left-aligned">Condition associated with biallelic loss of function variants. Three brothers form one family were found to have a spondylo-metaphyseal dysplasia phenotype (in OMIM as “619638 - Spondylometaphyseal dysplasia, Pagnamenta type”. Needs to be confirmed)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0030</td>
                        
                        <td class="left-aligned">Grebe dysplasia, GDF5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GDF5</i></td>
                        
                        <td class="left-aligned">200700</td>
                        
                        <td class="left-aligned">Includes acromesomelic dysplasia Hunter-Thompson type and acromesomelic dysplasia with genital anomalies; see also see other GDF5-related disorders</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0040</td>
                        
                        <td class="left-aligned">Grebe dysplasia, BMPR1B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BMPR1B</i></td>
                        
                        <td class="left-aligned">609441</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0050</td>
                        
                        <td class="left-aligned">Fibular hypoplasia and complex brachydactyly (Du Pan), GDF5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GDF5</i></td>
                        
                        <td class="left-aligned">228900</td>
                        
                        <td class="left-aligned">See also other GDF5-related disorders</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0060</td>
                        
                        <td class="left-aligned">Fibular hypoplasia and complex brachydactyly (Du Pan), BMPR1B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BMPR1B</i></td>
                        
                        <td class="left-aligned">See 603248</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 16-0070</td>
                        
                        <td class="left-aligned">Acromesomelic dysplasia, Osebold-Remondini type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">112910</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 17</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Acromelic dysplasias</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0010</td>
                        
                        <td class="left-aligned">Acrocapitofemoral dysplasia, IHH-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IHH</i></td>
                        
                        <td class="left-aligned">607778</td>
                        
                        <td class="left-aligned">See other conditions associated with the <i>IHH</i> gene in this table</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0020</td>
                        
                        <td class="left-aligned">Geleophysic dysplasia, ADAMTSL2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ADAMTSL2</i></td>
                        
                        <td class="left-aligned">231050</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0030</td>
                        
                        <td class="left-aligned">Geleophysic dysplasia, FBN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBN1</i></td>
                        
                        <td class="left-aligned">614185</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0040</td>
                        
                        <td class="left-aligned">Geleophysic dysplasia, LTBP3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LTBP3</i></td>
                        
                        <td class="left-aligned">617809</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0050</td>
                        
                        <td class="left-aligned">Acromicric dysplasia, FBN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBN1</i></td>
                        
                        <td class="left-aligned">102370</td>
                        
                        <td class="left-aligned">Includes acrolaryngeal dysplasia, previously known as Fantasy Island dysplasia or Tattoo dysplasia, and Moore-Federman syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0060</td>
                        
                        <td class="left-aligned">Acromicric dysplasia, LTBP3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LTBP3</i></td>
                        
                        <td class="left-aligned">See 617809</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0070</td>
                        
                        <td class="left-aligned">Weill-Marchesani syndrome, dominant, FBN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBN1</i></td>
                        
                        <td class="left-aligned">608328</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0080</td>
                        
                        <td class="left-aligned">Weill-Marchesani syndrome, ADAMTS10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ADAMTS10</i></td>
                        
                        <td class="left-aligned">277600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0090</td>
                        
                        <td class="left-aligned">Weill-Marchesani syndrome, ADAMTS17-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ADAMTS17</i></td>
                        
                        <td class="left-aligned">613195</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0100</td>
                        
                        <td class="left-aligned">Weill-Marchesani syndrome, LTBP2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LTBP2</i></td>
                        
                        <td class="left-aligned">614819</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0110</td>
                        
                        <td class="left-aligned">Myhre dysplasia, SMAD4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMAD4</i></td>
                        
                        <td class="left-aligned">139210</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0120</td>
                        
                        <td class="left-aligned">Acrodysostosis, PDE4D-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PDE4D</i></td>
                        
                        <td class="left-aligned">614613</td>
                        
                        <td class="left-aligned">Includes acroscyphodysplasia (see PMID 30006632)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0130</td>
                        
                        <td class="left-aligned">Acrodysostosis, PRKAR1A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PRKAR1A</i></td>
                        
                        <td class="left-aligned">101800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0140</td>
                        
                        <td class="left-aligned">Angel-shaped phalango-epiphyseal dysplasia (ASPED)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">105835</td>
                        
                        <td class="left-aligned">Possibly related or allelic to brachydactyly type C</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0150</td>
                        
                        <td class="left-aligned">Albright hereditary osteodystrophy, GNAS-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GNAS</i></td>
                        
                        <td class="left-aligned">103580</td>
                        
                        <td class="left-aligned">Overlaps with progressive osseous heteroplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0160</td>
                        
                        <td class="left-aligned">Leri Pleonosteosis, linked to 8q22.1</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>8q22.1</i></td>
                        
                        <td class="left-aligned">151200</td>
                        
                        <td class="left-aligned">Duplication at 8q22.1 encompassing GDF6 and SDC2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 17-0170</td>
                        
                        <td class="left-aligned">SED with brachydactyly, MIR140-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MIR140</i></td>
                        
                        <td class="left-aligned">618618</td>
                        
                        <td class="left-aligned">Brachydactyly with cone-shaped epiphyses</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Cartilage-Hair Hypoplasia, <i>RMRP</i>-related, and the brachdydactyly groups, below (Groups 18 and 19)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 18</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Brachydactylies (isolated)</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0010</td>
                        
                        <td class="left-aligned">Brachydactyly type A1, IHH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IHH</i></td>
                        
                        <td class="left-aligned">112500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0020</td>
                        
                        <td class="left-aligned">Brachydactyly type A2, BMPR1B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>BMPR1B</i></td>
                        
                        <td class="left-aligned">112600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0030</td>
                        
                        <td class="left-aligned">Brachydactyly type A2, BMP2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>BMP2</i></td>
                        
                        <td class="left-aligned">112600</td>
                        
                        <td class="left-aligned">Duplication of <i>BMP2</i> enhancer</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0040</td>
                        
                        <td class="left-aligned">Brachydactyly type A2, GDF5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF5</i></td>
                        
                        <td class="left-aligned">112600</td>
                        
                        <td class="left-aligned">See also Grebe dysplasia, GDF5-related; Fibular hypoplasia and complex brachydactyly (Du Pan), GDF5-related; Brachydactyly type C, GDF5-related; and Multiple synostoses syndrome, GDF5-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0050</td>
                        
                        <td class="left-aligned">Brachydactyly type B1, ROR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ROR2</i></td>
                        
                        <td class="left-aligned">113000</td>
                        
                        <td class="left-aligned">See also Robinow syndrome/COVESDEM</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0060</td>
                        
                        <td class="left-aligned">Brachydactyly type B2, NOG-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NOG</i></td>
                        
                        <td class="left-aligned">611377</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0070</td>
                        
                        <td class="left-aligned">Brachydactyly type C, GDF5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF5</i></td>
                        
                        <td class="left-aligned">113100</td>
                        
                        <td class="left-aligned">See other GDF5-related disorders</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0080</td>
                        
                        <td class="left-aligned">Brachydactyly type D, HOXD13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXD13</i></td>
                        
                        <td class="left-aligned">113200</td>
                        
                        <td class="left-aligned">Brachydactyly type D is often a component of Brachydactyly type E</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0090</td>
                        
                        <td class="left-aligned">Brachydactyly type E, HOXD13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXD13</i></td>
                        
                        <td class="left-aligned">113300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0100</td>
                        
                        <td class="left-aligned">Brachydactyly with anonychia (Cooks syndrome), KCNJ2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>KCNJ2</i></td>
                        
                        <td class="left-aligned">106995</td>
                        
                        <td class="left-aligned">Duplications of <i>SOX9/KCNJ2</i> regulatory region</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 18-0110</td>
                        
                        <td class="left-aligned">Preaxial brachydactyly, PAX3 type, linked to 2q35-36</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>2q35-36</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Deletions leading to disruption of TADs and abnormal expression of <i>PAX3</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also brachdactyly, <i>PTHLH</i>-related (below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 19</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Brachydactylies as part of syndromes</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0010</td>
                        
                        <td class="left-aligned">Trichorhinophalangeal dysplasia types 1/3</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPS1</i></td>
                        
                        <td class="left-aligned">190350, 190351</td>
                        
                        <td class="left-aligned">TRPS1 and 3 are a phenotypic spectrum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0020</td>
                        
                        <td class="left-aligned">Langer-Giedion syndrome (Trichorhinophalangeal dysplasia type 2)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRPS1, EXT1</i></td>
                        
                        <td class="left-aligned">150230</td>
                        
                        <td class="left-aligned">Microdeletion syndrome; see also multiple cartilaginous exostoses</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0030</td>
                        
                        <td class="left-aligned">Catel-Manzke syndrome, TGDS-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TGDS</i></td>
                        
                        <td class="left-aligned">616145</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0040</td>
                        
                        <td class="left-aligned">Deafness, onychodystrophy, osteodystrophy, retardation and seizures (DOORS) syndrome</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TBC1D24</i></td>
                        
                        <td class="left-aligned">220500</td>
                        
                        <td class="left-aligned">“Osteodystrophy” and “retardation” are misnomers</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0050</td>
                        
                        <td class="left-aligned">Brachydactyly—intellectual disability syndrome, HDAC4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HDAC4</i></td>
                        
                        <td class="left-aligned">600430</td>
                        
                        <td class="left-aligned">The existence of this entity is questionable. <i>HDAC4</i> variants alone may not be sufficient to produce either brachydactyly or intellectual disability. Some patients have microdeletions involving contiguous genes (2q37 deletion syndrome). <i>HDAC4</i> variants have been associated with a developmental disorder (see MIM 619797)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0060</td>
                        
                        <td class="left-aligned">Hyperphosphatasia with intellectual disability, brachytelephalangy, and distinct face, PIGV-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PIGV</i></td>
                        
                        <td class="left-aligned">239300</td>
                        
                        <td class="left-aligned">Several other related defects of GPI synthesis known, most cases not known for skeletal changes; see for example, MIM 610293 for a summary</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0070</td>
                        
                        <td class="left-aligned">Brachydactyly-short stature-hypertension syndrome, PDE3A-related (Bilginturan syndrome)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PDE3A</i></td>
                        
                        <td class="left-aligned">112410</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0080</td>
                        
                        <td class="left-aligned">Brachydactyly, obesity and intellectual disability syndrome, PRMT7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PRMT7</i></td>
                        
                        <td class="left-aligned">617157</td>
                        
                        <td class="left-aligned">Phenotype reminiscent of Albright Hereditary Ostedystrophy (AHO), GNAS-related (see above) but recessive. In OMIM as “617157—Short stature, brachydactyly, intellectual developmental disability, and seizures”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0090</td>
                        
                        <td class="left-aligned">Microcephaly-oculo-digito-esophageal-duodenal syndrome, MYCN-related (Feingold syndrome)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MYCN</i></td>
                        
                        <td class="left-aligned">164280</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0100</td>
                        
                        <td class="left-aligned">Hand-foot-genital syndrome, HOXA13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXA13</i></td>
                        
                        <td class="left-aligned">140000</td>
                        
                        <td class="left-aligned">Includes Guttmacher syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0110</td>
                        
                        <td class="left-aligned">Rubinstein-Taybi syndrome, CREBBP-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CREBBP</i></td>
                        
                        <td class="left-aligned">180849</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0120</td>
                        
                        <td class="left-aligned">Rubinstein-Taybi syndrome, EP300-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EP300</i></td>
                        
                        <td class="left-aligned">613684</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0130</td>
                        
                        <td class="left-aligned">Brachydactyly, Temtamy type, CHSY1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CHSY1</i></td>
                        
                        <td class="left-aligned">605282</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0140</td>
                        
                        <td class="left-aligned">Hyperphalangism, characteristic facies, hallux valgus and bronchomalacia (Chitayat syndrome), ERF-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ERF</i></td>
                        
                        <td class="left-aligned">617180</td>
                        
                        <td class="left-aligned">Typically a monoallelic Y89C substitution</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0150</td>
                        
                        <td class="left-aligned">Hypoacusis with facial an digital anomalies (Keipert syndrome), GPC4-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>GPC4</i></td>
                        
                        <td class="left-aligned">301026</td>
                        
                        <td class="left-aligned">Brachytelephalangy is the most consistent skeletal signs</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0160</td>
                        
                        <td class="left-aligned">Christian type brachydactyly</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">112450</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0170</td>
                        
                        <td class="left-aligned">Coffin-Siris syndrome, ARID1A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ARID1A</i></td>
                        
                        <td class="left-aligned">614607</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0180</td>
                        
                        <td class="left-aligned">Coffin-Siris syndrome, ARIB1B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ARID1B</i></td>
                        
                        <td class="left-aligned">135900</td>
                        
                        <td class="left-aligned">Variants in various components of the SWI/SNF complex have been reported in patients with a diagnosis of Coffin-Siris syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0190</td>
                        
                        <td class="left-aligned">Coffin-Siris syndrome, SMARCB1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMARCB1</i></td>
                        
                        <td class="left-aligned">614608</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0200</td>
                        
                        <td class="left-aligned">Coffin-Siris syndrome, SMARCA4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMARCA4</i></td>
                        
                        <td class="left-aligned">614609</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0210</td>
                        
                        <td class="left-aligned">Coffin-Siris syndrome, SMARCE1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMARCE1</i></td>
                        
                        <td class="left-aligned">616938</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 19-0220</td>
                        
                        <td class="left-aligned">Cardiomyopathy and brachydactyly, LMNA-related (Heart-hand syndrome type IV)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LMNA</i></td>
                        
                        <td class="left-aligned">610140</td>
                        
                        <td class="left-aligned">in OMIM as “Heart-Hand syndrome, Slovenian type”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also CDP, X-linked recessive, <i>ARSE</i>-related (brachytelephalangic type; CDPX1)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 20</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Bent bones dysplasia group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0010</td>
                        
                        <td class="left-aligned">Campomelic dysplasia (CD), SOX9-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SOX9</i></td>
                        
                        <td class="left-aligned">114290</td>
                        
                        <td class="left-aligned">Includes acampomelic campomelic dysplasia (ACD), mild campomelic dysplasia (MIM 602196); so-called Ischio-pubic-patellar dysplasia, as well as some cases of isolated Pierre-Robin sequence</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0020</td>
                        
                        <td class="left-aligned">Stüve-Wiedemann syndrome, LIFR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LIFR</i></td>
                        
                        <td class="left-aligned">601559</td>
                        
                        <td class="left-aligned">Includes former neonatal Schwartz-Jampel syndrome or SJS type 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0030</td>
                        
                        <td class="left-aligned">Stüve-Wiedemann syndrome, IL6ST-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IL6ST</i></td>
                        
                        <td class="left-aligned">619751</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0040</td>
                        
                        <td class="left-aligned">Kyphomelic dysplasia with facial dysmorphism, KIF5B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>KIF5B</i></td>
                        
                        <td class="left-aligned">211350</td>
                        
                        <td class="left-aligned">The name “kyphomelic dysplasia” has been applied to heterogeneous conditions</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0050</td>
                        
                        <td class="left-aligned">Bent bone dysplasia, FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">614592</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 20-0060</td>
                        
                        <td class="left-aligned">Bent bone dysplasia, LAMA5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LAMA5</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Biallelic LAMA5 variants are associated with congenital or infantile nephrotic syndrome (MIM)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Bent bones is an unspecific finding, particularly in a prenatal setting, that can be observed in numerous other conditions, such as those with bone fragility; thus see the OI-bone fragility group (group 26) as well as Hypophosphatasia, <i>ALPL</i>-related.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 21</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Primordial dwarfism and slender bones group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0010</td>
                        
                        <td class="left-aligned">3-M syndrome, CUL7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CUL7</i></td>
                        
                        <td class="left-aligned">273750</td>
                        
                        <td class="left-aligned">Includes dolichospondylic dysplasia and Yakut short stature syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0020</td>
                        
                        <td class="left-aligned">3-M syndrome, OBSL1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>OBSL1</i></td>
                        
                        <td class="left-aligned">612921</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0030</td>
                        
                        <td class="left-aligned">3-M syndrome, CCDC8-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CCDC8</i></td>
                        
                        <td class="left-aligned">614205</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0040</td>
                        
                        <td class="left-aligned">Sanjad-Sakati syndrome, recessive, TBCE-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TBCE</i></td>
                        
                        <td class="left-aligned">241410</td>
                        
                        <td class="left-aligned">In OMIM as “Kenny-Caffey type 1” but does not correspond to the disorder described by Kenny and Caffey which is the dominant form</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0050</td>
                        
                        <td class="left-aligned">Kenny-Caffey syndrome, dominant, FAM111A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FAM111A</i></td>
                        
                        <td class="left-aligned">127000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0060</td>
                        
                        <td class="left-aligned">Osteocraniostenosis, FAM111A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FAM111A</i></td>
                        
                        <td class="left-aligned">602361</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0070</td>
                        
                        <td class="left-aligned">Hallermann-Streiff syndrome</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">234100</td>
                        
                        <td class="left-aligned">Usually sporadic; some cases have phenotypic overlap with osteocraniostenosis, FAM111A-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0080</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, RNU4ATAC-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RNU4ATAC</i></td>
                        
                        <td class="left-aligned">210710</td>
                        
                        <td class="left-aligned">Was MOPD 1/3; usually homozygous variants; includes Taybi-Linder cephaloskeletal dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0090</td>
                        
                        <td class="left-aligned">Roifman syndrome, RNU4ATAC-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RNU4ATAC</i></td>
                        
                        <td class="left-aligned">616651</td>
                        
                        <td class="left-aligned">See other RNU4ATAC-related condition in this table</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0100</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, PCNT-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PCNT</i></td>
                        
                        <td class="left-aligned">210720</td>
                        
                        <td class="left-aligned">Was MOPD2, Majewski type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0110</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, ATR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ATR</i></td>
                        
                        <td class="left-aligned">210600</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 1</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0120</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, RBBP8-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RBBP8</i></td>
                        
                        <td class="left-aligned">606744</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 2. The RBBP8 gene is also associated with Jawad syndrome (microcephaly with intellectual disability and digital anomalies; MIM 251255)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0130</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, CEP152-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CEP152</i></td>
                        
                        <td class="left-aligned">613823</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 5. The CEP152 gene also causes primary microcephaly (MIM 614852)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0140</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, DNA2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DNA2</i></td>
                        
                        <td class="left-aligned">615807</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 8. The DNA2 gene is also associated with autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions (MIM 615156)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0150</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, TRAIP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRAIP</i></td>
                        
                        <td class="left-aligned">616777</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 9</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0160</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, NSMCE2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NSMCE2</i></td>
                        
                        <td class="left-aligned">617253</td>
                        
                        <td class="left-aligned">In MIM as Seckel syndrome 10</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0170</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, CENPE-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CENPE</i></td>
                        
                        <td class="left-aligned">see 616051</td>
                        
                        <td class="left-aligned">In MIM as autosomal recessive primary microcephaly</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0180</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, CRIPT-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CRIPT</i></td>
                        
                        <td class="left-aligned">615789</td>
                        
                        <td class="left-aligned">In MIM as short stature with microcephaly and distinctive facies</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0190</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, XRCC4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>XRCC4</i></td>
                        
                        <td class="left-aligned">616541</td>
                        
                        <td class="left-aligned">In MIM as short stature, microcephaly and endocrine dysfunction</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0200</td>
                        
                        <td class="left-aligned">Microcephalic osteodysplastic primordial dwarfism, or microcephaly-short stature-micromelia-limb abnormalities, DONSON-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DONSON</i></td>
                        
                        <td class="left-aligned">251230, 617604</td>
                        
                        <td class="left-aligned">Milder affected patients may fall into the Meier-Gorlin syndrome spectrum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0210</td>
                        
                        <td class="left-aligned">IMAGE syndrome (intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia, and genital anomalies)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CDKN1C</i></td>
                        
                        <td class="left-aligned">614732</td>
                        
                        <td class="left-aligned">Gene also known to cause Beckwith-Wiedemann syndrome (MIM 130650). IMAGE-associated variants are clustered in the PCNA-binding region and are maternally transmitted (gene is imprinted with preferential maternal expression)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0220</td>
                        
                        <td class="left-aligned">IMAGE syndrome/FILS syndrome, POLE-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POLE</i></td>
                        
                        <td class="left-aligned">618336, 615139</td>
                        
                        <td class="left-aligned">The phenotype is variable and may include immune deficiency (OMIM 615139)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0230</td>
                        
                        <td class="left-aligned">Saul-Wilson syndrome, COG4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COG4</i></td>
                        
                        <td class="left-aligned">618150</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0240</td>
                        
                        <td class="left-aligned">Short stature, facial dysmorphism, skeletal and dental anomalies syndrome, SCUBE3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SCUBE3</i></td>
                        
                        <td class="left-aligned">619184</td>
                        
                        <td class="left-aligned">in OMIM as “short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0250</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), ORC4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ORC1</i></td>
                        
                        <td class="left-aligned">224690</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0260</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), ORC4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ORC4</i></td>
                        
                        <td class="left-aligned">613800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0270</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), ORC6-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ORC6</i></td>
                        
                        <td class="left-aligned">613803</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0280</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), CDT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CDT1</i></td>
                        
                        <td class="left-aligned">605525</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0290</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), CDC6-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CDC6</i></td>
                        
                        <td class="left-aligned">613805</td>
                        
                        <td class="left-aligned">A single case reported so far</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0300</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), CDC45-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CDC45</i></td>
                        
                        <td class="left-aligned">603465</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0310</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), MCM3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MCM3</i></td>
                        
                        <td class="left-aligned">See 602693</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0320</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), MCM5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MCM5</i></td>
                        
                        <td class="left-aligned">602696</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0330</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), MCM7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MCM7</i></td>
                        
                        <td class="left-aligned">See 600592</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0340</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin), GMNN-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GMNN</i></td>
                        
                        <td class="left-aligned">613804</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 21-0350</td>
                        
                        <td class="left-aligned">Ear-patella-primordial short stature syndrome (Meier-Gorlin) with craniosynostosis, GINS2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GINS2</i></td>
                        
                        <td class="left-aligned">See 610609</td>
                        
                        <td class="left-aligned">A single case reported so far</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 22</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Lysosomal storage diseases with skeletal involvement</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0010</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 1, IDUA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IDUA</i></td>
                        
                        <td class="left-aligned">607014, 607015, 607016</td>
                        
                        <td class="left-aligned">Was type 1H-Hurler syndrome, type 1S-Scheie syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0020</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 2, IDS-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>IDS</i></td>
                        
                        <td class="left-aligned">309900</td>
                        
                        <td class="left-aligned">Known as Hunter syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0030</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 3, SGSH-related (type 3A)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SGSH</i></td>
                        
                        <td class="left-aligned">252900</td>
                        
                        <td class="left-aligned">Known as Sanfilippo A syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0040</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 3, NAGLU-related (type 3B)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NAGLU</i></td>
                        
                        <td class="left-aligned">252920</td>
                        
                        <td class="left-aligned">Known as Sanfilippo B syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0050</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 3, HSGNAT-related (type 3C)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HSGNAT</i></td>
                        
                        <td class="left-aligned">252930</td>
                        
                        <td class="left-aligned">Known as Sanfilippo C syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0060</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 3, GNS-related (type 3D)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GNS</i></td>
                        
                        <td class="left-aligned">252940</td>
                        
                        <td class="left-aligned">Known as Sanfilippo D syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0070</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 4, GALNS-related (type 4A)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GALNS</i></td>
                        
                        <td class="left-aligned">253000</td>
                        
                        <td class="left-aligned">Known as Morquio A syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0080</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 4, GLB1-related (type 4B)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GLB1</i></td>
                        
                        <td class="left-aligned">253010</td>
                        
                        <td class="left-aligned">Known as Morquio B syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0090</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 6, ARSB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ARSB</i></td>
                        
                        <td class="left-aligned">253200</td>
                        
                        <td class="left-aligned">Known as Maroteaux-Lamy syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0100</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 7, GUSB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GUSB</i></td>
                        
                        <td class="left-aligned">253220</td>
                        
                        <td class="left-aligned">Known as Sly syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0110</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis type 10, ARSK-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ARSK</i></td>
                        
                        <td class="left-aligned">610011</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0120</td>
                        
                        <td class="left-aligned">Mucopolysaccharidosis-plus syndrome, VPS33A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>VPS33A</i></td>
                        
                        <td class="left-aligned">617303</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0130</td>
                        
                        <td class="left-aligned">Fucosidosis, FUCA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FUCA</i></td>
                        
                        <td class="left-aligned">230000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0140</td>
                        
                        <td class="left-aligned">alpha-Mannosidosis, MAN2B1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MAN2B1</i></td>
                        
                        <td class="left-aligned">248500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0150</td>
                        
                        <td class="left-aligned">beta-Mannosidosis, MANBA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MANBA</i></td>
                        
                        <td class="left-aligned">248510</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0160</td>
                        
                        <td class="left-aligned">Aspartylglucosaminuria, AGA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>AGA</i></td>
                        
                        <td class="left-aligned">208400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0170</td>
                        
                        <td class="left-aligned">Gangliosidosis GM1, GLB1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GLB1</i></td>
                        
                        <td class="left-aligned">230500</td>
                        
                        <td class="left-aligned">Several forms, see also mucopolysaccharidosis type 4B (Morquio B) above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0180</td>
                        
                        <td class="left-aligned">Sialidosis, NEU1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NEU1</i></td>
                        
                        <td class="left-aligned">256550</td>
                        
                        <td class="left-aligned">Several forms of different severity</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0190</td>
                        
                        <td class="left-aligned">Galactosialidosis, PPGB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PPGB</i></td>
                        
                        <td class="left-aligned">256540</td>
                        
                        <td class="left-aligned">Several forms of different severity</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0200</td>
                        
                        <td class="left-aligned">Sialic acid storage disease (SIASD), SLC17A5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC17A5</i></td>
                        
                        <td class="left-aligned">269920</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0210</td>
                        
                        <td class="left-aligned">Multiple sulfatase deficiency, SUMF-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SUMF1</i></td>
                        
                        <td class="left-aligned">272200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0220</td>
                        
                        <td class="left-aligned">Mucolipidosis II (I-cell disease), GNPTAB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GNPTAB</i></td>
                        
                        <td class="left-aligned">252500</td>
                        
                        <td class="left-aligned">The old entity of Pacman dysplasia is the prenatal manifestation of mucolipidosis II with hyperparathyroidism</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0230</td>
                        
                        <td class="left-aligned">Mucolipidosis III (Pseudo-Hurler polydystrophy), GNPTAB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GNPTAB</i></td>
                        
                        <td class="left-aligned">252600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0240</td>
                        
                        <td class="left-aligned">Mucolipidosis III (Pseudo-Hurler polydystrophy), GNPTG-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GNPTG</i></td>
                        
                        <td class="left-aligned">252605</td>
                        
                        <td class="left-aligned">In general somewhat milder phenotype than the GNPTAB-related form</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0250</td>
                        
                        <td class="left-aligned">Mucolipidosis, GCAF-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CGAF</i></td>
                        
                        <td class="left-aligned">619345</td>
                        
                        <td class="left-aligned">The gene was previously known as TMEM251 and encodes for a “GNTAP cleavage and activity factor” (see GNTAP, above)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 22-0260</td>
                        
                        <td class="left-aligned">Gaucher disease, GBA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GBA</i></td>
                        
                        <td class="left-aligned">230800</td>
                        
                        <td class="left-aligned">Long-standing Gaucher disease can have bone changes that are different from the “dysostosis multiplex” pattern seen in other lysosomal diseases in this group</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also familial arthritis with hyaluronidase deficiency (“mucopolysaccharidosis type 9”), <i>HYAL1</i>-related; SEMD with elevated lysosomal enzymes, <i>MBTPS1</i>-related, above; as well as Farber disease, <i>ASAH1</i>-related, below.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 23</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Chondrodysplasia punctata (CDP) group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0010</td>
                        
                        <td class="left-aligned">CDP, X-linked recessive, ARSE-related (brachytelephalangic type; CDPX1)</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>ARSE</i></td>
                        
                        <td class="left-aligned">302950</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0020</td>
                        
                        <td class="left-aligned">CDP, X-linked dominant, EBP-related (Conradi-Hünermann type; CDPX2)</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>EBP</i></td>
                        
                        <td class="left-aligned">302960</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0030</td>
                        
                        <td class="left-aligned">Congenital hemidysplasia, ichthyosis, limb defects (CHILD) syndrome, NSDHL-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>NSDHL</i></td>
                        
                        <td class="left-aligned">308050</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0040</td>
                        
                        <td class="left-aligned">Keutel syndrome, MGP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MGP</i></td>
                        
                        <td class="left-aligned">245150</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0050</td>
                        
                        <td class="left-aligned">Greenberg dysplasia, LBR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LBR</i></td>
                        
                        <td class="left-aligned">215140</td>
                        
                        <td class="left-aligned">Includes hydrops-ectopic calcification-moth-eaten appearance dysplasia (HEM) and dappled diaphyseal dysplasia; possibly includes also the ultrarare entity designed as Astley-Kendall dysplasia. See also the non-lethal condition associated with <i>LBR</i>, above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0060</td>
                        
                        <td class="left-aligned">Rhizomelic CDP, PEX7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PEX7</i></td>
                        
                        <td class="left-aligned">215100</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0070</td>
                        
                        <td class="left-aligned">Rhizomelic CDP, DHPAT-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DHPAT</i></td>
                        
                        <td class="left-aligned">222765</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0080</td>
                        
                        <td class="left-aligned">Rhizomelic CDP, AGP5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>AGPS</i></td>
                        
                        <td class="left-aligned">600121</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0090</td>
                        
                        <td class="left-aligned">Rhizomelic CDP, FAR1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FAR1</i></td>
                        
                        <td class="left-aligned">616154</td>
                        
                        <td class="left-aligned">MIM calls this entity “peroxisomal fatty acyl-CoA reductase 1 disorder”; skeletal phenotype milder than other rCDP forms. The <i>FAR1</i> gene is also associated with cataracts, spastic paraparesis, and speech delay (MIM 619338, AD)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0100</td>
                        
                        <td class="left-aligned">Rhizomelic CDP, PEX5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PEX5</i></td>
                        
                        <td class="left-aligned">616716</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 23-0110</td>
                        
                        <td class="left-aligned">CDP tibial-metacarpal type</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">118651</td>
                        
                        <td class="left-aligned">Some cases possibly caused by maternal auto-immune disease</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: stippling can occur in several syndromes such as Zellweger cerebro-hepato-renal syndrome (see OMIM for the many genetic types), Smith-Lemli-Opitz (MIM 270400), in Mucolipidosis II (I-cell disease), <i>GNPTAB-</i>related, mild forms of Raine dysplasia, <i>FAM20C</i>-related, and others. See also SEMD short limb-abnormal calcification type, <i>DDR2</i>-related. Stippling in the fetus is also observed as a consequence of maternal auto-immune disease, sometimes presenting as “CDP tibial-metacarpal type”.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 24</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Osteopetrosis and related osteoclast disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0010</td>
                        
                        <td class="left-aligned">Osteopetrosis, neonatal or infantile form, TCIRG1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TCIRG1</i></td>
                        
                        <td class="left-aligned">259700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0020</td>
                        
                        <td class="left-aligned">Osteopetrosis, neonatal or infantile form, CLCN7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CLCN7</i></td>
                        
                        <td class="left-aligned">611490</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0030</td>
                        
                        <td class="left-aligned">Osteopetrosis, neonatal or infantile form, SNX10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SNX10</i></td>
                        
                        <td class="left-aligned">615085</td>
                        
                        <td class="left-aligned">-</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0040</td>
                        
                        <td class="left-aligned">Osteopetrosis, infantile form, with nervous system involvement, OSTM1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>OSTM1</i></td>
                        
                        <td class="left-aligned">259720</td>
                        
                        <td class="left-aligned">Includes former osteopetrosis with infantile neuraxonal dysplasia (MIM 600329)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0050</td>
                        
                        <td class="left-aligned">Osteopetrosis, infantile form, osteoclast-poor with immunoglobulin deficiency, TNFRSF11A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TNFRSF11A</i></td>
                        
                        <td class="left-aligned">612301</td>
                        
                        <td class="left-aligned">See also below in this group, dysosteosclerosis, TNFRSF11A-related, as well as MIM 602080-familial expansile osteolysis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0060</td>
                        
                        <td class="left-aligned">Osteopetrosis, intermediate form, TCIRG1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TCIRG1</i></td>
                        
                        <td class="left-aligned">259700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0070</td>
                        
                        <td class="left-aligned">Osteopetrosis, intermediate form, TNFSF11-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TNFSF11</i></td>
                        
                        <td class="left-aligned">259710</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0080</td>
                        
                        <td class="left-aligned">Osteopetrosis, intermediate form, PLEKHM-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PLEKHM1</i></td>
                        
                        <td class="left-aligned">611497</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0090</td>
                        
                        <td class="left-aligned">Osteopetrosis, intermediate form, CLCN7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CLCN7</i></td>
                        
                        <td class="left-aligned">259710</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0100</td>
                        
                        <td class="left-aligned">Osteopetrosis, late-onset, dominant form, CLCN7-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CLCN7</i></td>
                        
                        <td class="left-aligned">166600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0110</td>
                        
                        <td class="left-aligned">Osteopetrosis with renal tubular acidosis, CA2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CA2</i></td>
                        
                        <td class="left-aligned">259730</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0120</td>
                        
                        <td class="left-aligned">Osteopetrosis with ectodermal dysplasia and immune defect (OLEDAID), IKBKG-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>IKBKG</i></td>
                        
                        <td class="left-aligned">300301</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0130</td>
                        
                        <td class="left-aligned">Osteopetrosis, moderate form, SLC4A2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC4A2</i></td>
                        
                        <td class="left-aligned">See 109280</td>
                        
                        <td class="left-aligned">A single adult patient reported, phenotype may evolve</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0140</td>
                        
                        <td class="left-aligned">Osteopetrosis, moderate form with defective leucocyte adhesion, FERMT3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FERMT3</i></td>
                        
                        <td class="left-aligned">612840</td>
                        
                        <td class="left-aligned">In OMIM as Leucocyte Adhesion Deficiency 3 (LAD3)—MIM 612840</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0150</td>
                        
                        <td class="left-aligned">Osteopetrosis, moderate form with defective leucocyte adhesion, RASGRP2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RASGRP2</i></td>
                        
                        <td class="left-aligned">615888</td>
                        
                        <td class="left-aligned">OMIM only includes bleeding disorder, platelet type, 18 (MIM 615888) for this gene</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0160</td>
                        
                        <td class="left-aligned">Osteosclerotic metaphyseal dysplasia, LRKK1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LRRK1</i></td>
                        
                        <td class="left-aligned">615198</td>
                        
                        <td class="left-aligned">The name may be misleading as the condition is best described as a form of osteopetrosis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0170</td>
                        
                        <td class="left-aligned">Pyknodysostosis, CTSK-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CTSK</i></td>
                        
                        <td class="left-aligned">265800</td>
                        
                        <td class="left-aligned">In some individuals, the features of pyknodyostosis are absent and the disorder mimics osteopetrosis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0180</td>
                        
                        <td class="left-aligned">Dysosteosclerosis, SLC29A3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC29A3</i></td>
                        
                        <td class="left-aligned">224300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0190</td>
                        
                        <td class="left-aligned">Dysosteosclerosis, TNFRSF11A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TNFRSF11A</i></td>
                        
                        <td class="left-aligned">224300</td>
                        
                        <td class="left-aligned">This entity probably forms a spectrum with Osteopetrosis, intermediate form, TNFSF11-related (above)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 24-0200</td>
                        
                        <td class="left-aligned">Dysosteosclerosis with degenerative encephalopathy and brain malformation, CSF1R-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CSF1R</i></td>
                        
                        <td class="left-aligned">618476</td>
                        
                        <td class="left-aligned">In OMIM as “Brain abnormalities, neurodegeneration and dysosteosclerosis (BANDDOS)”; gene also associated with MIM 221820—leukoencephalopathy with spheroids.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: osteomesopyknosis (MIM 166450) may represent a form of osteopetrosis. In a pattern similar to the ciliary disorders, the phenotypes from individual loci are variable and may overlap with those of other loci.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 25</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Osteosclerotic disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0010</td>
                        
                        <td class="left-aligned">Desmosterolosis, DHCR4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DHCR24</i></td>
                        
                        <td class="left-aligned">602398</td>
                        
                        <td class="left-aligned">See also other sterol-metabolism related conditions</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0020</td>
                        
                        <td class="left-aligned">Raine dysplasia, FAM20C-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FAM20C</i></td>
                        
                        <td class="left-aligned">259775</td>
                        
                        <td class="left-aligned">Variable severity, many cases are perinatal severe, some cases show survival to adulthood; then often combined with FGF23 elevation and hypophosphatemic rickets</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0030</td>
                        
                        <td class="left-aligned">Caffey disease, COL1A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A1</i></td>
                        
                        <td class="left-aligned">114000</td>
                        
                        <td class="left-aligned">Rare specific variants in <i>COL1A1</i>. See also osteogenesis imperfecta related to collagen 1 genes.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0040</td>
                        
                        <td class="left-aligned">Caffey dysplasia (severe variants with prenatal onset)</td>
                        
                        <td class="left-aligned">AR?</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">114000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0050</td>
                        
                        <td class="left-aligned">Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">A few sporadic cases known, phenotype consistent, molecular basis unknown</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0060</td>
                        
                        <td class="left-aligned">Dysplastic cortical hyperostosis, Al-Gazali type</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">601356</td>
                        
                        <td class="left-aligned">Only a few cases known. Im OMIM as “Lethal short-limb skeletal dysplasia, Al Gazali type” . Not to be confused with “Al-Gazali syndrome”, a rare variant of <i>B3GALT6</i> disorders (see above)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0070</td>
                        
                        <td class="left-aligned">Osteopoikilosis, LEMD3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LEMD3</i></td>
                        
                        <td class="left-aligned">166700</td>
                        
                        <td class="left-aligned">Includes Buschke-Ollendorff syndrome (same OMIM entry)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0080</td>
                        
                        <td class="left-aligned">Melorheostosis with osteopoikilosis, LEMD3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LEMD3</i></td>
                        
                        <td class="left-aligned">166700</td>
                        
                        <td class="left-aligned">Includes mixed sclerosing bone dysplasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0090</td>
                        
                        <td class="left-aligned">Melorheostosis, MAP2K1-related</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"><i>MAP2K1</i></td>
                        
                        <td class="left-aligned">155950</td>
                        
                        <td class="left-aligned">Possibly locus heterogeneity</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0100</td>
                        
                        <td class="left-aligned">Osteopathia striata with cranial sclerosis (OSCS), AMER1-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>AMER1</i></td>
                        
                        <td class="left-aligned">300373</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0110</td>
                        
                        <td class="left-aligned">Pyle disease, SFRP4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SFRP4</i></td>
                        
                        <td class="left-aligned">265900</td>
                        
                        <td class="left-aligned">The name “metaphyseal dysplasia, Pyle type” is misleading (no growth plate dysplasia) and should be avoided</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0120</td>
                        
                        <td class="left-aligned">Craniometaphyseal dysplasia, ANKH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ANKH</i></td>
                        
                        <td class="left-aligned">123000</td>
                        
                        <td class="left-aligned">Dominant type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0130</td>
                        
                        <td class="left-aligned">Craniometaphyseal dysplasia, GJA1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GJA1</i></td>
                        
                        <td class="left-aligned">218400</td>
                        
                        <td class="left-aligned">Recessive type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0140</td>
                        
                        <td class="left-aligned">Diaphyseal dysplasia Camurati-Engelmann, TGFB1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TGFB1</i></td>
                        
                        <td class="left-aligned">131300</td>
                        
                        <td class="left-aligned">Gain-of-function variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0150</td>
                        
                        <td class="left-aligned">Hyperostosis-Hyperphosphatemia syndrome, GALNT3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GALNT3</i></td>
                        
                        <td class="left-aligned">211900</td>
                        
                        <td class="left-aligned">Formerly hyperphosphatemic tumoral calcinosis type 1</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0160</td>
                        
                        <td class="left-aligned">Hyperostosis-Hyperphosphatemia syndrome, FGF23-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FGF23</i></td>
                        
                        <td class="left-aligned">617993</td>
                        
                        <td class="left-aligned">Formerly hyperphosphatemic tumoral calcinosis type 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0170</td>
                        
                        <td class="left-aligned">Hyperostosis-Hyperphosphatemia syndrome, KL-relathed</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KL</i></td>
                        
                        <td class="left-aligned">617994</td>
                        
                        <td class="left-aligned">Formerly hyperphosphatemic tumoral calcinosis type 3</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0180</td>
                        
                        <td class="left-aligned">Cerebellar hypoplasia-endosteal sclerosis, POLR3B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POLR3B</i></td>
                        
                        <td class="left-aligned">213002</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0190</td>
                        
                        <td class="left-aligned">Hematodiaphyseal dysplasia Ghosal, TBXAS1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TBXAS1</i></td>
                        
                        <td class="left-aligned">231095</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0200</td>
                        
                        <td class="left-aligned">Hypertrophic osteoarthropathy, HPGD-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HPGD</i></td>
                        
                        <td class="left-aligned">259100</td>
                        
                        <td class="left-aligned">Includes cranio-osteoarthropathy, some cases of recessive pachydermoperiostosis, as well as recessively inherited isolated digital clubbing (MIM 119900)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0210</td>
                        
                        <td class="left-aligned">Hypertrophic osteoarthropathy, SLCO2A1-related</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>SLCO2A1</i></td>
                        
                        <td class="left-aligned">614441</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0220</td>
                        
                        <td class="left-aligned">Oculodentoosseous dysplasia (ODOD), GJA1-related, dominant, mild type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GJA1</i></td>
                        
                        <td class="left-aligned">164200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0230</td>
                        
                        <td class="left-aligned">Oculodentoosseous dysplasia (ODOD) GJA1-related, recessive, severe type</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GJA1</i></td>
                        
                        <td class="left-aligned">257850</td>
                        
                        <td class="left-aligned">Possibly homozygous form of mild ODOD</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0240</td>
                        
                        <td class="left-aligned">Osteoectasia with hyperphosphatasia (juvenile Paget disease), OPG-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>OPG</i></td>
                        
                        <td class="left-aligned">239000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0250</td>
                        
                        <td class="left-aligned">Osteosclerosis, LRP5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LRP5</i></td>
                        
                        <td class="left-aligned">144750, 607634</td>
                        
                        <td class="left-aligned">Includes previous AD osteopetrosis type 1 (OPTA1)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0260</td>
                        
                        <td class="left-aligned">Sclerosteosis, SOST-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SOST</i></td>
                        
                        <td class="left-aligned">269500</td>
                        
                        <td class="left-aligned">See also sclerosteosis, SOST-related, below</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0270</td>
                        
                        <td class="left-aligned">Sclerosteosis, LRP4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LRP4</i></td>
                        
                        <td class="left-aligned">614305</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0280</td>
                        
                        <td class="left-aligned">Endosteal hyperostosis, van Buchem type, SOST-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SOST</i></td>
                        
                        <td class="left-aligned">239100</td>
                        
                        <td class="left-aligned">Specific 52 kb deletion downstream of <i>SOST</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0290</td>
                        
                        <td class="left-aligned">Endosteal hyperostosis, Worth type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LRP5</i></td>
                        
                        <td class="left-aligned">144750</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0300</td>
                        
                        <td class="left-aligned">Craniodiaphyseal dysplasia, SOST-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SOST</i></td>
                        
                        <td class="left-aligned">122860</td>
                        
                        <td class="left-aligned">Presumed dominant negative variant</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0310</td>
                        
                        <td class="left-aligned">Craniodiaphyseal dysplasia, SP7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SP7</i></td>
                        
                        <td class="left-aligned">See 606633</td>
                        
                        <td class="left-aligned">One family reported; SP7 variants also associated with Osteogenesis imperfecta (MIM 613849), see below</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0320</td>
                        
                        <td class="left-aligned">Trichodentoosseous dysplasia, DLX3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DLX3</i></td>
                        
                        <td class="left-aligned">190320</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0330</td>
                        
                        <td class="left-aligned">Diaphyseal medullary stenosis with malignant fibrous histiocytoma, MTAP-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MTAP</i></td>
                        
                        <td class="left-aligned">112250</td>
                        
                        <td class="left-aligned">Also known as Hardcastle disease</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0340</td>
                        
                        <td class="left-aligned">Craniotubular dysplasia, TMEM53-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMEM53</i></td>
                        
                        <td class="left-aligned">619727</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0350</td>
                        
                        <td class="left-aligned">Craniometadiaphyseal dysplasia, Wormian bone type</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">269300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0360</td>
                        
                        <td class="left-aligned">Lenz-Majewski hyperostotic dysplasia, PTDSS1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PTDSS1</i></td>
                        
                        <td class="left-aligned">151050</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0370</td>
                        
                        <td class="left-aligned">Osteochondrodysplasia with hypertrichosis (Cantu syndrome), ABCC9-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ABCC9</i></td>
                        
                        <td class="left-aligned">239850</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0380</td>
                        
                        <td class="left-aligned">Familial Paget disease of bone, SQSTM1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SQSTM1</i></td>
                        
                        <td class="left-aligned">167250</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0390</td>
                        
                        <td class="left-aligned">Inclusion body myopathy, Paget disease of bone and frontotemporal dementia</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>VCP</i></td>
                        
                        <td class="left-aligned">167320</td>
                        
                        <td class="left-aligned">Monoallelic variants in the VCP gene are also associated with MIM 616687-Charcot-Marie-Tooth disease 2Y, and with MIM 613954-Frontotemporal dementia and/or amyotrophic lateral sclerosis 6.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0400</td>
                        
                        <td class="left-aligned">Endosteal hyperostosis, oligodontia, short stature, facial dysmorphism and intellectual disability, POLR3GL-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POLR3GL</i></td>
                        
                        <td class="left-aligned">619234</td>
                        
                        <td class="left-aligned">Phenotypic elements will need to be evaluated more precisely; one patient reported as Wiedemann-Rautenstrauch-syndrome-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0410</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia, Braun-Tinschert type</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">605946</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 25-0420</td>
                        
                        <td class="left-aligned">Trichothiodystrophy with axial osteosclerosis</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">A subset of patients with trichothiodystrophy have marked osteosclerosis but have not been molecularly characterized so far</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also the chondrodysplasia punctata group (group 23); as well as familial expansile osteolysis, <i>TNFRSF11A</i>-related (below); and trichothiodystrophy with central osteosclerosis (PMID 15148554)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 26</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Osteogenesis imperfecta and bone fragility group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0010</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, non-deforming (Sillence type 1), COL1A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A1</i></td>
                        
                        <td class="left-aligned">166200</td>
                        
                        <td class="left-aligned">Usually with persistently blue sclerae, can have signs of connective tissue weakness (in MIM as OI type I)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0020</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, non-deforming (Sillence type 1), COL1A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A2</i></td>
                        
                        <td class="left-aligned">166200</td>
                        
                        <td class="left-aligned">Usually with persistently blue sclerae, can have signs of connective tissue weakness (in MIM as OI type I)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0030</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, severe perinatal form (Sillence type 2) COL1A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A1</i></td>
                        
                        <td class="left-aligned">166210</td>
                        
                        <td class="left-aligned">Formerly “perinatal lethal”; in OMIM as OI type II</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0040</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, severe perinatal form (Sillence type 2), COL1A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A2</i></td>
                        
                        <td class="left-aligned">166210</td>
                        
                        <td class="left-aligned">Formerly “perinatal lethal”; in OMIM as OI type II</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0050</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, severe perinatal form (Sillence type 2), CRTAP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CRTAP</i></td>
                        
                        <td class="left-aligned">610682</td>
                        
                        <td class="left-aligned">Formerly “perinatal lethal”; in OMIM as OI type VII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0060</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, severe perinatal form (Sillence type 2), P3H1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>P3H1</i></td>
                        
                        <td class="left-aligned">610915</td>
                        
                        <td class="left-aligned">Formerly “perinatal lethal”; in OMIM as OI type VIII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0070</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, severe perinatal form (Sillence type 2), PPIB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PPIB</i></td>
                        
                        <td class="left-aligned">259440</td>
                        
                        <td class="left-aligned">Formerly “perinatal lethal”; in OMIM as OI type IX</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0080</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), COL1A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A1</i></td>
                        
                        <td class="left-aligned">259420</td>
                        
                        <td class="left-aligned">In OMIM as OI type III</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0090</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), COL1A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A2</i></td>
                        
                        <td class="left-aligned">259420</td>
                        
                        <td class="left-aligned">In OMIM as OI type III</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0100</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), IFITM5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IFITM5</i></td>
                        
                        <td class="left-aligned">610967</td>
                        
                        <td class="left-aligned">In OMIM OI type III; phenotype is distinct but in some instances can minimize OI type III</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0110</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), SERPINF1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SERPINF1</i></td>
                        
                        <td class="left-aligned">613982</td>
                        
                        <td class="left-aligned">In OMIM as OI type VI</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0120</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), CRTAP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CRTAP</i></td>
                        
                        <td class="left-aligned">610682</td>
                        
                        <td class="left-aligned">In OMIM OI type VII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0130</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), P3H1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>P3H1</i></td>
                        
                        <td class="left-aligned">610915</td>
                        
                        <td class="left-aligned">In OMIM OI type VIII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0140</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), PPIB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PPIB</i></td>
                        
                        <td class="left-aligned">see 259440</td>
                        
                        <td class="left-aligned">In OMIM OI type IX</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0150</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), SERPINH1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SERPINH1</i></td>
                        
                        <td class="left-aligned">613848</td>
                        
                        <td class="left-aligned">In OMIM OI type X</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0160</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), FKBP10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FKBP10</i></td>
                        
                        <td class="left-aligned">610968</td>
                        
                        <td class="left-aligned">In OMIM OI type XI</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0170</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), TMEM38B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMEM38B</i></td>
                        
                        <td class="left-aligned">615066</td>
                        
                        <td class="left-aligned">In OMIM OI type XIV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0180</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), BMP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BMP1</i></td>
                        
                        <td class="left-aligned">614856</td>
                        
                        <td class="left-aligned">In OMIM OI type XIII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0190</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), WNT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WNT1</i></td>
                        
                        <td class="left-aligned">615220</td>
                        
                        <td class="left-aligned">In OMIM as OI type XV. Biallelic variants; monoallelic variants may result in AD osteoporosis.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0200</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), CREB3L1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CREB3L1</i></td>
                        
                        <td class="left-aligned">616229</td>
                        
                        <td class="left-aligned">In OMIM as OI type XVI. Has severe joint laxity and scoliosis, Ehlers-Danlos-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0210</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), SPARC-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SPARC</i></td>
                        
                        <td class="left-aligned">616507</td>
                        
                        <td class="left-aligned">In OMIM as OI type XVII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0220</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), TENT5A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TENT5A</i></td>
                        
                        <td class="left-aligned">617952</td>
                        
                        <td class="left-aligned">In OMIM as OI type XVIII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0230</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), MBTPS2-related</td>
                        
                        <td class="left-aligned">XLR</td>
                        
                        <td class="left-aligned"><i>MBTPS2</i></td>
                        
                        <td class="left-aligned">301014</td>
                        
                        <td class="left-aligned">In OMIM as OI type XIX</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0240</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), MESD-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MESD</i></td>
                        
                        <td class="left-aligned">618644</td>
                        
                        <td class="left-aligned">In OMIM as OI type XX</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0250</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3) with neurodevelopmental features, KDELR2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KDELR2</i></td>
                        
                        <td class="left-aligned">619131</td>
                        
                        <td class="left-aligned">In OMIM as OI type XXI. Frequency of neurodevelopmental delay not clear yet.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0260</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, progressively deforming (Sillence type 3), CCD134-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CCD134</i></td>
                        
                        <td class="left-aligned">619795</td>
                        
                        <td class="left-aligned">In OMIM as OI typeXXII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0270</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), COL1A1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A1</i></td>
                        
                        <td class="left-aligned">166220</td>
                        
                        <td class="left-aligned">In OMIM as OI type IV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0280</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), COL1A2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COL1A2</i></td>
                        
                        <td class="left-aligned">166220</td>
                        
                        <td class="left-aligned">In OMIM as OI type IV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0290</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), WNT1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WNT1</i></td>
                        
                        <td class="left-aligned">see 166220</td>
                        
                        <td class="left-aligned">In OMIM as OI type XV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0300</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), IFITM5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IFITM5</i></td>
                        
                        <td class="left-aligned">166220</td>
                        
                        <td class="left-aligned">in OMIM OI type IV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0310</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), CRTAP-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CRTAP</i></td>
                        
                        <td class="left-aligned">see 610682</td>
                        
                        <td class="left-aligned">In OMIM as OI type VII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0320</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), PPIB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PPIB</i></td>
                        
                        <td class="left-aligned">see 259440</td>
                        
                        <td class="left-aligned">In OMIM as OI type IX</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0330</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), FKBP10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FKBP10</i></td>
                        
                        <td class="left-aligned">see 610968</td>
                        
                        <td class="left-aligned">In OMIM as OI type XI</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0340</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta, moderate form (Sillence type 4), SP7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SP7</i></td>
                        
                        <td class="left-aligned">613849</td>
                        
                        <td class="left-aligned">In OMIM as OI type XII</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0350</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta with calcification of interosseous membranes and/or hypertrophic callus (OI type 5), IFITM5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IFITM5</i></td>
                        
                        <td class="left-aligned">610967</td>
                        
                        <td class="left-aligned">When calcification of intraosseous membranes or hypertrophic callus are not observed, may mimic progressively deforming or moderate OI (Sillence types 3 and 4)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0360</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta with craniosynostosis (Cole-Carpenter syndrome), P4HB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>P4HB</i></td>
                        
                        <td class="left-aligned">112240</td>
                        
                        <td class="left-aligned">Craniosynostosis is not well documented in this condition in spite of the name.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0370</td>
                        
                        <td class="left-aligned">Osteogenesis imperfecta with craniosynostosis (Cole-Carpenter syndrome), SEC24D-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SEC24D</i></td>
                        
                        <td class="left-aligned">616294</td>
                        
                        <td class="left-aligned">Was Cole-Carpenter syndrome 2. Possibly misnomer, as most patients do not have craniosynostosis but rather large fontanels.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0380</td>
                        
                        <td class="left-aligned">Osteoporosis – X-linked form, PLS3-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>PLS3</i></td>
                        
                        <td class="left-aligned">300910</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0390</td>
                        
                        <td class="left-aligned">Osteoporosis—X-linked form, MBPTS2-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>MBTPS2</i></td>
                        
                        <td class="left-aligned">301014</td>
                        
                        <td class="left-aligned">In OMIM as OI type XIX; gene also associated with MIM 300918, MIM308205, MIM 308800</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0400</td>
                        
                        <td class="left-aligned">Osteoporosis—dominant form, WNT1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>WNT1</i></td>
                        
                        <td class="left-aligned">615220</td>
                        
                        <td class="left-aligned">OMIM OI type XV</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0410</td>
                        
                        <td class="left-aligned">Osteoporosis – AD form, LRP5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LRP5</i></td>
                        
                        <td class="left-aligned">166710, 601884</td>
                        
                        <td class="left-aligned">Monoallelic variants; biallelic variants result in MIM 259770 osteoporosis-pseudoglioma (see below); this gene is also associated with hyperostotic forms (see below) as well as with MIM 601813—exudative vitreoretinopathy, as well as MIM 617875—polycystic liver disease</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0420</td>
                        
                        <td class="left-aligned">Osteoporosis—AD form, ARHGAP25-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ARHGAP25</i></td>
                        
                        <td class="left-aligned">see 610587</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0430</td>
                        
                        <td class="left-aligned">Bruck syndrome type 1 (BS1), FKBP10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FKBP10</i></td>
                        
                        <td class="left-aligned">259450</td>
                        
                        <td class="left-aligned">See autosomal recessive OI, above; intrafamilial variability between OI type 3, arthrogryposis and Bruck syndrome 1 is documented</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0440</td>
                        
                        <td class="left-aligned">Bruck syndrome type 2 (BS2), PLOD2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PLOD2</i></td>
                        
                        <td class="left-aligned">609220</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0450</td>
                        
                        <td class="left-aligned">Osteoporosis-pseudoglioma syndrome, LRP5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LRP5</i></td>
                        
                        <td class="left-aligned">259770</td>
                        
                        <td class="left-aligned">When eye involvement is absent, may mimic progressively deforming or moderate OI (Sillence types 3 and 4)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0460</td>
                        
                        <td class="left-aligned">Bone fragility with calvarial “doughnut” lesions, SGSM2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SGMS2</i></td>
                        
                        <td class="left-aligned">126550</td>
                        
                        <td class="left-aligned">Overlap with a spondylo-metaphyseal dysplasia phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0470</td>
                        
                        <td class="left-aligned">Spondylo-ocular dysplasia, XYLT2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>XYLT2</i></td>
                        
                        <td class="left-aligned">605822</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0480</td>
                        
                        <td class="left-aligned">Gnathodiaphyseal dysplasia, ANO5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ANO5</i></td>
                        
                        <td class="left-aligned">166260</td>
                        
                        <td class="left-aligned">Gene also associated with OMIM 613319-Miyoshi muscular dystrophy 3, and OMIM 611307-recessive limb-girdle muscular dystrophy 12</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0490</td>
                        
                        <td class="left-aligned">Osteoporosis with developmental delay and microcephaly, COPB2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>COPB2</i></td>
                        
                        <td class="left-aligned">619884</td>
                        
                        <td class="left-aligned">Clinically variable, microcephaly in some cases only</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0500</td>
                        
                        <td class="left-aligned">Geroderma osteodysplasticum, GORAB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GORAB</i></td>
                        
                        <td class="left-aligned">231070</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0510</td>
                        
                        <td class="left-aligned">Cutis laxa, PYCR1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PYCR1</i></td>
                        
                        <td class="left-aligned">612940</td>
                        
                        <td class="left-aligned">Autosomal recessive form, type 2B (ARCL2B). Skeletal features overlapping with progeroid EDS and geroderma osteodysplasticum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0520</td>
                        
                        <td class="left-aligned">Cutis laxa, ATP6V0A2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ATP6V0A2</i></td>
                        
                        <td class="left-aligned">278250, 219200</td>
                        
                        <td class="left-aligned">Autosomal recessive form, type 2A (ARCL2A); wrinkly skin syndrome. Skeletal features overlapping with progeroid EDS and geroderma osteodysplasticum</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0530</td>
                        
                        <td class="left-aligned">Wiedemann-Rautenstrauch syndrome, POLR3A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POLR3A</i></td>
                        
                        <td class="left-aligned">264090</td>
                        
                        <td class="left-aligned">Gene also associated with MIM 607694- Leukodystrophy, hypomyelinating, with or without oligodontia and/or hypogonadotropic hypogonadism</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0540</td>
                        
                        <td class="left-aligned">Singleton-Merten dysplasia, IFIH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IFIH1</i></td>
                        
                        <td class="left-aligned">182250</td>
                        
                        <td class="left-aligned">Gene also associated with MIM 615846-Aicardi-Goutieres syndrome 7, and OMIM 619773-Immunodeficiency 95</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 26-0550</td>
                        
                        <td class="left-aligned">Singleton-Merten dysplasia, DDX58-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DDX58</i></td>
                        
                        <td class="left-aligned">616298</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: some of the recently discovered OI variants are still limited to very small numbers of patients; thus, the association with OI “Sillence type 3” is tentative and may be too restrictive as other phenotypes might emerge in the future. See also: Short stature, skeletal dysplasia, liver failure, optic nerve atrophy and Pelger-Huet anomaly, <i>NBAS</i>-related, above (Group 13); as well as all the Loeys-Dietz syndrome variants and the Snyder-Robinson syndrome, <i>SMS</i>-related (Group 31).</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 27</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Disorders of bone mineralisation</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0010</td>
                        
                        <td class="left-aligned">Hypophosphatasia, ALPL-related, recessive (biallelic) forms</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ALPL</i></td>
                        
                        <td class="left-aligned">241500</td>
                        
                        <td class="left-aligned">Includes perinatal, infantile and juvenile forms</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0020</td>
                        
                        <td class="left-aligned">Hypophosphatasia, ALPL-related, dominant (monoallelic) forms</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ALPL</i></td>
                        
                        <td class="left-aligned">146300</td>
                        
                        <td class="left-aligned">Includes juvenile and adult forms as well as odontohypophosphatasia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0030</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets, PHEX-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>PHEX</i></td>
                        
                        <td class="left-aligned">307800</td>
                        
                        <td class="left-aligned">X-linked, most common genetic form of hypophosphatemic rickets</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0040</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets, FGF23-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGF23</i></td>
                        
                        <td class="left-aligned">193100</td>
                        
                        <td class="left-aligned">Autosomal dominant</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0050</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets, DMP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DMP1</i></td>
                        
                        <td class="left-aligned">241520</td>
                        
                        <td class="left-aligned">Autosomal recessive (ARHR1)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0060</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets, ENPP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ENPP1</i></td>
                        
                        <td class="left-aligned">613312</td>
                        
                        <td class="left-aligned">Autosomal recessive (ARHR2)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0070</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets, SGK3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SGK3</i></td>
                        
                        <td class="left-aligned">see 607591</td>
                        
                        <td class="left-aligned">Autosomal dominant</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0080</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets with hypercalciuria, CLCN5-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>CLCN5</i></td>
                        
                        <td class="left-aligned">300554</td>
                        
                        <td class="left-aligned">X-linked; part of Dent's disease complex (progressive proximal renal tubulopathy with hypercalciuria, low molecular weight proteinuria, and nephrocalcinosis; MIM 300009)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0090</td>
                        
                        <td class="left-aligned">Hypophosphatemic rickets with hypercalciuria, SLC34A3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SLC34A3</i></td>
                        
                        <td class="left-aligned">241530</td>
                        
                        <td class="left-aligned">Autosomal recessive (HHRH)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0100</td>
                        
                        <td class="left-aligned">Vitamin D-dependent rickets, CYP27B1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CYP27B1</i></td>
                        
                        <td class="left-aligned">264700</td>
                        
                        <td class="left-aligned">Formerly type 1A</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0110</td>
                        
                        <td class="left-aligned">Vitamin D-dependent rickets, CYP2R1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CYP2R1</i></td>
                        
                        <td class="left-aligned">600081</td>
                        
                        <td class="left-aligned">Formerly type 1B</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0120</td>
                        
                        <td class="left-aligned">Vitamin D-dependent rickets, VDR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>VDR</i></td>
                        
                        <td class="left-aligned">277440</td>
                        
                        <td class="left-aligned">Formerly type 2A</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0130</td>
                        
                        <td class="left-aligned">Vitamin D-dependent rickets, CYP3A4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CYP3A4</i></td>
                        
                        <td class="left-aligned">619073</td>
                        
                        <td class="left-aligned">Formerly type 3; specific monoallelic variants that increase enzyme activity leading to rapid degradation of active vitamin D</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0140</td>
                        
                        <td class="left-aligned">Vitamin D-dependent rickets, HNRNPC-related</td>
                        
                        <td class="left-aligned">AD?</td>
                        
                        <td class="left-aligned"><i>HNRNPC</i></td>
                        
                        <td class="left-aligned">see 164020</td>
                        
                        <td class="left-aligned">Formerly type 2B; molecular basis (supposed HNRNPC dominant negative) from a single patient</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0150</td>
                        
                        <td class="left-aligned">Familial hyperparathyroidism, CDC73-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CDC73</i></td>
                        
                        <td class="left-aligned">145000, 145001</td>
                        
                        <td class="left-aligned">With or without jaw tumors</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0160</td>
                        
                        <td class="left-aligned">Familial hyperparathyroidism linked to chromosome 2</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>2p14-p13.3</i></td>
                        
                        <td class="left-aligned">610071</td>
                        
                        <td class="left-aligned">Linkage studies; no gene identified</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0170</td>
                        
                        <td class="left-aligned">Familial hyperparathyroidism, GCM2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GCM2</i></td>
                        
                        <td class="left-aligned">617343</td>
                        
                        <td class="left-aligned">Variants in this gene also cause familial isolated hypoparathyroidism (MIM 618883)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0180</td>
                        
                        <td class="left-aligned">Neonatal hyperparathyroidism, CASR-related</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>CASR</i></td>
                        
                        <td class="left-aligned">239200</td>
                        
                        <td class="left-aligned">“Severe” form (but see below, transient form also CASR-related). Variants in the <i>CASR</i> gene can also result in autosomal dominant hypocalcemia (MIM 601198)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0190</td>
                        
                        <td class="left-aligned">Neonatal hyperparathyroidism, TRPV6-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TRPV6</i></td>
                        
                        <td class="left-aligned">618188</td>
                        
                        <td class="left-aligned">Transient form</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0200</td>
                        
                        <td class="left-aligned">Familial hypocalciuric hypercalcemia with transient neonatal hyperparathyroidism, CASR-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CASR</i></td>
                        
                        <td class="left-aligned">145980</td>
                        
                        <td class="left-aligned">Other forms of familial hypocalciuric hypercalcemia do not show significant skeletal phenotypes</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0210</td>
                        
                        <td class="left-aligned">Calcium pyrophosphate deposition disease (familial chondrocalcinosis), ANKH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ANKH</i></td>
                        
                        <td class="left-aligned">118600</td>
                        
                        <td class="left-aligned">Loss-of-function variants (see also craniometaphyseal dysplasia, dominant type)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0220</td>
                        
                        <td class="left-aligned">Calcium pyrophosphate deposition disease (familial chondrocalcinosis), TNFRSF11B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TNFRSF11B</i></td>
                        
                        <td class="left-aligned">see 602643</td>
                        
                        <td class="left-aligned">Apparently monoallelic gain-of-function variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0230</td>
                        
                        <td class="left-aligned">Cutaneous skeletal hypophosphatemia syndrome</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>HRAS</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Somatic mosaicism for activating variants in <i>HRAS</i> with elevated FGF23 levels</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 27-0240</td>
                        
                        <td class="left-aligned">Cutaneous skeletal hypophosphatemia syndrome</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>NRAS</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Somatic mosaicism for activating variants in <i>NRAS</i> with elevated FGF23 levels</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: Hyperparathyroidism due to parathyroid adenoma occurs in a number of genetic disorders, for example, in Multiple Endocrine Neoplasias (see MIM for variants). See also Group 28, below, as well as Raine dysplasia, <i>FAM20C</i>-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 28</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Skeletal disorders of the parathyroid hormone signaling cascade</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0010</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia, Jansen type, PTHR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PTHR1</i></td>
                        
                        <td class="left-aligned">156400</td>
                        
                        <td class="left-aligned">Caused by activating variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0020</td>
                        
                        <td class="left-aligned">Metaphyseal dysplasia, Csukasi-Krakow type, SIK3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SIK3</i></td>
                        
                        <td class="left-aligned">618162</td>
                        
                        <td class="left-aligned">disruption of mTOR signaling downstream of the PTH receptor</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0030</td>
                        
                        <td class="left-aligned">Blomstrand dysplasia, PTHR1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PTHR1</i></td>
                        
                        <td class="left-aligned">215045</td>
                        
                        <td class="left-aligned">Caused by recessive (biallelic) loss-of-function variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0040</td>
                        
                        <td class="left-aligned">Eiken dysplasia, PTHR1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PTHR1</i></td>
                        
                        <td class="left-aligned">600002</td>
                        
                        <td class="left-aligned">Caused by recessive (biallelic) hypomorphic variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0050</td>
                        
                        <td class="left-aligned">Brachydactyly, PTHLH-related (brachdactyly type E2)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PTHLH</i></td>
                        
                        <td class="left-aligned">613382</td>
                        
                        <td class="left-aligned">Haploinsufficiency; with or without short stature</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 28-0060</td>
                        
                        <td class="left-aligned">Osteolysis, PTHLH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PTHLH</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Duplications of <i>PTHLH</i> causing acro-osteolysis; see also Groups 30 and 18</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: see also Acrodysostosis, <i>PDE4D</i>-related and <i>PRKAR1A</i>-related, above; and Albright hereditary osteodystrophy, <i>GNAS</i>-related. Monoallelic loss-of-function variants in <i>PTHR1</i> lead to primary failure of tooth eruption (MIM 125350)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 29</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Osteolysis group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0010</td>
                        
                        <td class="left-aligned">Familial expansile osteolysis, TNFRSF11A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TNFRSF11A</i></td>
                        
                        <td class="left-aligned">174810, 602080</td>
                        
                        <td class="left-aligned">Includes early-onset familial Paget disease of bone. See other <i>TNFRSF11A</i>-related phenoytpes in Group 24</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0020</td>
                        
                        <td class="left-aligned">Mandibuloacral dysplasia, LMNA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LMNA</i></td>
                        
                        <td class="left-aligned">248370</td>
                        
                        <td class="left-aligned">See also Progeria (in this group), <i>LMNA</i>-related cardiomyopathy and brachydactyly (Group 19) as well as many other conditions in MIM related to <i>LMNA</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0030</td>
                        
                        <td class="left-aligned">Mandibuloacral dysplasia, ZMPSTE24-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ZMPSTE24</i></td>
                        
                        <td class="left-aligned">608612</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0040</td>
                        
                        <td class="left-aligned">Mandiculoacral dysplasia, MTX2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MTX2</i></td>
                        
                        <td class="left-aligned">619127</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0050</td>
                        
                        <td class="left-aligned">Progeria, Hutchinson-Gilford type, LMNA-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LMNA</i></td>
                        
                        <td class="left-aligned">176670</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0060</td>
                        
                        <td class="left-aligned">Multicentric osteolysis, nodulosis and arthropathy (MONA), MMP2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MMP2</i></td>
                        
                        <td class="left-aligned">259600</td>
                        
                        <td class="left-aligned">Includes Winchester-Torg syndrome and nodulosis-arthropathy-osteolysis syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0070</td>
                        
                        <td class="left-aligned">Multicentric osteolysis, nodulosis and arthropathy (MONA), MMP14-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MMP14</i></td>
                        
                        <td class="left-aligned">277950</td>
                        
                        <td class="left-aligned">A biallelic homozygous <i>MMP14</i> variant seen in the original Winchester syndrome family</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0080</td>
                        
                        <td class="left-aligned">Hajdu-Cheney syndrome, NOTCH2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NOTCH2</i></td>
                        
                        <td class="left-aligned">102500</td>
                        
                        <td class="left-aligned">Includes the Serpentine fibula-polycystic kidney syndrome (SFPKS)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0090</td>
                        
                        <td class="left-aligned">Multicentric carpal-tarsal osteolysis with and without nephropathy, MAFB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MAFB</i></td>
                        
                        <td class="left-aligned">166300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0100</td>
                        
                        <td class="left-aligned">Penttinen syndrome, PDGFRB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PDGFRB</i></td>
                        
                        <td class="left-aligned">601812</td>
                        
                        <td class="left-aligned">See also MIM 601812-Kosaki overgrowth syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0110</td>
                        
                        <td class="left-aligned">Nestor Guillermo progeria syndrome, BANF1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BANF1</i></td>
                        
                        <td class="left-aligned">603811</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 29-0120</td>
                        
                        <td class="left-aligned">Farber disease, ASAH1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ASAH1</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">The chronic, adult form of Farber disease can present as osteolysis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: several neurologic conditions may cause acroosteolysis. See also Osteolysis, <i>PTHLH</i>-related (above), Pyknodysostosis, <i>CTSK</i>-related; cleidocranial dysplasia, <i>RUNX2</i>-related; Keutel syndrome, <i>MGP</i>-related; Singleton-Merten dysplasia, <i>IFIH</i>-related; and Singleton-Merten dysplasia, <i>DDX58</i>-related</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 30</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Disorganized development of skeletal components group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0010</td>
                        
                        <td class="left-aligned">Multiple cartilaginous exostoses, EXT1-related (MCE; or multiple osteochondromas, MO)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EXT1</i></td>
                        
                        <td class="left-aligned">133700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0020</td>
                        
                        <td class="left-aligned">Multiple cartilaginous exostoses, EXT2-related (MCE; or multiple osteochondromas, MO)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EXT2</i></td>
                        
                        <td class="left-aligned">133701</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0030</td>
                        
                        <td class="left-aligned">Cherubism, SH3BP2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SH3BP2</i></td>
                        
                        <td class="left-aligned">118400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0040</td>
                        
                        <td class="left-aligned">Fibrous dysplasia, polyostotic form (McCune-Albright syndrome), GNAS-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>GNAS</i></td>
                        
                        <td class="left-aligned">174800</td>
                        
                        <td class="left-aligned">Somatic mosaicism for gain-of-function variants; includes Mazabraud syndrome with intramuscular myxomas</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0050</td>
                        
                        <td class="left-aligned">Progressive osseous heteroplasia (POH), GNAS-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GNAS</i></td>
                        
                        <td class="left-aligned">166350</td>
                        
                        <td class="left-aligned">Germline loss-of-function of paternal allele</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0060</td>
                        
                        <td class="left-aligned">Metachondromatosis, PTPN11-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PTPN11</i></td>
                        
                        <td class="left-aligned">156250</td>
                        
                        <td class="left-aligned">Loss-of-function variants (in contrast to Noonan syndrome) with loss of heterozygosity in lesional tissue</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0070</td>
                        
                        <td class="left-aligned">Osteoglophonic dysplasia, FGFR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR1</i></td>
                        
                        <td class="left-aligned">166250</td>
                        
                        <td class="left-aligned">Craniosynostosis is also an important feature (Group 34)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0080</td>
                        
                        <td class="left-aligned">Fibrodysplasia ossificans progressiva (FOP), ACVR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ACVR1</i></td>
                        
                        <td class="left-aligned">135100</td>
                        
                        <td class="left-aligned">Most cases sporadic but dominant transmission documented</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0090</td>
                        
                        <td class="left-aligned">Neurofibromatosis type 1, NF1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NF1</i></td>
                        
                        <td class="left-aligned">162200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0100</td>
                        
                        <td class="left-aligned">Cherubism with gingival fibromatosis (Ramon syndrome)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">266270</td>
                        
                        <td class="left-aligned">Some similarities to primary intraosseous vascular malformation, ELMO2-related (see below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0110</td>
                        
                        <td class="left-aligned">Dysplasia epiphysealis hemimelica (Trevor)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">127800</td>
                        
                        <td class="left-aligned">Some familial cases reported (“familial Trevor disease”) but probably represent a different condition</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0120</td>
                        
                        <td class="left-aligned">Lipomembraneous osteodystrophy with leukoencephalopathy, TREM2-related (Nasu-Hakola)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TREM2</i></td>
                        
                        <td class="left-aligned">618193</td>
                        
                        <td class="left-aligned">Also known as presenile dementia with bone cysts</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0130</td>
                        
                        <td class="left-aligned">Lipomembraneous osteodystrophy with leukoencephalopathy, TYROBP-related (Nasu-Hakola)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TYROBP</i></td>
                        
                        <td class="left-aligned">221770</td>
                        
                        <td class="left-aligned">Also known as presenile dementia with bone cysts</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0140</td>
                        
                        <td class="left-aligned">Enchondromatosis, IDH1-related (Ollier disease)</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>IDH1</i></td>
                        
                        <td class="left-aligned">166000</td>
                        
                        <td class="left-aligned">Somatic mosaicism for specific <i>IDH1</i> variants. See also MIM 147700 and 137800</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0150</td>
                        
                        <td class="left-aligned">Enchondromatosis, IDH2-related (Ollier disease)</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>IDH2</i></td>
                        
                        <td class="left-aligned">166000</td>
                        
                        <td class="left-aligned">Somatic mosaicism for <i>IDH2</i> variants; significantly rarer than IDH1 variants. See also MIM 147650 and 613657, D-2-hydroxyglutaric aciduria 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0160</td>
                        
                        <td class="left-aligned">Enchondromatosis with hemangiomas, IDH1-related (Maffucci disease)</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>IDH1</i></td>
                        
                        <td class="left-aligned">614569</td>
                        
                        <td class="left-aligned">Somatic mosaicism for specific IDH1 variants. See also MIM 147700 and 137800</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0170</td>
                        
                        <td class="left-aligned">Enchondromatosis with hemangiomas, IDH2-related (Maffucci disease)</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>IDH2</i></td>
                        
                        <td class="left-aligned">614569</td>
                        
                        <td class="left-aligned">Somatic mosaicism for IDH2 variants; significantly rarer than IDH1 variants. See also MIM 147650 and 613657, D-2-hydroxyglutaric aciduria 2</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0180</td>
                        
                        <td class="left-aligned">Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria, IDH1-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>IDH1</i></td>
                        
                        <td class="left-aligned">614875</td>
                        
                        <td class="left-aligned">Includes so-called cheirospondyloenchondromatosis. Somatic mosaicism for <i>IDH1</i> variants. Possibly also <i>IDH2</i> variants but not yet well documented</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0190</td>
                        
                        <td class="left-aligned">Primary intraosseous vascular malformation, ELMO2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ELMO2</i></td>
                        
                        <td class="left-aligned">606893</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0200</td>
                        
                        <td class="left-aligned">Osteofibrous dysplasia, MET-related</td>
                        
                        <td class="left-aligned">AD, SP</td>
                        
                        <td class="left-aligned"><i>MET</i></td>
                        
                        <td class="left-aligned">607278</td>
                        
                        <td class="left-aligned">Possibly corresponding to the former “Campanacci dysplasia”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0210</td>
                        
                        <td class="left-aligned">Genochondromatosis</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">137360</td>
                        
                        <td class="left-aligned">“Geno” from Greek “knee”, but upper limbs also affected. Probably includes the condition known as Vaandrager-Peña syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 30-0220</td>
                        
                        <td class="left-aligned">Gorham-Stout disease and familial diffuse angiomatosis of bone</td>
                        
                        <td class="left-aligned">SP (MOS?), AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">see 123880</td>
                        
                        <td class="left-aligned">Severe Gorham-Stout disease is mostly sporadic. Somatic <i>KRAS</i> variants have been found in rare cases. In contrast, milder cases may be familial (“familial diffuse cystic angiomatosis of bone”; see OMIM 123880).</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: <i>PTEN</i>-related disorders are not included because the overgrowth is restricted to macrocephaly.- See also: Proteus syndrome, <i>AKT1</i>-related; Spondyloenchondrodysplasia with immune dysregulation (SPENCD), <i>ACP5</i>-related; Spondyloepimetaphyseal dysplasia, <i>COL2A1</i>-related (“SED with marked metaphyseal changes”, including dysspondyloenchondromatosis); Cutaneous skeletal hypophosphatemia syndrome, <i>HRAS-</i> related and <i>NRAS</i>-related. Some patients with <i>SOX6</i> variants have osteochondromas.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 31</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Overgrowth (tall stature) syndromes and segmental overgrowth</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0010</td>
                        
                        <td class="left-aligned">Marfan syndrome, FBN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBN1</i></td>
                        
                        <td class="left-aligned">154700</td>
                        
                        <td class="left-aligned">See also as differential diagnosis: homocystinuria and marfanoid habitus with ID (Lujan Fryns syndrome): <i>MED12</i>; <i>ZDHHC9</i>; <i>UPF3B</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0020</td>
                        
                        <td class="left-aligned">Congenital contractural arachnodactyly (Beals-Hecht syndrome), FBN2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBN2</i></td>
                        
                        <td class="left-aligned">121050</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0030</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, TGFBR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TGFBR1</i></td>
                        
                        <td class="left-aligned">609192</td>
                        
                        <td class="left-aligned">Osteopenia with propensity to fractures may be observed in all variants of the Loeys-Dietz syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0040</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, TGFBR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TGFBR2</i></td>
                        
                        <td class="left-aligned">610168</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0050</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, TGFB2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TGFB2</i></td>
                        
                        <td class="left-aligned">614816</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0060</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, TGFB3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TGFB3</i></td>
                        
                        <td class="left-aligned">615582</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0070</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, SMAD2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMAD2</i></td>
                        
                        <td class="left-aligned">619656</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0080</td>
                        
                        <td class="left-aligned">Loeys-Dietz syndrome, SMAD3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMAD3</i></td>
                        
                        <td class="left-aligned">613795</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0090</td>
                        
                        <td class="left-aligned">Weaver syndrome, EZH2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EZH2</i></td>
                        
                        <td class="left-aligned">277590</td>
                        
                        <td class="left-aligned">Some cases reported with <i>NSD1</i>, <i>EED</i>, and <i>SUZ12</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0100</td>
                        
                        <td class="left-aligned">Cohen-Gibson (Weaver-like) syndrome, EED-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EED</i></td>
                        
                        <td class="left-aligned">617561</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0110</td>
                        
                        <td class="left-aligned">Imagawa-Matsumoto (Weaver like) syndrome, SUZ12-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SUZ12</i></td>
                        
                        <td class="left-aligned">606245</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0120</td>
                        
                        <td class="left-aligned">Sotos syndrome, NSD1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NSD1</i></td>
                        
                        <td class="left-aligned">117550</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0130</td>
                        
                        <td class="left-aligned">Sotos syndrome, APC2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>APC2</i></td>
                        
                        <td class="left-aligned">617169</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0140</td>
                        
                        <td class="left-aligned">Malan (Sotos-like) syndrome, NFIX-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NFIX</i></td>
                        
                        <td class="left-aligned">614753</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0150</td>
                        
                        <td class="left-aligned">Luscan-Lumish syndrome, SETD2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SETD2</i></td>
                        
                        <td class="left-aligned">616831</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0160</td>
                        
                        <td class="left-aligned">Tatton-Brown-Rahman syndrome, DNMT3A-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DNMT3A</i></td>
                        
                        <td class="left-aligned">615879</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0170</td>
                        
                        <td class="left-aligned">Marshall-Smith syndrome, NFIX-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NFIX</i></td>
                        
                        <td class="left-aligned">602535</td>
                        
                        <td class="left-aligned">See also Malan syndrome. The localization of the monoallelic variants determine the Malan vs. Marshall-Smith phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0180</td>
                        
                        <td class="left-aligned">Beckwith-Wiedemann syndrome</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>11p15.5 region</i></td>
                        
                        <td class="left-aligned">130650</td>
                        
                        <td class="left-aligned">Variant or deletion of imprinted genes within the chromosome 11p15.5 region</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0190</td>
                        
                        <td class="left-aligned">Simpson-Golabi-Behmel syndrome, GPC3-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>GPC3</i></td>
                        
                        <td class="left-aligned">312870</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0200</td>
                        
                        <td class="left-aligned">Proteus syndrome, AKT1-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>AKT1</i></td>
                        
                        <td class="left-aligned">176920</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0210</td>
                        
                        <td class="left-aligned">Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH), AKT2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>AKT2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Gene also associated with OMIM 125853 diabetes mellitus type II</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0220</td>
                        
                        <td class="left-aligned">Congenital ipomatous overgrowth, vascular Malformations, epidermal Nevi, spinal/skeletal anomalies/scoliosis (CLOVES) syndrome, PIK3CA-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>PIK3CA</i></td>
                        
                        <td class="left-aligned">612918</td>
                        
                        <td class="left-aligned">Also named PIK3CA-related overgrowth syndrome (PROS); somatic variants; see MIM 171834</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0230</td>
                        
                        <td class="left-aligned">Fibroadipose hyperplasia, PIK3CA-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>PIK3CA</i></td>
                        
                        <td class="left-aligned">See 171834</td>
                        
                        <td class="left-aligned">See MIM 171834 for the many conditions associated with somatic <i>PIK3CA</i> variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0240</td>
                        
                        <td class="left-aligned">Snyder-Robinson syndrome (intellectual disability, tall stature, osteoporosis and fractures), SMS-related</td>
                        
                        <td class="left-aligned">XLR</td>
                        
                        <td class="left-aligned"><i>SMS</i></td>
                        
                        <td class="left-aligned">309583</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0250</td>
                        
                        <td class="left-aligned">Overgrowth syndrome with 2q37 translocations</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"><i>NPPC</i></td>
                        
                        <td class="left-aligned">see 600296</td>
                        
                        <td class="left-aligned">Overgrowth probably caused by overexpression of <i>NPPC</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0260</td>
                        
                        <td class="left-aligned">Tall stature with long halluces, NPR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NPR2</i></td>
                        
                        <td class="left-aligned">615923</td>
                        
                        <td class="left-aligned">Monoallelic gain-of-function variants in <i>NPR2</i>; in OMIM as epiphyseal chondrodysplasia, Miura type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0270</td>
                        
                        <td class="left-aligned">Tall stature with long halluces, NPR3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NPR3</i></td>
                        
                        <td class="left-aligned">619543</td>
                        
                        <td class="left-aligned">Biallelic loss-of-function variants in <i>NPR3</i>; in OMIM as Boudin-Mortier syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0280</td>
                        
                        <td class="left-aligned">Moreno-Nishimura-Schmidt syndrome</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">608811</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0290</td>
                        
                        <td class="left-aligned">Camptodactyly, tall stature and hearing loss syndrome (CATSHL), FGFR3-related</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">610474</td>
                        
                        <td class="left-aligned">Original family with monoallelic (dominant negative?) variant; a second family with biallelic variants (see Group 1)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0300</td>
                        
                        <td class="left-aligned">Kosaki overgrowth syndrome, PDGFRB-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>PDGFRB</i></td>
                        
                        <td class="left-aligned">616592</td>
                        
                        <td class="left-aligned">See also MIM 601812-Pentinnen syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 31-0310</td>
                        
                        <td class="left-aligned">Segmental odontomaxillary dysplasia, ACTB-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>ACTB</i></td>
                        
                        <td class="left-aligned">see 102630</td>
                        
                        <td class="left-aligned">See PMID 32585735; see also MIM 243310-Baraitser-Winter syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also: Shprintzen-Goldberg syndrome, <i>SKI</i>-related, in the craniosynostosis group. Note: this group does not include disorders that cause overgrowth secondary to vascular malformations, such as Klippel-Trenaunay syndrome, at least until a genetic (somatic) origin will have been demonstrated.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 32</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Genetic inflammatory or rheumatoid-like osteoarthropathies</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0010</td>
                        
                        <td class="left-aligned">Progressive pseudorheumatoid dysplasia (PPRD), WISP3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WISP3</i></td>
                        
                        <td class="left-aligned">208230</td>
                        
                        <td class="left-aligned">Also known as SED with progressive arthropathy</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0020</td>
                        
                        <td class="left-aligned">Chronic infantile neurologic cutaneous articular syndrome (CINCA), CIAS1-related (neonatal onset multisystem inflammatory disease (NOMID))</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CIAS1</i></td>
                        
                        <td class="left-aligned">607115</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0030</td>
                        
                        <td class="left-aligned">Sterile multifocal osteomyelitis, periostitis, and pustulosis (CINCA/NOMID-like), IL1RN-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IL1RN</i></td>
                        
                        <td class="left-aligned">See 147679</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0040</td>
                        
                        <td class="left-aligned">Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anemia (CRMO with CDA; Majeed syndrome), LPIN2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LPIN2</i></td>
                        
                        <td class="left-aligned">609628</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0050</td>
                        
                        <td class="left-aligned">Familial juvenile arthritis with hyaluronidase deficiency, HYAL1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HYAL1</i></td>
                        
                        <td class="left-aligned">601492</td>
                        
                        <td class="left-aligned">Also known as mucopolysaccharidosis type 9, although clinically no storage</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 32-0060</td>
                        
                        <td class="left-aligned">Hyaline Fibromatosis Syndrome, ANTXR2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ANTXR2</i></td>
                        
                        <td class="left-aligned">236490, 228600</td>
                        
                        <td class="left-aligned">Previously known as infantile systemic hyalinosis, juvenile hyaline fibromatosis, and puretic syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Farber disease, <i>ASAH1</i>-related (osteolysis group 29, and MIM 228000) shows phenotypic overlap with the conditions in this group.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 33</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Cleidocranial dysplasia and related disorders</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0010</td>
                        
                        <td class="left-aligned">Cleidocranial dysplasia, RUNX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RUNX2</i></td>
                        
                        <td class="left-aligned">119600</td>
                        
                        <td class="left-aligned">See also MIM 156510-metaphyseal dysplasia with maxillary hypoplasia, as well as non-syndromic midline craniosynostosis, RUNX2-related, below</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0020</td>
                        
                        <td class="left-aligned">Cleidocranial-like dysplasia, CBFB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>CBFB</i></td>
                        
                        <td class="left-aligned">See 121360</td>
                        
                        <td class="left-aligned">See also MIM 601626, familial leukemia</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0030</td>
                        
                        <td class="left-aligned">CDAGS syndrome (craniosynostosis, delayed fontanel closure, parietal foramina, imperforate anus, genital anomalies, skin eruption), RNU12-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RNU12</i></td>
                        
                        <td class="left-aligned">603116</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0040</td>
                        
                        <td class="left-aligned">Yunis-Varon dysplasia, FIG4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FIG4</i></td>
                        
                        <td class="left-aligned">216340</td>
                        
                        <td class="left-aligned">Gene also causes OMIM 612577 amyotrophic lateral sclerosis 11, and OMIM 611228 CMT disease 4J</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0050</td>
                        
                        <td class="left-aligned">Yunis-Varon dysplasia, VAC14-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>VAC14</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Only one case of VAC14-related Yunis-Varon reported so far, so association needs to be confirmed. Gene also associated with OMIM 617054 Striatonigral degeneration, childhood-onset (several patients reported)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0060</td>
                        
                        <td class="left-aligned">Parietal foramina, MSX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MSX2</i></td>
                        
                        <td class="left-aligned">168500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0070</td>
                        
                        <td class="left-aligned">Parietal foramina, ALX4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ALX4</i></td>
                        
                        <td class="left-aligned">609597</td>
                        
                        <td class="left-aligned">See also frontonasal dysplasia type 1</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 33-0080</td>
                        
                        <td class="left-aligned">Parietal foramina with cleidocranial dysplasia, MSX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MSX2</i></td>
                        
                        <td class="left-aligned">168550</td>
                        
                        <td class="left-aligned"><i>MSX2</i> variants also cause craniosynostosis Boston type</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also: pyknodysostosis, <i>CTSK</i>-related; cutis laxa, <i>ATP6V0A2</i>-related; mandibuloacral dysplasia, <i>LMNA</i>-related; progeria, Hutchinson-Gilford type, <i>LMNA</i>-related; and Hajdu-Cheney syndrome, <i>NOTCH2</i>-related, for similar clavicular defects or osteolysis. See also Crane-Heise syndrome (MIM 218090), the nosologic status of which remains unclear.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 34</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Syndromes featuring craniosynostosis</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0010</td>
                        
                        <td class="left-aligned">Pfeiffer syndrome, FGFR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR1</i></td>
                        
                        <td class="left-aligned">101600</td>
                        
                        <td class="left-aligned">Most have <i>FGFR1</i> p.P252R variant; Includes Jackson-Weiss syndrome (MIM 123150)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0020</td>
                        
                        <td class="left-aligned">Pfeiffer syndrome, FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">101600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0030</td>
                        
                        <td class="left-aligned">Apert syndrome, FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">101200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0040</td>
                        
                        <td class="left-aligned">Craniosynostosis with cutis gyrata (Beare-Stevenson), FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">123790</td>
                        
                        <td class="left-aligned">Notably p.S372Y or p.Y375C variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0050</td>
                        
                        <td class="left-aligned">Crouzon syndrome, FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">123500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0060</td>
                        
                        <td class="left-aligned">Crouzon-like craniosynostosis with acanthosis nigricans, FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">612247</td>
                        
                        <td class="left-aligned">Defined by specific <i>FGFR3</i> p.A391E variant; also known as Crouzonodermoskeletal syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0070</td>
                        
                        <td class="left-aligned">Craniosynostosis, Muenke type, FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">602849</td>
                        
                        <td class="left-aligned">Defined by specific <i>FGFR3</i> p.P250R variant</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0080</td>
                        
                        <td class="left-aligned">Antley-Bixler syndrome, POR-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POR</i></td>
                        
                        <td class="left-aligned">201750</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0090</td>
                        
                        <td class="left-aligned">Craniosynostosis Boston type, MSX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MSX2</i></td>
                        
                        <td class="left-aligned">604757</td>
                        
                        <td class="left-aligned">Heterozygous p.P148H variant in a two families</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0100</td>
                        
                        <td class="left-aligned">Saethre-Chotzen syndrome, TWIST1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TWIST1</i></td>
                        
                        <td class="left-aligned">101400</td>
                        
                        <td class="left-aligned">Variants in <i>FGFR3</i>, <i>FGFR2</i>, and <i>TCF12</i> have been reported to cause phenotypes resembling Saethre-Chotzen syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0110</td>
                        
                        <td class="left-aligned">Shprintzen-Goldberg syndrome, SKI-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SKI</i></td>
                        
                        <td class="left-aligned">182212</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0120</td>
                        
                        <td class="left-aligned">Baller-Gerold syndrome, RECQL4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RECQL4</i></td>
                        
                        <td class="left-aligned">218600</td>
                        
                        <td class="left-aligned">See other phenotypes associated with RECQL4 variants, above</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0130</td>
                        
                        <td class="left-aligned">Carpenter syndrome, RAB23-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RAB23</i></td>
                        
                        <td class="left-aligned">201000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0140</td>
                        
                        <td class="left-aligned">Carpenter syndrome, MEGF8-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MEGF8</i></td>
                        
                        <td class="left-aligned">614976</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0150</td>
                        
                        <td class="left-aligned">Craniosynostosis, TCF12-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TCF12</i></td>
                        
                        <td class="left-aligned">615314</td>
                        
                        <td class="left-aligned">Frequently coronal craniosynostosis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0160</td>
                        
                        <td class="left-aligned">Craniosynostosis, SIX1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SIX1</i></td>
                        
                        <td class="left-aligned">see 601205</td>
                        
                        <td class="left-aligned">Frequently sagittal and lambdoid synostosis. See also MIM 608389—Branchiootic syndrome 3, and 605192—deafness, autosomal dominant 23, for other SIX1-related phenotypes</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0170</td>
                        
                        <td class="left-aligned">Complex craniosynostosis, ERF-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ERF</i></td>
                        
                        <td class="left-aligned">600775</td>
                        
                        <td class="left-aligned">Variants in <i>ERF</i> also cause Chitayat hyperphalangism syndrome (Group 19)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0180</td>
                        
                        <td class="left-aligned">Non-syndromic midline (metopic / sagittal) craniosynostosis, SMAD6-related</td>
                        
                        <td class="left-aligned">AD?</td>
                        
                        <td class="left-aligned"><i>SMAD6</i></td>
                        
                        <td class="left-aligned">617439</td>
                        
                        <td class="left-aligned">Rare <i>SMAD6</i> variants and a common <i>BMP2</i> polymorphism may interact to produce craniosynostosis; subject disputed</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0190</td>
                        
                        <td class="left-aligned">Non-syndromic midline craniosynostosis, RUNX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RUNX2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Gain-of-function variants, duplications, triplications</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0200</td>
                        
                        <td class="left-aligned">Structural brain anomalies with impaired ID and craniosynostosis / craniosynostosis type 6</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ZIC1</i></td>
                        
                        <td class="left-aligned">618736</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0210</td>
                        
                        <td class="left-aligned">Craniosynostosis and dental anomalies (CRSDA), IL11RA-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IL11RA</i></td>
                        
                        <td class="left-aligned">614188</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0220</td>
                        
                        <td class="left-aligned">Craniosynostosis, retained deciduous teeth and intellectual disability, IL6ST-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>IL6ST</i></td>
                        
                        <td class="left-aligned">see 600694</td>
                        
                        <td class="left-aligned">Single case reported, with preserved LIF signaling. See Stüve-Wiedemann syndrome, <i>IL6ST</i>-related (above, group 24) as well as <i>IL6ST-</i>MIM 600694 for other phenotypes associated with <i>IL6ST</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0230</td>
                        
                        <td class="left-aligned">Cutis laxa with craniosynostosis, short stature, brachydactyly, and syndactyly, LTBP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LTBP1</i></td>
                        
                        <td class="left-aligned">619451</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0240</td>
                        
                        <td class="left-aligned">Bohring-Opitz syndrome, ASXL1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ASXL1</i></td>
                        
                        <td class="left-aligned">605039</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0250</td>
                        
                        <td class="left-aligned">Craniosynostosis, radiohumeral fusion and other skeletal defects, CYP26B1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CYP26B1</i></td>
                        
                        <td class="left-aligned">614416</td>
                        
                        <td class="left-aligned"><i>CYP26B1</i> is a retinoid acid-degrading enzyme, pathogenesis involves retinoic acid-associated morphogenesis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0260</td>
                        
                        <td class="left-aligned">Cardiac, facial and digital anomalies with developmental delay (CAFDADD), TRAF7-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TRAF7</i></td>
                        
                        <td class="left-aligned">618164</td>
                        
                        <td class="left-aligned">Multistructure craniosynostosis is one of the features</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0270</td>
                        
                        <td class="left-aligned">Craniosynostosis, hypertrichosis, progeroid appearance, bone dysplasia, characteristic face (Fontaine progeroid syndrome, Gorlin-Chaudhry-Moss syndrome), SLC25A24-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SLC25A24</i></td>
                        
                        <td class="left-aligned">612289</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0280</td>
                        
                        <td class="left-aligned">Curry-Jones syndrome, SMO-related</td>
                        
                        <td class="left-aligned">MOS</td>
                        
                        <td class="left-aligned"><i>SMO</i></td>
                        
                        <td class="left-aligned">601707</td>
                        
                        <td class="left-aligned">Activating variant c.1234C&gt;T (p.L412F)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0290</td>
                        
                        <td class="left-aligned">3MC syndrome, MASP1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MASP1</i></td>
                        
                        <td class="left-aligned">257920</td>
                        
                        <td class="left-aligned">Craniosynostosis in 20%–30%</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0300</td>
                        
                        <td class="left-aligned">3MC syndrome, COLEC11-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COLEC11</i></td>
                        
                        <td class="left-aligned">265050</td>
                        
                        <td class="left-aligned">Craniosynostosis in 20%–30%</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0310</td>
                        
                        <td class="left-aligned">3MC syndrome, COLEC10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COLEC10</i></td>
                        
                        <td class="left-aligned">248340</td>
                        
                        <td class="left-aligned">Craniosynostosis in 20%–30%</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0320</td>
                        
                        <td class="left-aligned">Weiss-Kruszka syndrome, ZNF462-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ZNF462</i></td>
                        
                        <td class="left-aligned">618619</td>
                        
                        <td class="left-aligned">Metopic ridging or CSO (metopic, lambdoid, 9/24)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0330</td>
                        
                        <td class="left-aligned">Au-Kline syndrome, HNRNPK-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HNRNPK</i></td>
                        
                        <td class="left-aligned">616580</td>
                        
                        <td class="left-aligned">Craniosynostosis and vertebral anomalies in a significant proportion of cases</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0340</td>
                        
                        <td class="left-aligned">Char syndrome, TFAP2B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TFAP2B</i></td>
                        
                        <td class="left-aligned">169100</td>
                        
                        <td class="left-aligned">Mainly with loss-of-function variants</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 34-0350</td>
                        
                        <td class="left-aligned">Syndrome with developmental and speech delay, dysmorphic facies, craniosynostosis and T-cell abnormalities</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>BCL11B</i></td>
                        
                        <td class="left-aligned">618092</td>
                        
                        <td class="left-aligned">Craniosynostosis in some affected individuals</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Craniosynostosis is not rare and may have a non-genetic pathogenesis in many cases. It can also occur secondarily in any form of rickets. Conditions in which craniosynostosis is an occasional feature have not been included. See also: cranioectodermal dysplasia (several types in the ciliopathy group); SEMD, <i>RSPRY1</i>-related; osteocraniostenosis, <i>FAM111A</i>-related; Osteogenesis imperfecta with craniosynostosis (Cole-Carpenter syndrome), <i>P4HB</i>-related; CDAGS syndrome, <i>RNU12</i>-related; syndactyly (Lueken type, with or without craniosynostosis), <i>IHH</i>-related; and Multiple synostoses syndrome, <i>FGF9</i>-related. Craniosynostosis can also be present in Loeys-Dietz syndromes, Meier-Gorlin syndrome, <i>CDC45</i>-related and <i>GINS2</i>-related; Hypophosphatasia, <i>ALPL</i>-related; Hypophosphatemic rickets, <i>PHEX</i>-related; Greig cephalopolysyndactyly syndrome, GLI3-related; and others.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 35</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Craniofacial dysostoses</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0010</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis, TCOF1-related (Treacher-Collins, Franceschetti-Klein)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TCOF1</i></td>
                        
                        <td class="left-aligned">154500</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0020</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis, POLR1B-related (Treacher-Collins, Franceschetti-Klein)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>POLR1B</i></td>
                        
                        <td class="left-aligned">618939</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0030</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis, POLR1C-related (Treacher-Collins, Franceschetti-Klein)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>POLR1C</i></td>
                        
                        <td class="left-aligned">248390</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0040</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis, POLR1D-related (Treacher-Collins, Franceschetti-Klein)</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>POLR1D</i></td>
                        
                        <td class="left-aligned">613717</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0050</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis with limb deficiencies, POLR1A-related (Cincinnati type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>POLR1A</i></td>
                        
                        <td class="left-aligned">616462</td>
                        
                        <td class="left-aligned">The original description was “acrofacial dysostosis: a mandibulofacial dysostosis with limb anomalies”. The limb anomalies are variable</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0060</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis with microcephaly, EFTUD2-related (Guion-Almeida type)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EFTUD2</i></td>
                        
                        <td class="left-aligned">610536</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0070</td>
                        
                        <td class="left-aligned">Mandibulofacial dysostosis with alopecia, EDNRA-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EDNRA</i></td>
                        
                        <td class="left-aligned">616367</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0080</td>
                        
                        <td class="left-aligned">Burns-McKeown syndrome, TXNL4A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TXNL4A</i></td>
                        
                        <td class="left-aligned">608572</td>
                        
                        <td class="left-aligned">Some pathogenic variants are in the promoter region; severity is variable</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0090</td>
                        
                        <td class="left-aligned">Postaxial acrofacial dysostosis, DHODH-related (Miller syndrome)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DHODH</i></td>
                        
                        <td class="left-aligned">263750</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0100</td>
                        
                        <td class="left-aligned">Acrofacial dysostosis, SF3B4-related (Nager syndrome)</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>SF3B4</i></td>
                        
                        <td class="left-aligned">154400, 201170</td>
                        
                        <td class="left-aligned">Both monoallelic and biallelic variants are at the basis of a spectrum that also includes the former “Rodriguez type” of acrofacial dysostosis</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0110</td>
                        
                        <td class="left-aligned">Agnathia-Otocephaly complex, PRRX1-related</td>
                        
                        <td class="left-aligned">AD, AR</td>
                        
                        <td class="left-aligned"><i>PRRX1</i></td>
                        
                        <td class="left-aligned">202650</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0120</td>
                        
                        <td class="left-aligned">Frontonasal dysplasia, ALX3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ALX3</i></td>
                        
                        <td class="left-aligned">136760</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0130</td>
                        
                        <td class="left-aligned">Frontonasal dysplasia, ALX4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ALX4</i></td>
                        
                        <td class="left-aligned">613451</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0140</td>
                        
                        <td class="left-aligned">Frontonasal dysplasia, ALX1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ALX1</i></td>
                        
                        <td class="left-aligned">613456</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0150</td>
                        
                        <td class="left-aligned">Frontonasal dysplasia, SIX2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SIX2</i></td>
                        
                        <td class="left-aligned">See 604994</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0160</td>
                        
                        <td class="left-aligned">Frontonasal dysplasia with additional malformations (Sweeney-Cox syndrome), TWIST1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TWIST1</i></td>
                        
                        <td class="left-aligned">617746</td>
                        
                        <td class="left-aligned">Results from specific amino acid substitutions in TWIST1</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0170</td>
                        
                        <td class="left-aligned">Craniofrontonasal syndrome, EFN1B-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>EFNB1</i></td>
                        
                        <td class="left-aligned">304110</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0180</td>
                        
                        <td class="left-aligned">Acromelic frontonasal dysostosis, ZSWIM6-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ZSWIM6</i></td>
                        
                        <td class="left-aligned">603671</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0190</td>
                        
                        <td class="left-aligned">Richieri-Costa-Pereira syndrome, EIF4A3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EIF4A3</i></td>
                        
                        <td class="left-aligned">268305</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0200</td>
                        
                        <td class="left-aligned">Auriculocondylar syndrome, GNAI3-related (type 1)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GNAI3</i></td>
                        
                        <td class="left-aligned">602483</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0210</td>
                        
                        <td class="left-aligned">Auriculocondylar syndrome, PLCB4-related (type 2)</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>PLCB4</i></td>
                        
                        <td class="left-aligned">614669</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0220</td>
                        
                        <td class="left-aligned">Auriculocondylar syndrome, EDN1-related (type 3)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EDN1</i></td>
                        
                        <td class="left-aligned">615706</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0230</td>
                        
                        <td class="left-aligned">Orofaciodigital syndrome type I, OFD1-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>OFD1</i></td>
                        
                        <td class="left-aligned">311200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0240</td>
                        
                        <td class="left-aligned">Weyers acrofacial (acrodental) dysostosis, EVC1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EVC1</i></td>
                        
                        <td class="left-aligned">193530</td>
                        
                        <td class="left-aligned">See also Group 10</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0250</td>
                        
                        <td class="left-aligned">Weyers acrofacial (acrodental) dysostosis, EVC2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EVC2</i></td>
                        
                        <td class="left-aligned">193530</td>
                        
                        <td class="left-aligned">See also Group 10</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0260</td>
                        
                        <td class="left-aligned">Teebi hypertelorism syndrome, SPECCIL-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SPECC1L</i></td>
                        
                        <td class="left-aligned">145420</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0270</td>
                        
                        <td class="left-aligned">Craniolenticulosutural dysplasia, SEC23A-related</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>SEC23A</i></td>
                        
                        <td class="left-aligned">607812</td>
                        
                        <td class="left-aligned">Monoallelic and biallelic inheritance observed</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0280</td>
                        
                        <td class="left-aligned">Faciogenital dysplasia, FGD1-related (Aarskog-Scott syndrome)</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FGD1</i></td>
                        
                        <td class="left-aligned">305400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0290</td>
                        
                        <td class="left-aligned">Baraitser-Winter syndrome, ACTB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ACTB</i></td>
                        
                        <td class="left-aligned">243310</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0300</td>
                        
                        <td class="left-aligned">Baraitser-Winter syndrome, ACTG1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ACTG1</i></td>
                        
                        <td class="left-aligned">614583</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0310</td>
                        
                        <td class="left-aligned">Cerebrofaciothoracic dysplasia, TMCO1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TMCO1</i></td>
                        
                        <td class="left-aligned">213980</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0320</td>
                        
                        <td class="left-aligned">Opitz GBBB syndrome, MID1-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>MID1</i></td>
                        
                        <td class="left-aligned">300000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0330</td>
                        
                        <td class="left-aligned">Arhinia microphthalmia syndrome, SMCHD1-related (Bosma)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMCHD1</i></td>
                        
                        <td class="left-aligned">603457</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0340</td>
                        
                        <td class="left-aligned">Acrofrontofacionasal dysostosis</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">201180</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 35-0350</td>
                        
                        <td class="left-aligned">Hemifacial microsomia</td>
                        
                        <td class="left-aligned">SP, AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">164210</td>
                        
                        <td class="left-aligned">Includes Goldenhar syndrome and Oculo-Auriculo-Vertebral spectrum; genetically heterogeneous; SF3B2 haploinsufficiency identified in ~3% of sporadic and ~25% of familial cases; in some cases a microduplication on 14q23.1</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also orofaciodigital syndrome type 4 (Mohr-Majewski), <i>TCTN3</i>-related; Endocrine-cerebro-osteo dysplasia (ECO), <i>CILK1</i>-related; the Cerebro-Costo-Mandibular syndrome, SNRPB-related (group 36, below); and Robinow syndrome (see variants in Group 15)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 36</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Vertebral and costal dysostoses</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0010</td>
                        
                        <td class="left-aligned">Currarino syndrome, MNX1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MNX1</i></td>
                        
                        <td class="left-aligned">176450</td>
                        
                        <td class="left-aligned">Possible clinical overlap with caudal regression syndrome (see MIM 600145; the role of heterozygous variants in <i>VANGL1</i> remains to be confirmed)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0020</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, DLL3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DLL3</i></td>
                        
                        <td class="left-aligned">277300</td>
                        
                        <td class="left-aligned">Possible role of CNVs in <i>TBX6</i> in modulating the phenotype?</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0030</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, MESP2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MESP2</i></td>
                        
                        <td class="left-aligned">608681</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0040</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, LFNG-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LFNG</i></td>
                        
                        <td class="left-aligned">609813</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0050</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, HES7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HES7</i></td>
                        
                        <td class="left-aligned">613686</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0060</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, TBX6-related</td>
                        
                        <td class="left-aligned">AR, AD</td>
                        
                        <td class="left-aligned"><i>TBX6</i></td>
                        
                        <td class="left-aligned">122600</td>
                        
                        <td class="left-aligned">Possible role of CNVs in <i>TBX6</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0070</td>
                        
                        <td class="left-aligned">Spondylocostal dysostosis, RIPPLY2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RIPPLY2</i></td>
                        
                        <td class="left-aligned">616566</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0080</td>
                        
                        <td class="left-aligned">Vertebral segmentation defect (congenital scoliosis) with variable penetrance, MESP2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MESP2</i></td>
                        
                        <td class="left-aligned">608681</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0090</td>
                        
                        <td class="left-aligned">Vertebral segmentation defect (congenital scoliosis) with variable penetrance, HES7-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HES7</i></td>
                        
                        <td class="left-aligned">613686</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0100</td>
                        
                        <td class="left-aligned">Short stature, cervical segmentation defects, and developmental delay, CDK10-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CDK10</i></td>
                        
                        <td class="left-aligned">617694</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0110</td>
                        
                        <td class="left-aligned">Klippel-Feil syndrome, GDF6-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF6</i></td>
                        
                        <td class="left-aligned">118100</td>
                        
                        <td class="left-aligned">Role of <i>GDF6</i> variants in Klippel-Feil syndrome as well as in AD spondylothoracic dysostosis remains unclear</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0120</td>
                        
                        <td class="left-aligned">Klippel-Feil syndrome, MEOX1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MEOX1</i></td>
                        
                        <td class="left-aligned">214300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0130</td>
                        
                        <td class="left-aligned">Klippel-Feil syndrome, GDF3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF3</i></td>
                        
                        <td class="left-aligned">613702</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0140</td>
                        
                        <td class="left-aligned">Klippel-Feil syndrome, MYO18B-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MYO18B</i></td>
                        
                        <td class="left-aligned">616549</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0150</td>
                        
                        <td class="left-aligned">Cervico-oculo-acoustic (Wildervanck) syndrome</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">314600</td>
                        
                        <td class="left-aligned">Congenital perceptive deafness, Klippel-Feil anomaly (see 118100), and abducens palsy with retractio bulbi</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0160</td>
                        
                        <td class="left-aligned">Cerebro-costo-mandibular syndrome (rib gap syndrome), SNRPB-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SNRPB</i></td>
                        
                        <td class="left-aligned">117650</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0170</td>
                        
                        <td class="left-aligned">Cerebro-costo-mandibular-like syndrome, COG1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>COG1</i></td>
                        
                        <td class="left-aligned">611209</td>
                        
                        <td class="left-aligned">Also known as CDG IIg</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0180</td>
                        
                        <td class="left-aligned">Diaphanospondylodysostosis, BMPER-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>BMPER</i></td>
                        
                        <td class="left-aligned">608022</td>
                        
                        <td class="left-aligned">Includes ischiospinal dysostosis, a term that has been used for milder cases</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0190</td>
                        
                        <td class="left-aligned">Spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD), NKX3-2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NKX3-2</i></td>
                        
                        <td class="left-aligned">613330</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0200</td>
                        
                        <td class="left-aligned">NAD deficiency syndrome, HAAO-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>HAAO</i></td>
                        
                        <td class="left-aligned">617660</td>
                        
                        <td class="left-aligned">With associated cardiac, limb and renal defects; VACTERL-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0210</td>
                        
                        <td class="left-aligned">NAD deficiency syndrome, KYNU-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KYNU</i></td>
                        
                        <td class="left-aligned">617661</td>
                        
                        <td class="left-aligned">In some cases VACTERL-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0220</td>
                        
                        <td class="left-aligned">NAD deficiency syndrome, NADSYN1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>NADSYN1</i></td>
                        
                        <td class="left-aligned">618845</td>
                        
                        <td class="left-aligned">In some cases VACTERL-like</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0230</td>
                        
                        <td class="left-aligned">VATER/VACTERL association</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">192350</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0240</td>
                        
                        <td class="left-aligned">VACTERL association with hydrocephalus (VACTERL-H), FANCB-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>FANCB</i></td>
                        
                        <td class="left-aligned">300514</td>
                        
                        <td class="left-aligned"><i>FANCB</i>-related Fanconi anemia may present in hemizygous males with the VACTERL-hydrocephalus phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0250</td>
                        
                        <td class="left-aligned">VACTERL association with hydrocephalus (VACTERL-H), ZIC3-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>ZIC3</i></td>
                        
                        <td class="left-aligned">314390</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 36-0260</td>
                        
                        <td class="left-aligned">Uniparental disomy, paternal, for chromosome 14 (UPD14; Kagami-Ogata syndrome)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"><i>14q32?</i></td>
                        
                        <td class="left-aligned">608149</td>
                        
                        <td class="left-aligned">Imprinted genes at 14q32 may have a role in this complex phenotype with skeletal malformations such as “coat-hanger ribs”</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">VACTERL is nowadays defined as a “Recurrent Constellation of Embryonic Malformations” (RCEM; see Adam et al, AJMG 2020) without a single genetic basis. It may be mimicked by NAD deficiency syndrome, Fanconi anemia and others. The diagnosis is supported by negative genetic analysis. See also spondylocarpotarsal synostosis syndrome, FLNB-related and RFLNA-related, Robinow syndrome (variants in Group 15), and cerebrofaciothoracic dysplasia, TMCO1-related (Group 35)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 37</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Patellar dysostoses</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 37-0010</td>
                        
                        <td class="left-aligned">Ischiopatellar dysplasia (small patella syndrome), TBX4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TBX4</i></td>
                        
                        <td class="left-aligned">147891</td>
                        
                        <td class="left-aligned">See MIM 601360—posterior amelia for the biallelic phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 37-0020</td>
                        
                        <td class="left-aligned">Nail-patella syndrome, LMX1B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>LMX1B</i></td>
                        
                        <td class="left-aligned">161200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 37-0030</td>
                        
                        <td class="left-aligned">Genitopatellar syndrome, KAT6B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>KAT6B</i></td>
                        
                        <td class="left-aligned">606170</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Meier-Gorlin syndromes in the primordial dwarfism group (Group 21), and the pseudoachondroplasia/MED group (Group 9) for conditions with patellar changes; see also ischio-pubic-patellar dysplasia as mild expression of campomelic dysplasia, <i>SOX9</i>-related; RAPADILINO syndrome, <i>RECQL4</i>-related. Patellar hypoplasia is variably present in Clubfoot with or without deficiency of long bones and/or mirror-image polydactyly, <i>PITX1</i>-related.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 38</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Limb hypoplasia—reduction defects group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0010</td>
                        
                        <td class="left-aligned">Ulnar-mammary syndrome, TBX3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TBX3</i></td>
                        
                        <td class="left-aligned">181450</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0020</td>
                        
                        <td class="left-aligned">Holt-Oram syndrome, TBX5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TBX5</i></td>
                        
                        <td class="left-aligned">142900</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0030</td>
                        
                        <td class="left-aligned">Holt-Oram/Ulnar Mammary blended phenotype</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TBX3, TBX5</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">CNVs involving both <i>TBX3</i> and <i>TBX5</i> may result in combined phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0040</td>
                        
                        <td class="left-aligned">Posterior Amelia, TBX4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TBX4</i></td>
                        
                        <td class="left-aligned">601360</td>
                        
                        <td class="left-aligned">See also ischiopatellar syndrome for the monoallelic TBX4-related phenotype</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0050</td>
                        
                        <td class="left-aligned">Cornelia de Lange syndrome, NIPBL-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NIPBL</i></td>
                        
                        <td class="left-aligned">122470</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0060</td>
                        
                        <td class="left-aligned">Cornelia de Lange syndrome, SMC1A-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>SMC1A</i></td>
                        
                        <td class="left-aligned">300590</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0070</td>
                        
                        <td class="left-aligned">Cornelia de Lange syndrome, SMC3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SMC3</i></td>
                        
                        <td class="left-aligned">610759</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0080</td>
                        
                        <td class="left-aligned">Cornelia de Lange syndrome, RAD21-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RAD21</i></td>
                        
                        <td class="left-aligned">614701</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0090</td>
                        
                        <td class="left-aligned">Cornelia de Lange syndrome, HDAC8-related</td>
                        
                        <td class="left-aligned">XL</td>
                        
                        <td class="left-aligned"><i>HDAC8</i></td>
                        
                        <td class="left-aligned">300882</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0100</td>
                        
                        <td class="left-aligned">Thrombocytopenia-absent radius (TAR) syndrome, RBM8A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RBM8A</i></td>
                        
                        <td class="left-aligned">274000</td>
                        
                        <td class="left-aligned">Deletion and common SNP on other allele that has regulatory function</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0110</td>
                        
                        <td class="left-aligned">Thrombocythemia with distal limb defects, THPO-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>THPO</i></td>
                        
                        <td class="left-aligned">187950</td>
                        
                        <td class="left-aligned">Distal limb defects postulated as consequence of vascular occlusions</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0120</td>
                        
                        <td class="left-aligned">Okihiro syndrome (Duane syndrome with radial ray anomaly), SALL4-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SALL4</i></td>
                        
                        <td class="left-aligned">607323</td>
                        
                        <td class="left-aligned">Includes IVIC syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0130</td>
                        
                        <td class="left-aligned">Cousin syndrome, TBX15-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>TBX15</i></td>
                        
                        <td class="left-aligned">260660</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0140</td>
                        
                        <td class="left-aligned">Roberts syndrome, ESCO2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ESCO2</i></td>
                        
                        <td class="left-aligned">268300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0150</td>
                        
                        <td class="left-aligned">Tibial hemimelia-polysyndactyly-triphalangeal thumb (Werner syndrome), ZRS-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ZRS</i></td>
                        
                        <td class="left-aligned">188740</td>
                        
                        <td class="left-aligned">Monoallelic variants in <i>ZRS</i>, a limb-specific enhancer of <i>SHH</i> that is located within intron 5 of the <i>LMBR1</i> gene</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0160</td>
                        
                        <td class="left-aligned">Clubfoot with or without deficiency of long bones and/or mirror-image polydactyly, PITX1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PITX1</i></td>
                        
                        <td class="left-aligned">119800</td>
                        
                        <td class="left-aligned">In some patients bilateral patellar hypoplasia (see Group 37)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0170</td>
                        
                        <td class="left-aligned">Acheiropodia, LMBR1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LMBR1</i></td>
                        
                        <td class="left-aligned">200500</td>
                        
                        <td class="left-aligned">The Brazilian founder allele is deletion spanning exon 4 of <i>LMBR1</i> that probably affects the activity of <i>ZRS</i>, the limb-specific enhancer of <i>SHH</i>. In a further patient, biallelic deletion of exons 1 to 16 of <i>LMBR1</i>, including the <i>ZRS</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0180</td>
                        
                        <td class="left-aligned">Engrailed-1 related dorsoventral syndrome (ENDOVES), limb-brain type</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>EN1</i></td>
                        
                        <td class="left-aligned">619218</td>
                        
                        <td class="left-aligned">One single patient with a biallelic frameshift variant described</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0190</td>
                        
                        <td class="left-aligned">Engrailed-1 related dorsoventral syndrome (ENDOVES), limb-only type</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MAENLI</i></td>
                        
                        <td class="left-aligned">619217</td>
                        
                        <td class="left-aligned"><i>MAENLI</i> is a lncRNA regulating <i>EN1</i> expression</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0200</td>
                        
                        <td class="left-aligned">Tetra-amelia, WNT3-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WNT3</i></td>
                        
                        <td class="left-aligned">273395</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0210</td>
                        
                        <td class="left-aligned">Tetra-amelia, RSPO2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RSPO2</i></td>
                        
                        <td class="left-aligned">618021</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0220</td>
                        
                        <td class="left-aligned">Limb reduction syndrome, WNT7A-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WNT7A</i></td>
                        
                        <td class="left-aligned">276820, 228930</td>
                        
                        <td class="left-aligned">Includes former Al-Awadi Raas-Rothschild limb-pelvis hypoplasia-aplasia as well as Fuhrmann syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0230</td>
                        
                        <td class="left-aligned">RAPADILINO syndrome, RECQL4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RECQL4</i></td>
                        
                        <td class="left-aligned">266280</td>
                        
                        <td class="left-aligned">See also Baller-Gerold syndrome, <i>RECQL4</i>-related. See MIM 266280 for explanation of the RAPADILINO acronym</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0240</td>
                        
                        <td class="left-aligned">Rothmund-Thompson syndrome, RECQL4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>RECQL4</i></td>
                        
                        <td class="left-aligned">268400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0250</td>
                        
                        <td class="left-aligned">Rothmund-Thompson syndrome, ANAPC1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ANAPC1</i></td>
                        
                        <td class="left-aligned">618625</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0260</td>
                        
                        <td class="left-aligned">Rothmund-Thompson syndrome, DNA2-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DNA2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0270</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), ARHGAP31-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>ARHGAP31</i></td>
                        
                        <td class="left-aligned">100300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0280</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), DOCK6-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DOCK6</i></td>
                        
                        <td class="left-aligned">614219</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0290</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), RBPJ-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>RBPJ</i></td>
                        
                        <td class="left-aligned">614814</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0300</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), DLL4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>DLL4</i></td>
                        
                        <td class="left-aligned">616589</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0310</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), EOGT-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EOGT</i></td>
                        
                        <td class="left-aligned">615297</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0320</td>
                        
                        <td class="left-aligned">Adams-Oliver syndrome (aplasia cutis congenita and transverse limb defects), NOTCH1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NOTCH1</i></td>
                        
                        <td class="left-aligned">616028</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0330</td>
                        
                        <td class="left-aligned">B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome (BILU syndrome), TOP2B-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TOP2B</i></td>
                        
                        <td class="left-aligned">609296</td>
                        
                        <td class="left-aligned">Also known as Hoffmann syndrome (see MIM 609296)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0340</td>
                        
                        <td class="left-aligned">Scapulo-iliac dysplasia (Kosenow syndrome)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">169550</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0350</td>
                        
                        <td class="left-aligned">Hypoglossia-hypodactylia (Hanhart syndrome)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">103300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0360</td>
                        
                        <td class="left-aligned">Poland syndrome</td>
                        
                        <td class="left-aligned">SP, AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">173800</td>
                        
                        <td class="left-aligned">Most commonly sporadic and probably non-genetic; some familial cases reported but no specific gene identified so far</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0370</td>
                        
                        <td class="left-aligned">Femoral facial syndrome (FFS)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">134780</td>
                        
                        <td class="left-aligned">Some phenotypic overlap with FFU syndrome (below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0380</td>
                        
                        <td class="left-aligned">Femur-fibula-ulna syndrome (FFU)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">228200</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0390</td>
                        
                        <td class="left-aligned">Fibular aplasia, tibial campomelia, and oligosyndactyly syndrome (FATCO)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">246570</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0400</td>
                        
                        <td class="left-aligned">Tibial hemimelia (isolated)</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">275220</td>
                        
                        <td class="left-aligned">Possibly non-genetic etiology</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0410</td>
                        
                        <td class="left-aligned">Sirenomelia</td>
                        
                        <td class="left-aligned">SP</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Rare cases reported as associated with monoallelic <i>CDX2</i> variants with variable expressivity</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 38-0420</td>
                        
                        <td class="left-aligned">Fanconi anemia</td>
                        
                        <td class="left-aligned"><i>AR</i></td>
                        
                        <td class="left-aligned">(<i>several</i>)</td>
                        
                        <td class="left-aligned">227650</td>
                        
                        <td class="left-aligned">The complex genetic basis of Fanconi anemia and its complementation groups and loci is acknowledged but not further listed in this Nosology; please refer to MIM or to specialized reviews</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">There is overlap between this group and the split hand-foot malformation group. <i>See also</i> Baller-Gerold syndrome, <i>RECQL4</i>-related; congenital hemidysplasia, ichthyosis, limb defects (CHILD) syndrome, <i>NSDHL</i>-related; as well as the mesomelic and acromesomelic dysplasias groups (above). Some entities in this group (e.g. the Femoral-facial syndrome and the Femur-fibula-ulna [FFU] syndromes) might be considered (RCEM; see the note to VACTERL in Group 36)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 39</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Split hand/foot with and without other manifestations</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0010</td>
                        
                        <td class="left-aligned">Ankyloblepharon-ectodermal dysplasia-cleft palate (AEC)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TP63</i></td>
                        
                        <td class="left-aligned">106260</td>
                        
                        <td class="left-aligned">See other TP63-related disorders in this group (below)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0020</td>
                        
                        <td class="left-aligned">Ectrodactyly-ectodermal dysplasia cleft-palate syndrome Type 3 (EEC3)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TP63</i></td>
                        
                        <td class="left-aligned">604292</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0030</td>
                        
                        <td class="left-aligned">Ectrodactyly-ectodermal dysplasia-macular dystrophy syndrome (EEM)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CDH3</i></td>
                        
                        <td class="left-aligned">225280</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0040</td>
                        
                        <td class="left-aligned">Limb-mammary syndrome (including ADULT syndrome)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TP63</i></td>
                        
                        <td class="left-aligned">603543</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0050</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, isolated form, type 4 (SHFM4)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>TP63</i></td>
                        
                        <td class="left-aligned">605289</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0060</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, isolated form, type 1 (SHFM1)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DLX5</i></td>
                        
                        <td class="left-aligned">220600</td>
                        
                        <td class="left-aligned">Structural variations at locus; also regulatory variants affecting exons of <i>DYNC1I1</i> that regulate <i>DLX5</i>; association with deafness in a single family may be coincidental; a recessive <i>DLX5</i> syndrome may exist</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0070</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, isolated form, type 1 (SHFM1)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>DLX6</i></td>
                        
                        <td class="left-aligned">183600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0080</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, isolated form, type 3 (SHFM3)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>10q24</i></td>
                        
                        <td class="left-aligned">246560</td>
                        
                        <td class="left-aligned">Duplications at 10q24 encompassing <i>LBX1</i>, <i>BTRC</i>, <i>POLL</i>, <i>DPCD</i> and <i>FBXW4</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0090</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, isolated form, type 6 (SHFM6)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>WNT10B</i></td>
                        
                        <td class="left-aligned">225300</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0100</td>
                        
                        <td class="left-aligned">Split-foot malformation with mesoaxial polydactyly (SFMMP)</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>ZAK</i></td>
                        
                        <td class="left-aligned">616890</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0110</td>
                        
                        <td class="left-aligned">Split-hand-foot malformation with or without long bone deficiency (SHFLD), BHLHA9-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>BHLHA9</i></td>
                        
                        <td class="left-aligned">612576</td>
                        
                        <td class="left-aligned">Duplications at 17p13.3 that include <i>BHLHA9</i>. Phenotypic penetrance is less than 50% and shows markedly variable expressivity; includes the so-called Gollop-Wolfgang complex</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0120</td>
                        
                        <td class="left-aligned">Hartsfield syndrome, FGFR1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR1</i></td>
                        
                        <td class="left-aligned">615465</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0130</td>
                        
                        <td class="left-aligned">Split hand-foot malformation, EPS15L-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>EPS15L1</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Structural variants (deletions) at this locus; one consanguineous family with homozygous point variant in <i>EPS15L1</i> but inheritance still unclear</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0140</td>
                        
                        <td class="left-aligned">Aplasia cutis congenita with ectrodactyly, UBA2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>UBA2</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">19q13.11 deletions may also cause this phenotype. In OMIM as “aplasia cutis congenita with ectrodactyly skeletal syndrome” (a redundant name)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 39-0150</td>
                        
                        <td class="left-aligned">Focal dermal hypoplasia (Goltz Syndrome), PORCN-related</td>
                        
                        <td class="left-aligned">XLD</td>
                        
                        <td class="left-aligned"><i>PORCN</i></td>
                        
                        <td class="left-aligned">305600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 40</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Polydactyly-Syndactyly-Triphalangism group</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0010</td>
                        
                        <td class="left-aligned">Preaxial polydactyly, SHH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SHH</i></td>
                        
                        <td class="left-aligned">174400</td>
                        
                        <td class="left-aligned">Formerly preaxial polydactyly types 1 and 2 (with triphalangeal thumb); regulatory domain variant or duplication of <i>ZRS</i> (limb enhancer of <i>SHH</i>)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0020</td>
                        
                        <td class="left-aligned">Preaxial polydactyly, GLI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GLI1</i></td>
                        
                        <td class="left-aligned">174400</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0030</td>
                        
                        <td class="left-aligned">Preaxial polydactyly, GLI3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GLI3</i></td>
                        
                        <td class="left-aligned">174700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0040</td>
                        
                        <td class="left-aligned">Preaxial polydactyly type 3 (PPD3)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">174600</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0050</td>
                        
                        <td class="left-aligned">Mirror-image polydactyly of hands and feet (Laurin-Sandrow syndrome), SHH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SHH</i></td>
                        
                        <td class="left-aligned">135750</td>
                        
                        <td class="left-aligned">Duplication of <i>ZRS</i> (limb enhancer of <i>SHH</i>)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0060</td>
                        
                        <td class="left-aligned">Postaxial polydactyly, GLI1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GLI1</i></td>
                        
                        <td class="left-aligned">618123</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0070</td>
                        
                        <td class="left-aligned">Greig cephalopolysyndactyly syndrome, GLI3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GLI3</i></td>
                        
                        <td class="left-aligned">175700</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0080</td>
                        
                        <td class="left-aligned">Pallister-Hall syndrome, GLI3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GLI3</i></td>
                        
                        <td class="left-aligned">146510</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0090</td>
                        
                        <td class="left-aligned">Hypothalamic hamartomas and polydactyly (Pallister-Hall-like) syndrome, SMO-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>SMO</i></td>
                        
                        <td class="left-aligned">241800</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0100</td>
                        
                        <td class="left-aligned">Culler-Jones syndrome, GLI2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GLI2</i></td>
                        
                        <td class="left-aligned">615849</td>
                        
                        <td class="left-aligned">Hypopituitarism</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0110</td>
                        
                        <td class="left-aligned">Synpolydactyly, FBLN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FBLN1</i></td>
                        
                        <td class="left-aligned">608180</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0120</td>
                        
                        <td class="left-aligned">Synpolydactyly, HOXD13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXD13</i></td>
                        
                        <td class="left-aligned">186000</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0130</td>
                        
                        <td class="left-aligned">Postaxial polydactyly, isolated (type A10), KIAA0825-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KIAA0825</i></td>
                        
                        <td class="left-aligned">618498</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0140</td>
                        
                        <td class="left-aligned">Townes-Brocks syndrome, SALL1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SALL1</i></td>
                        
                        <td class="left-aligned">107480</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0150</td>
                        
                        <td class="left-aligned">Lacrimo-auriculo-dento-digital syndrome (LADD), FGFR2-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR2</i></td>
                        
                        <td class="left-aligned">149730</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0160</td>
                        
                        <td class="left-aligned">Lacrimo-auriculo-dento-digital syndrome (LADD), FGFR3-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGFR3</i></td>
                        
                        <td class="left-aligned">149730</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0170</td>
                        
                        <td class="left-aligned">Lacrimo-auriculo-dento-digital syndrome (LADD), FGF10-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGF10</i></td>
                        
                        <td class="left-aligned">149730</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0180</td>
                        
                        <td class="left-aligned">Acrocallosal syndrome, KIF7-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>KIF7</i></td>
                        
                        <td class="left-aligned">200990</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0190</td>
                        
                        <td class="left-aligned">Acro-pectoral-vertebral dysplasia (F-syndrome), WNT6-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>WNT6</i></td>
                        
                        <td class="left-aligned">102510</td>
                        
                        <td class="left-aligned">Structural variations of locus resulting in ectopic activation of <i>WNT6</i></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0200</td>
                        
                        <td class="left-aligned">Cenani-Lenz syndactyly, LRP4-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>LRP4</i></td>
                        
                        <td class="left-aligned">212780</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0210</td>
                        
                        <td class="left-aligned">Cenani-Lenz-like syndactyly, GREM/FMN1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GREM1, FMN1</i></td>
                        
                        <td class="left-aligned">see 212780</td>
                        
                        <td class="left-aligned">Monoallelic duplication of both <i>GREM1</i> and <i>FMN1</i> loci (one individual)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0220</td>
                        
                        <td class="left-aligned">Oligosyndactyly, radio-ulnar synostosis, hearing loss and renal defects syndrome, FMN1-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>FMN1</i></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">Biallelic deletion of the <i>FMN1</i> gene (one individual)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0230</td>
                        
                        <td class="left-aligned">Mesoaxial synostotic syndactyly with phalangeal reduction (Malik-Percin), BHLHA9-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>BHLHA9</i></td>
                        
                        <td class="left-aligned">609432</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0240</td>
                        
                        <td class="left-aligned">STAR syndrome (syndactyly of toes, telecanthus, anal and renal malformations), FAM58A-related</td>
                        
                        <td class="left-aligned">XLD</td>
                        
                        <td class="left-aligned"><i>FAM58A</i></td>
                        
                        <td class="left-aligned">300707</td>
                        
                        <td class="left-aligned">X-linked dominant (only affected females known, possibly lethal in males)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0250</td>
                        
                        <td class="left-aligned">Syndactyly type 1 (III-IV)</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">185900</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0260</td>
                        
                        <td class="left-aligned">Syndactyly type 3 (IV-V), GJA1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GJA1</i></td>
                        
                        <td class="left-aligned">186100</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0270</td>
                        
                        <td class="left-aligned">Syndactyly type 4 (I-V) Haas type, SHH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>SHH</i></td>
                        
                        <td class="left-aligned">186200</td>
                        
                        <td class="left-aligned">Duplication of <i>ZRS</i> (limb enhancer of <i>SHH</i>)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0280</td>
                        
                        <td class="left-aligned">Syndactyly type 5 (Brachydactyly-Syndactyly syndrome; syndactyly with metacarpal and metarsal fusion), HOXD13-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXD13</i></td>
                        
                        <td class="left-aligned">186300, 610713</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0290</td>
                        
                        <td class="left-aligned">Syndactyly (Lueken type, with or without craniosynostosis), IHH-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>IHH</i></td>
                        
                        <td class="left-aligned">185900</td>
                        
                        <td class="left-aligned">Duplication of <i>IHH</i> and regulatory region on 2q35; includes syndactyly with craniosynostosis (Philadelphia type)</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0300</td>
                        
                        <td class="left-aligned">Metacarpal 4-5 fusion, FGF16-related</td>
                        
                        <td class="left-aligned">XLR</td>
                        
                        <td class="left-aligned"><i>FGF16</i></td>
                        
                        <td class="left-aligned">309630</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0310</td>
                        
                        <td class="left-aligned">Syndactyly with microcephaly and mental retardation (Filippi syndrome), CKAP2L-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>CKAP2L</i></td>
                        
                        <td class="left-aligned">272440</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 40-0320</td>
                        
                        <td class="left-aligned">Synpolydactyly plus syndrome, MAPKAPK5-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>MAPKAPK5</i></td>
                        
                        <td class="left-aligned">619869</td>
                        
                        <td class="left-aligned">In OMIM as neurocardiofaciodigital syndrome</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">Note: the Smith-Lemli-Opitz syndrome can present with polydactyly and/or syndactyly. The different variants of Meckel syndrome can have polydactyly and are included under the ciliopathies (see there). The Bardet-Biedl syndromes may have polydactyly as a secondary feature and have not been included in this neither in this group nor in the ciliopathies. See also Clubfoot with or without deficiency of long bones and/or mirror-image polydactyly, <i>PITX1</i>-related. The entity called “Crossed polysyndactyly” not included as unclear whether or not it is a distinct entity.</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"><b>Group 41</b></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#E2EEDA"><b>Defects in joint formation and synostoses</b></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0010</td>
                        
                        <td class="left-aligned">Multiple synostoses syndrome, NOG-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>NOG</i></td>
                        
                        <td class="left-aligned">186500, 186570</td>
                        
                        <td class="left-aligned">Includes: Stapes ankylosis with broad thumbs and toes, Tarsal-Carpal coalition syndrome, proximal Symphalangism 1A; see also Brachydactyly type B2, <i>NOG</i>-related, in the brachydactyly group</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0020</td>
                        
                        <td class="left-aligned">Multiple synostoses syndrome, GDF5-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF5</i></td>
                        
                        <td class="left-aligned">610017</td>
                        
                        <td class="left-aligned">See other <i>GDF5</i>-related disorders</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0030</td>
                        
                        <td class="left-aligned">Multiple synostoses syndrome, FGF9-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>FGF9</i></td>
                        
                        <td class="left-aligned">612961</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0040</td>
                        
                        <td class="left-aligned">Multiple synostoses syndrome, GDF6-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>GDF6</i></td>
                        
                        <td class="left-aligned">617898</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0050</td>
                        
                        <td class="left-aligned">Liebenberg syndrome, PITX1-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>PITX1</i></td>
                        
                        <td class="left-aligned">186550</td>
                        
                        <td class="left-aligned">Structural variants encompassing the <i>H2AFY</i> gene resulting in ectopic activation of <i>PITX1</i> in upper limb</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0060</td>
                        
                        <td class="left-aligned">Short stature, auditory atresia, mandibular hypoplasia, skeletal abnormalities (SAMS) syndrome, GSC-related</td>
                        
                        <td class="left-aligned">AR</td>
                        
                        <td class="left-aligned"><i>GSC</i></td>
                        
                        <td class="left-aligned">602471</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0070</td>
                        
                        <td class="left-aligned">Radio-ulnar synostosis with amegakaryocytic thrombocytopenia, HOXA11-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>HOXA11</i></td>
                        
                        <td class="left-aligned">605432</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0080</td>
                        
                        <td class="left-aligned">Radio-ulnar synostosis with amegakaryocytic thrombocytopenia, MECOM-related</td>
                        
                        <td class="left-aligned">AD</td>
                        
                        <td class="left-aligned"><i>MECOM</i></td>
                        
                        <td class="left-aligned">616738</td>
                        
                        <td class="left-aligned"></td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned">NOS 41-0090</td>
                        
                        <td class="left-aligned">Radio-ulnar synostosis with microcephaly (Giuffré-Tsukahara syndrome)</td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned"></td>
                        
                        <td class="left-aligned">603438</td>
                        
                        <td class="left-aligned">X-linked recessive inheritance suggested</td>
                        </tr>
                     
                     <tr>
                        
                        <td class="right-bordered-cell left-aligned"></td>
                        
                        <td colspan="5" class="left-aligned" style="background-color:#DEEAF6">See also Spondylocarpotarsal synostosis syndrome, <i>FLNB</i>-related and <i>RFLNA</i>-related; Cardiospondylocarpofacial syndrome, <i>MAP3K7</i>-related; mesomelic dysplasia with acral synostoses (Verloes-David-Pfeiffer type); Baller-Gerold syndrome, <i>RECQL4</i>-related; and Antley-Bixler syndrome, <i>POR</i>-related</td>
                        </tr>
                     </tbody>
                  </table>
            </div>
            
            
            
            <div class="article-section__table-footnotes">
               <ul>
                  <li id="ajmga63132-note-0002">
                     <i>Note</i>: The numbering system (first column) includes “NOS” for “Nosology, skeletal”, followed by the group number and the number of the disorder. The abbreviations are as follows: in the disorder names, SED in spondylo-ephyseal dysplasia; SEMD is spondylo-epi-metaphyseal dysplasia; MED is multiple epiphyseal dysplasia; CDP is chondrodysplasia punctata. In the “Inheritance” column: AD, autosomal recessive; AR, autosomal recessive; XL, X-linked; MOS, somatic mosaicism; SP, sporadic and inheritance unknown. Pseudo-AD and Pseudo-AR refers to genes in the pseudoautosomal regions of chromosome X and Y. The “MIM No.” column shows the MIM number of the disorder; when the number is preceded by “see”, the MIM number is that of the underlying gene.
                     </li>
               </ul>
            </div>
            <div class="article-section__table-source"></div>
         </div>
         
         <p>The recognition of chromosomal aneuploidies at the transition between the 50s and the 60s provided a biological foundation to genetics and ushered in a first golden era of clinical genetics. The Birth Defects Conferences between 1969 and 1971 signaled the awareness and importance of clinical genetics throughout the sixties and initiated a prolific period in disease identification, delineation, and description. In this context, it became apparent that “chondrodysplasia” was not a single diagnosis, but that many distinct, true-breeding forms existed; for example, diastrophic dysplasia, spondylo-epiphyseal dysplasia congenita, and the so-called “pseudo-Morquio” disorders were distinguished and clinically described. In addition, biochemistry allowed subtypes of clinically similar disorders to be distinguished, the most notable example at the time being the mucopolysaccharidoses. The contribution of radiologic features and radiologists to the delineation of skeletal dysplasias deserves explicit recognition. In many instances, it was the radiographic features and their time dependent evolution (the “fourth dimension” emphasized by the late Andres Giedion) that permitted not only to discriminate between disorders that had outward similarities but also to recognize a gene's radiographic signature in phenotypically distinct disorders (e.g., Achondrogenesis type 2 and Spondyloepiphyseal dysplasia congenita) and thus create the first gene families (Spranger,&nbsp;<span><a href="#ajmga63132-bib-0018" id="#ajmga63132-bib-0018_R_d7369469e18892" class="bibLink tab-link" data-tab="pane-pcw-references">1985</a></span>) (and see below).</p>
         
         <p>In 1970, the first prototype of the “Nosology” was drafted (A nomenclature for constitutional (intrinsic) diseases of bone,&nbsp;<span><a href="#ajmga63132-bib-0001" id="#ajmga63132-bib-0001_R_d7369469e18898" class="bibLink tab-link" data-tab="pane-pcw-references">1971</a></span>; [International nomenclature of constitutional bone diseases. Constitutional bone diseases without known pathogenesis],&nbsp;<span><a href="#ajmga63132-bib-0009" id="#ajmga63132-bib-0009_R_d7369469e18901" class="bibLink tab-link" data-tab="pane-pcw-references">1971</a></span>; [International nomenclature of constitutional diseases of bone],&nbsp;<span><a href="#ajmga63132-bib-0012" id="#ajmga63132-bib-0012_R_d7369469e18904" class="bibLink tab-link" data-tab="pane-pcw-references">1970</a></span>; McKusick & Scott,&nbsp;<span><a href="#ajmga63132-bib-0014" id="#ajmga63132-bib-0014_R_d7369469e18907" class="bibLink tab-link" data-tab="pane-pcw-references">1971</a></span>). At that time, however, the work was called a “Nomenclature” rather than a Nosology; the goal was to bring all scholars to use the same name for the same condition.</p>
         
         <p>Molecular criteria began to inform the Nosology in the 1980s, first with osteogenesis imperfecta and the discovery of genetic variants in collagen 1. The concept of “bone dysplasia families” originating from different pathogenic variants in a single gene was proposed in the 1980s (Spranger,&nbsp;<span><a href="#ajmga63132-bib-0018" id="#ajmga63132-bib-0018_R_d7369469e18913" class="bibLink tab-link" data-tab="pane-pcw-references">1985</a></span>) and confirmed in the 1990s, with the <i>COL2A1</i> and <i>FGFR3</i> disorders being prominent examples. Ever since, the Nosology has straddled the fence between defining disorders based either on their clinical and radiographic features or on the responsible genes (Beighton et al.,&nbsp;<span><a href="#ajmga63132-bib-0002" id="#ajmga63132-bib-0002_R_d7369469e18920" class="bibLink tab-link" data-tab="pane-pcw-references">1992</a></span>; Bonafe et al.,&nbsp;<span><a href="#ajmga63132-bib-0004" id="#ajmga63132-bib-0004_R_d7369469e18923" class="bibLink tab-link" data-tab="pane-pcw-references">2015</a></span>; Hall,&nbsp;<span><a href="#ajmga63132-bib-0007" id="#ajmga63132-bib-0007_R_d7369469e18927" class="bibLink tab-link" data-tab="pane-pcw-references">2002</a></span>; International nomenclature and classification of the osteochondrodysplasias (<span><a href="#ajmga63132-bib-0008" id="#ajmga63132-bib-0008_R_d7369469e18930" class="bibLink tab-link" data-tab="pane-pcw-references">1997</a></span>). International working group on constitutional diseases of bone, 1998; International nomenclature of constitutional diseases of bone,&nbsp;<span><a href="#ajmga63132-bib-0011" id="#ajmga63132-bib-0011_R_d7369469e18933" class="bibLink tab-link" data-tab="pane-pcw-references">1979</a></span>; International nomenclature of constitutional diseases of bone. Revision, May 1983,&nbsp;<span><a href="#ajmga63132-bib-0010" id="#ajmga63132-bib-0010_R_d7369469e18936" class="bibLink tab-link" data-tab="pane-pcw-references">1983</a></span>; Lachman,&nbsp;<span><a href="#ajmga63132-bib-0013" id="#ajmga63132-bib-0013_R_d7369469e18939" class="bibLink tab-link" data-tab="pane-pcw-references">1998</a></span>; Mortier et al.,&nbsp;<span><a href="#ajmga63132-bib-0015" id="#ajmga63132-bib-0015_R_d7369469e18942" class="bibLink tab-link" data-tab="pane-pcw-references">2019</a></span>; Superti-Furga & Unger,&nbsp;<span><a href="#ajmga63132-bib-0019" id="#ajmga63132-bib-0019_R_d7369469e18946" class="bibLink tab-link" data-tab="pane-pcw-references">2007</a></span>; Warman et al.,&nbsp;<span><a href="#ajmga63132-bib-0021" id="#ajmga63132-bib-0021_R_d7369469e18949" class="bibLink tab-link" data-tab="pane-pcw-references">2011</a></span>).</p>
         
         <p>Traditionally, the Nosology has been organized into groups of disorders—initially based on radiographic criteria, then by biochemical criteria (metabolic pathways) and subsequently, more and more, by functional and molecular criteria. The organization into groups has been maintained in the current revision as it helps in finding the disorders relevant for a particular patient of finding. On the other hand, Nature has more complexity than can be captured in the Nosology, and our attempt at classification is necessarily both arbitrary and a simplification, as many disorders might warrant classification in more than one group. Thus, we have elected to drop the term “classification” from the title; this is just a “Nosology”.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0002">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0002-title">1 NAMING PROBLEMS AND THE DYADIC APPROACH AS A WAY FORWARD</h2>
         
         <p>Between 2010 and 2020, the technology of massively parallel sequencing has taken center stage in medical genetics research and diagnostics. Among the many lessons learned from next-generation sequencing (NGS) results are (1) the large number of previously unrecognized rare and ultrarare disorders in each domain of genetic medicine, (2) the phenotypic heterogeneity arising from a single locus is much greater than previously suspected, and (3) for many dyadic entities, individuals who present all the phenotypic criteria as described in the textbooks are the exception rather than the rule.</p>
         
         <p>On this background, it has been proposed that the phenotypic descriptor of a genetic disorder (the “name” of a condition) is no longer sufficient to distinguish the disorder unequivocally. Furthermore, the sequential numbering of conditions with the same name (as applied e.g., for osteogenesis imperfecta or ataxias in Mendelian Inheritance in Man [MIM]) may be unsatisfactory, as a number has no inherent information, making it necessary to consult the numbering reference. As a consequence, it has been suggested that instead of being attributed by a number (or an eponym, see below), the main phenotypic descriptor of a genetic disorder should best be coupled to the name of the underlying gene, allowing for more direct and pertinent information, less prone to ambiguities and errors; the so-called dyadic approach (Biesecker et al.,&nbsp;<span><a href="#ajmga63132-bib-0003" id="#ajmga63132-bib-0003_R_d7369469e18966" class="bibLink tab-link" data-tab="pane-pcw-references">2021</a></span>). Of note, the dyadic concept has been pioneered by the editors of the well-known resource GeneReviews starting in 2020 (Dr. M. Adam, personal communication; and Biesecker et al.,&nbsp;<span><a href="#ajmga63132-bib-0003" id="#ajmga63132-bib-0003_R_d7369469e18969" class="bibLink tab-link" data-tab="pane-pcw-references">2021</a></span>).</p>
         
         <p>The Nosology has not been immune to the proliferation of numbered lists, such as, for example, in osteogenesis imperfecta (Sillence & Rimoin,&nbsp;<span><a href="#ajmga63132-bib-0016" id="#ajmga63132-bib-0016_R_d7369469e18975" class="bibLink tab-link" data-tab="pane-pcw-references">1978</a></span>; Sillence et al.,&nbsp;<span><a href="#ajmga63132-bib-0017" id="#ajmga63132-bib-0017_R_d7369469e18978" class="bibLink tab-link" data-tab="pane-pcw-references">1979</a></span>; Van Dijk & Sillence,&nbsp;<span><a href="#ajmga63132-bib-0020" id="#ajmga63132-bib-0020_R_d7369469e18981" class="bibLink tab-link" data-tab="pane-pcw-references">2014</a></span>). In this 2023 revision, the curators have decided to adopt the dyadic naming approach as it allows for more precision both in the clinic and in the laboratory. However, compromises have been made in some instances to account for the historic evolution of the Nosology, as well as to maintain congruence and interoperability with what is considered the most important reference database for genetic disorders, MIM (MIM and its online version, OMIM).</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0003">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0003-title">2 THE MENDELIAN INHERITANCE IN MAN CATALOG AND THE NOSOLOGY</h2>
         
         <p>The late Victor McKusick's opus, MIM, remains the single most important general reference database for genetic disorders. The way in which MIM was created and is still curated allows for a detailed documentation of the history of each and every disorder. For the same reason, it is less well-suited to document the changes that occur in the nosography, for instance when one disorder is subsumed under another; several disorders listed in MIM have been subsumed under other conditions in the Nosology, or are altogether not recognized as distinct phenotypic entities in the Nosology (e.g., mesomelic dysplasia, Camera type; MIM 611886). Also, MIM makes extensive use of eponyms to distinguish related but distinct disorders (e.g., Dyggve-Melchior-Clausen disease and Smith-McCort dysplasia); while for others the eponymic descriptors are too similar, leading to diagnostic confusion (e.g., Shprintzen-Goldberg and Goldberg-Shprintzen syndromes represent distinct disorders). MIM's choice of these eponyms may not reflect the most significant contribution to the delineation of a phenotypic entity. By adopting the dyadic system, we have elected to describe each disorder with the name of the responsible gene rather than with an eponym. While MIM remains the central reference database, the dyadic system allows the Nosology to group, lump, or dump disorders based on their molecular basis, especially in the light of the lessons of NGS (see above), and is less bound by historical constraints. Nevertheless, the Nosology curators have strived to maintain strong bridges to MIM: MIM numbers are included for all disorders when available, and when not available, the MIM number for the responsible gene is included. Moreover, references are made to the MIM denomination of individual disorders as well as to other MIM disorders arising from pathogenic variants in the same gene.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0004">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0004-title">3 THE ORPHANET NOMENCLATURE AND THE NOSOLOGY</h2>
         
         <p>In the context of a joint collaboration between the International Skeletal Dysplasia Society (ISDS), the European Reference Network on Rare Bone Disorders (ERN-BOND) and Orphanet, co-coordinated by Houda Ali (curator at Orphanet) and Geert Mortier (main curator of the 2019 Nosology), a detailed analysis of the Orphanet database in comparison with the 2019 Nosology, resulted in a list of approximately 248 phenotypic entities that were present in the Orphanet nomenclature of rare diseases but absent in the 2019 Nosology. To be included in the 2023 Nosology, disorders had to have a recognizable phenotype and a clear inheritance pattern or molecular definition. Approximately 30 of these disorders met inclusion criteria and have thus been included in the Nosology. Other disorders in this list had either been described in a single paper without molecular confirmation, or represent historical descriptions with limited available information, reflecting the policy followed by Orphanet to represent all disorders fitting the definition of a rare disease to the advantage of individuals affected by ultrarare presentations, as long as they constitute phenotypically distinct diagnoses (Ref. <a href="https://www.orpha.net/orphacom/cahiers/docs/GB/eproc_disease_inventory_R1_Nom_Dis_EP_04.pdf" class="linkBehavior">https://www.orpha.net/orphacom/cahiers/docs/GB/eproc_disease_inventory_R1_Nom_Dis_EP_04.pdf</a>). On the other hand, it became evident that many entries in the list do not seem to represent distinct phenotypic entities in view of the current knowledge and of the Nosology criteria. This has prompted an ongoing revision process by the Orphanet team to review and identify entries that need to be deactivated and subsequently removed from the Orphanet nomenclature of rare diseases.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0005">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0005-title">4 THE NOSOLOGY AND THE CLINGEN CURATION INITIATIVE</h2>
         
         <p>The ClinGen initiative (<a href="https://clinicalgenome.org/affiliation/40065/" class="linkBehavior">https://clinicalgenome.org/affiliation/40065/</a>) is currently working on a set of genes associated with skeletal disorders in order to provide strength of evidence for gene-disease associations, and using strictly verified criteria to assess pathogenicity of variants in genes found to have a definitive association with disease. It has already done so for other groups of genetic disorders, such as the cardiomyopathies and others. Several of the present Nosology curators participate in this effort. However, the sheer number of genes involved in constitutional skeletal conditions is such that the ClinGen section for skeletal dysplasia genes will take time to be completed. In this context, the Nosology, with its list of curated genes and disorders (albeit not to the extent set out in the ClinGen initiative), will remain the best available resource for the foreseeable future. Of note, the ClinGen approach is much more “lumping” than the Nosology, to the extent that phenotypes due to pathogenic variants at a single locus must have significant qualitative differences to justify separate nosologic entries (phenotypic entities); a simple quantitative difference (typically, more or less severe) is not enough to justify separation. This may lead us to reflect on what constitutes a “dysplasia” or a “syndrome”. Some of us have also contributed to the development of the “Nosology of inborn errors of metabolism” and the subsequent “International Classification of Inherited Metabolic Disorders” (ICIMD) (Ferreira et al.,&nbsp;<span><a href="#ajmga63132-bib-0006" id="#ajmga63132-bib-0006_R_d7369469e19018" class="bibLink tab-link" data-tab="pane-pcw-references">2019</a></span>, <span><a href="#ajmga63132-bib-0005" id="#ajmga63132-bib-0005_R_d7369469e19021" class="bibLink tab-link" data-tab="pane-pcw-references">2021</a></span>). That nosology applies the “one gene – one condition” principle, unless there are qualitative differences. However, it is more difficult to apply this principle to the skeletal conditions. For example, children affected by methylmalonic acidemia may have different urinary concentrations of methylmalonic acid but will be considered to have the same disorder (MIM 251000). It would be more difficult to claim that a fetus with achondrogenesis type 1B (MIM 600972) and a child with recessive multiple epiphyseal dysplasia (MIM 226900) have the same disorder, even if the responsible gene is the same and the phenotypes represent opposite ends of severity within the same spectrum, as the morphologic features and clinical prognosis are so radically distinct.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0006">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0006-title">5 CHANGES COMPARED TO PREVIOUS REVISIONS</h2>
         
         <p>Some changes in the structure of the Nosology deserve to be mentioned. The total number of groups decreased from 42 to 41. This decrease has to do with restructuring of a few groups. Specifically, the previous “Perlecan group” and “Aggrecan group” were incorporated into the new group of “Proteoglycan core protein disorders”, and the former groups of “Neonatal osteosclerotic dysplasias” and of “Other sclerosing bone disorders” were fused into the group of (non-osteopetrotic) “Osteosclerotic disorders”. A new group of “Skeletal disorders of parathyroid hormone signaling cascade” was added to the current Nosology. The two brachydactylies groups (isolated or as part of syndromes; now groups 18 and 19) were found to be more organically placed right after the acromesomelic and acromelic groups (groups 16 and 17).</p>
         
         <p>Several groups were renamed. The group of “Osteopetrosis and related disorders” is now named “Osteopetrosis and related osteoclast disorders”, to highlight the fact that the osteopetroses represent disorders in the number or function of osteoclasts. The “Osteogenesis Imperfecta and decreased bone density group” was renamed “Osteogenesis Imperfecta and bone fragility group” to reflect the fact that skeletal fragility is a hallmark of these disorders irrespective of the bone mineral density (as in fact a small subset of osteogenesis imperfecta patients can have high bone mass). The name of the group of “Overgrowth (tall stature) syndromes with skeletal involvement” was changed to the more encompassing “Overgrowth (tall stature) syndromes and segmental overgrowth”. The group of “Craniosynostosis syndromes” was renamed “Syndromes featuring craniosynostosis”, as although disorders in this group frequently feature craniosynostosis, this finding does not always represent the most salient feature. Other changes in group nomenclature included “Brachydactylies (without extraskeletal manifestations)” to “Isolated brachydactylies”; “Brachydactylies (with extraskeletal manifestations)” to “Brachydactylies as part of syndromes”; “Ciliopathies with major skeletal involvement” to “Skeletal disorders caused by abnormalities of cilia or ciliary signaling”; “Abnormal mineralization group” to “Disorders of bone mineralization”; and “Ectrodactyly with and without other manifestations” to “Split hand/foot with and without other manifestations”.</p>
         
         <p>Some disorders were reassigned. As an example, trichorhinophalangeal dysplasia types 1/3 was moved from the “Acromelic dysplasias” group to the group of “Brachydactylies as part of syndromes”.</p>
         
         <p>The total number of disorders increased from 461 to 771, and the number of genes from 437 to 552. Although we are aware of the problems inherent to numeric lists (as discussed above), we have tentatively included a numbering system including the abbreviation “NOS” (for “Nosology, skeletal”), the group number, and a sequential number withing the group, taking care to leave gaps that may allow for the inclusion of disorders in the future. Such a numbering system might prove helpful in cross-referencing with MIM, Orphanet and other databases.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0007">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0007-title">6 WHAT IS THE UTILITY OF THE NOSOLOGY?</h2>
         
         <p>Since its early revisions, the Nosology has been helpful for pediatricians, geneticists, radiologists, and others as a reminder of the differential diagnosis. Its original structure in groups of disorders with similar radiographic features reflected the diagnostic approach of the clinical geneticist and, even more, of the radiologist, to the osteochondrodysplasias. Over the years, the inclusion of brachydactylies, craniosynostoses, craniofacial dysostoses, syndactylies, limb reductions, and other dysostoses, as well as primordial short stature and overgrowth syndromes has broadened its utility for the differential diagnosis within these groups of disorders. The 2010 revision stated that “<i>The aim is to provide the Genetics, Pediatrics and Radiology community with a list of recognized genetic skeletal disorders that can be of help in the diagnosis of individual cases, in the delineation of novel disorders, and in building bridges between clinicians and scientists interested in skeletal biology. (…) The Nosology should be useful for the diagnosis of patients with genetic skeletal diseases, particularly in view of the information flood expected with the novel sequencing technologies; in the delineation of clinical entities and novel disorders, by providing an overview of established nosologic entities; and for scientists looking for the clinical correlates of genes, proteins and pathways involved in skeletal biology.”</i> Thirteen years later, the Nosology may have an additional role in molecular genetic diagnostic testing. In a pre-test setting, the Nosology may inform the decision on which genes to include in a diagnostic panel tailored to a specific clinical situation. Current diagnostic workflows often involve plausibility verification of variants observed in panel or exome sequencing tests (reverse phenotyping). Also, in the post-test setting, the Nosology may be helpful for rapid reference and orientation.</p>
         
         <p>The Nosology is also an illustration of the complexity of the human genome as demonstrated by the sheer number of genes and gene products required for normal skeletal development and growth. The included table with its over 750 entries and its rows and columns is like the musical score for the orchestra of skeletal development and growth that may be an inspiration to geneticists and basic scientists. Perhaps the hybrid nature of the Nosology, combining clinical, radiographic, and molecular criteria, is a strength and not a weakness, allowing colleagues with varied backgrounds an approach to the data.</p>
         
         <p>It is clear that no nosology in medicine is perfect nor complete. They are always dynamic and evolving. However, the frequent citations of previous versions of the Nosology suggest that, despite the many compromises necessary in its preparation the Nosology has been useful to, and widely adopted by, the medical and scientific community. Thanks to the continuous progress in delineating genetic conditions, the Nosology starts its obsolescence at the moment it is published. Nevertheless, may this new version encounter the same benevolent reception, and also be replaced in time by novel and more complete versions.</p>
         </section>
      <section class="article-section__content" id="ajmga63132-sec-0008">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0008-title"> AUTHORS' CONTRIBUTIONS</h2>
         
         <p>All authors conceptualized the revision work, contributed to the revision of several groups of disorders, and participated in the discussion and decision making. Sheila Unger, Carlos R. Ferreira, and Andrea Superti-Furga collated the contributions, compiled the final table and drafted the manuscript. The table and the manuscript were then revised by all authors and subsequently finalized by Sheila Unger, Carlos R. Ferreira, and Andrea Superti-Furga.</p>
         </section>
      <div class="article-section__content">
         
         <h2 class="article-section__title section__title section1" id="ajmga63132-sec-0009-title"> ACKNOWLEDGMENTS</h2>
         
         <p>We wish to acknowledge constructive exchanges with Dr. Ada Hamosh at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, USA, concerning the integration between the Nosology and the MIM catalog, as well as with Dr. Leslie G. Biesecker, Center for Precision Health Research, NHGRI, Bethesda, USA, concerning the adoption of the dyadic nomenclature system. The skillful assistance and graciousness of Mrs. Nathalie Zumstein in organizing the Nosology sessions in Lausanne (March 2022) is also gratefully acknowledged. This work was supported by the International Skeletal Dysplasia Society (<a href="http://www.isds.ch" class="linkBehavior">www.isds.ch</a>) with secretarial logistics, the University of Lausanne (support to Sheila Unger and Andrea Superti-Furga), the NIH/NHGRI (to Carlos R. Ferreira), the DBT/Wellcome Trust India Alliance Grant “Center for Rare Disease Diagnosis, Research and Training number: IA/CRC/20/1/600002” (to Katta M. Girisha), the Sigrid Jusélius Foundation (grant to Outi Makitie), the National Health and Medical Research Council of Australia Leadership Fellow Grant #GNT2018081 (to Ravi Savarirayan), and Curekids New Zealand (support to Stephen P. Robertson). Open access funding provided by Universite de Lausanne.</p>
         
         <ol></ol>
      </div>
      <section id="openResearch" class="article-section article-section__open-research">
         <div class="accordion article-accordion">
            <h2><a href="#" class="accordion__control" role="button" aria-controls="open-research-content" aria-expanded="false"><span class="section__title" id="open-research-section">Open Research</span><i aria-hidden="true" class="icon-section_arrow_d"></i></a></h2>
            <div class="accordion__content" role="region" aria-labelledby="open-research-section" id="open-research-content">
               <h1></h1>
               <section class="article-section__sub-content" id="ajmga63132-sec-0011">
                  
                  <h1>DATA AVAILABILITY STATEMENT</h1>
                  
                  <p>Data sharing is not applicable to this article as no new data were created or analyzed in this study.</p>
                  </section>
            </div>
         </div>
      </section>
      <section class="article-section article-section__references" id="references-section">
         <div class="accordion article-accordion">
            <h2>
               <div tabindex="0" role="button" class="accordion__control" aria-controls="idajmga63132-bibl-0001" aria-expanded="false" data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&ajax=true&doi=10.1002%2Fajmg.a.63132&pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fajmg.a.v191.5%3Bjournal%3Ajournal%3A10968628%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3BrequestedJournal%3Ajournal%3A15524833%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fajmg.a.63132%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&accordionHeadingWrapper=h2&onlyLog=true"><span class="section__title" id="references-section-1">REFERENCES</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div>
            </h2>
            <div class="accordion__content" style="display: none;" role="region" aria-labelledby="references-section-1" id="ajmga63132-bibl-0001">
               <ul class="rlist separator">
                  
                  
                  <li data-bib-id="ajmga63132-bib-0001"> <span class="groupName">A nomenclature for constitutional (intrinsic) diseases of bones</span>. (<span class="pubYear">1971</span>). <span class="articleTitle">A nomenclature for constitutional (intrinsic) diseases of bones</span>. <i>The Journal of Pediatrics</i>,  <span class="vol">78</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">177</span>– <span class="pageLast">179</span>. <a href="https://doi.org/10.1016/s0022-3476(71)80286-x" class="linkBehavior">https://doi.org/10.1016/s0022-3476(71)80286-x</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_2_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0002"><span class="author">Beighton, P.</span>, <span class="author">Giedion, Z. A.</span>, <span class="author">Gorlin, R.</span>, <span class="author">Hall, J.</span>, <span class="author">Horton, B.</span>, <span class="author">Kozlowski, K.</span>, <span class="author">Lachman, R.</span>, <span class="author">Langer, L. O.</span>, <span class="author">Maroteaux, P.</span>, & <span class="author">Poznanski, A.</span> (<span class="pubYear">1992</span>). <span class="articleTitle">International classification of osteochondrodysplasias. International working group on constitutional diseases of bone</span>. <i>American Journal of Medical Genetics</i>,  <span class="vol">44</span>(<span class="citedIssue">2</span>),  <span class="pageFirst">223</span>– <span class="pageLast">229</span>. <a href="https://doi.org/10.1002/ajmg.1320440220" class="linkBehavior">https://doi.org/10.1002/ajmg.1320440220</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_3_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0003"><span class="author">Biesecker, L. G.</span>, <span class="author">Adam, M. P.</span>, <span class="author">Alkuraya, F. S.</span>, <span class="author">Amemiya, A. R.</span>, <span class="author">Bamshad, M. J.</span>, <span class="author">Beck, A. E.</span>, <span class="author">Bennett, J. T.</span>, <span class="author">Bird, L. M.</span>, <span class="author">Carey, J. C.</span>, <span class="author">Chung, B.</span>, <span class="author">Clark, R. D.</span>, <span class="author">Cox, T. C.</span>, <span class="author">Curry, C.</span>, <span class="author">Dinulos, M. B. P.</span>, <span class="author">Dobyns, W. B.</span>, <span class="author">Giampietro, P. F.</span>, <span class="author">Girisha, K. M.</span>, <span class="author">Glass, I. A.</span>, <span class="author">Graham, J. M.</span>, … <span class="author">Zarate, Y. A.</span> (<span class="pubYear">2021</span>). <span class="articleTitle">A dyadic approach to the delineation of diagnostic entities in clinical genomics</span>. <i>American Journal of Human Genetics</i>,  <span class="vol">108</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">8</span>– <span class="pageLast">15</span>. <a href="https://doi.org/10.1016/j.ajhg.2020.11.013" class="linkBehavior">https://doi.org/10.1016/j.ajhg.2020.11.013</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_4_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0004"><span class="author">Bonafe, L.</span>, <span class="author">Cormier-Daire, V.</span>, <span class="author">Hall, C.</span>, <span class="author">Lachman, R.</span>, <span class="author">Mortier, G.</span>, <span class="author">Mundlos, S.</span>, <span class="author">Nishimura, G.</span>, <span class="author">Sangiorgi, L.</span>, <span class="author">Savarirayan, R.</span>, <span class="author">Sillence, D.</span>, <span class="author">Spranger, J.</span>, <span class="author">Superti-Furga, A.</span>, <span class="author">Warman, M.</span>, & <span class="author">Unger, S.</span> (<span class="pubYear">2015</span>). <span class="articleTitle">Nosology and classification of genetic skeletal disorders: 2015 revision</span>. <i>American Journal of Medical Genetics. Part A</i>,  <span class="vol">167A</span>(<span class="citedIssue">12</span>),  <span class="pageFirst">2869</span>– <span class="pageLast">2892</span>. <a href="https://doi.org/10.1002/ajmg.a.37365" class="linkBehavior">https://doi.org/10.1002/ajmg.a.37365</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_5_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0005"><span class="author">Ferreira, C. R.</span>, <span class="author">Rahman, S.</span>, <span class="author">Keller, M.</span>, <span class="author">Zschocke, J.</span>, &  <span class="groupName">ICIMD Advisory Group</span>. (<span class="pubYear">2021</span>). <span class="articleTitle">An international classification of inherited metabolic disorders (ICIMD)</span>. <i>Journal of Inherited Metabolic Disease</i>,  <span class="vol">44</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">164</span>– <span class="pageLast">177</span>. <a href="https://doi.org/10.1002/jimd.12348" class="linkBehavior">https://doi.org/10.1002/jimd.12348</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_6_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0006"><span class="author">Ferreira, C. R.</span>, <span class="author">van Karnebeek, C. D. M.</span>, <span class="author">Vockley, J.</span>, & <span class="author">Blau, N.</span> (<span class="pubYear">2019</span>). <span class="articleTitle">A proposed nosology of inborn errors of metabolism</span>. <i>Genetics in Medicine: Official Journal of the American College of Medical Genetics</i>,  <span class="vol">21</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">102</span>– <span class="pageLast">106</span>. <a href="https://doi.org/10.1038/s41436-018-0022-8" class="linkBehavior">https://doi.org/10.1038/s41436-018-0022-8</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_7_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0007"><span class="author">Hall, C. M.</span> (<span class="pubYear">2002</span>). <span class="articleTitle">International nosology and classification of constitutional disorders of bone (2001)</span>. <i>American Journal of Medical Genetics</i>,  <span class="vol">113</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">65</span>– <span class="pageLast">77</span>. <a href="https://doi.org/10.1002/ajmg.10828" class="linkBehavior">https://doi.org/10.1002/ajmg.10828</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_8_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0008"> <span class="groupName">International nomenclature and classification of the osteochondrodysplasias</span>. (<span class="pubYear">1997</span>). <span class="articleTitle">International working group on constitutional diseases of bone (1998)</span>. <i>American Journal of Medical Genetics</i>,  <span class="vol">79</span>(<span class="citedIssue">5</span>),  <span class="pageFirst">376</span>– <span class="pageLast">382</span>. <a href="https://doi.org/10.1002/(sici)1096-8628(19981012)79:5%3c376::aid-ajmg9%3e3.0.co;2-h" class="linkBehavior">https://doi.org/10.1002/(sici)1096-8628(19981012)79:5&lt;376::aid-ajmg9&gt;3.0.co;2-h</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_9_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0009"> <span class="groupName">[International nomenclature of constitutional bone diseases. Constitutional bone diseases without known pathogenesis]</span>. (<span class="pubYear">1971</span>). <span class="articleTitle">International nomenclature of constitutional bone diseases. Constitutional bone diseases without known pathogenesis</span>. <i>Archives Francaises De Pediatrie</i>,  <span class="vol">28</span>(<span class="citedIssue">5</span>),  <span class="pageFirst">553</span>– <span class="pageLast">557</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_10_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0010"> <span class="groupName">International nomenclature of constitutional diseases of bone. Revision, May 1983</span>. (<span class="pubYear">1983</span>). <span class="articleTitle">International nomenclature of constitutional diseases of bone. Revision, May 1983</span>. <i>Annales de Radiologie</i>,  <span class="vol">26</span>(<span class="citedIssue">6</span>),  <span class="pageFirst">457</span>– <span class="pageLast">462</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_11_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0011"> <span class="groupName">International nomenclature of constitutional diseases of bone: Revision--May 1977</span>. (<span class="pubYear">1979</span>). <span class="articleTitle">International nomenclature of constitutional diseases of bone: Revision--May 1977</span>. <i>American Journal of Medical Genetics</i>,  <span class="vol">3</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">21</span>– <span class="pageLast">26</span>. <a href="https://doi.org/10.1002/ajmg.1320030107" class="linkBehavior">https://doi.org/10.1002/ajmg.1320030107</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_12_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0012"> <span class="groupName">[International nomenclature of constitutional diseases of bones]</span>. (<span class="pubYear">1970</span>). <span class="articleTitle">International nomenclature of constitutional diseases of bones</span>. <i>Annales de Radiologie</i>,  <span class="vol">13</span>(<span class="citedIssue">7</span>),  <span class="pageFirst">455</span>– <span class="pageLast">464</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_13_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0013"><span class="author">Lachman, R. S.</span> (<span class="pubYear">1998</span>). <span class="articleTitle">International nomenclature and classification of the osteochondrodysplasias (1997)</span>. <i>Pediatric Radiology</i>,  <span class="vol">28</span>(<span class="citedIssue">10</span>),  <span class="pageFirst">737</span>– <span class="pageLast">744</span>. <a href="https://doi.org/10.1007/s002470050458" class="linkBehavior">https://doi.org/10.1007/s002470050458</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_14_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0014"><span class="author">McKusick, V. A.</span>, & <span class="author">Scott, C. I.</span> (<span class="pubYear">1971</span>). <span class="articleTitle">A nomenclature for constitutional disorders of bone</span>. <i>The Journal of Bone and Joint Surgery. American</i>,  <span class="vol">53</span>(<span class="citedIssue">5</span>),  <span class="pageFirst">978</span>– <span class="pageLast">986</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_15_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0015"><span class="author">Mortier, G. R.</span>, <span class="author">Cohn, D. H.</span>, <span class="author">Cormier-Daire, V.</span>, <span class="author">Hall, C.</span>, <span class="author">Krakow, D.</span>, <span class="author">Mundlos, S.</span>, <span class="author">Nishimura, G.</span>, <span class="author">Robertson, S.</span>, <span class="author">Sangiorgi, L.</span>, <span class="author">Savarirayan, R.</span>, <span class="author">Sillence, D.</span>, <span class="author">Superti-Furga, A.</span>, <span class="author">Unger, S.</span>, & <span class="author">Warman, M. L.</span> (<span class="pubYear">2019</span>). <span class="articleTitle">Nosology and classification of genetic skeletal disorders: 2019 revision</span>. <i>American Journal of Medical Genetics. Part A</i>,  <span class="vol">179</span>(<span class="citedIssue">12</span>),  <span class="pageFirst">2393</span>– <span class="pageLast">2419</span>. <a href="https://doi.org/10.1002/ajmg.a.61366" class="linkBehavior">https://doi.org/10.1002/ajmg.a.61366</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_16_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0016"><span class="author">Sillence, D. O.</span>, & <span class="author">Rimoin, D. L.</span> (<span class="pubYear">1978</span>). <span class="articleTitle">Classification of osteogenesis imperfecta</span>. <i>Lancet (London, England)</i>,  <span class="vol">1</span>(<span class="citedIssue">8072</span>),  <span class="pageFirst">1041</span>– <span class="pageLast">1042</span>. <a href="https://doi.org/10.1016/s0140-6736(78)90763-8" class="linkBehavior">https://doi.org/10.1016/s0140-6736(78)90763-8</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_17_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0017"><span class="author">Sillence, D. O.</span>, <span class="author">Rimoin, D. L.</span>, & <span class="author">Danks, D. M.</span> (<span class="pubYear">1979</span>). <span class="articleTitle">Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity</span>. <i>Birth Defects Original Article Series</i>,  <span class="vol">15</span>(<span class="citedIssue">5B</span>),  <span class="pageFirst">113</span>– <span class="pageLast">129</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_18_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0018"><span class="author">Spranger, J.</span> (<span class="pubYear">1985</span>). <span class="articleTitle">Pattern recognition in bone dysplasias</span>. <i>Progress in Clinical and Biological Research</i>,  <span class="vol">200</span>,  <span class="pageFirst">315</span>– <span class="pageLast">342</span>.
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_19_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0019"><span class="author">Superti-Furga, A.</span>, & <span class="author">Unger, S.</span> (<span class="pubYear">2007</span>). <span class="articleTitle">Nosology and classification of genetic skeletal disorders: 2006 revision</span>. <i>American Journal of Medical Genetics. Part A</i>,  <span class="vol">143A</span>(<span class="citedIssue">1</span>),  <span class="pageFirst">1</span>– <span class="pageLast">18</span>. <a href="https://doi.org/10.1002/ajmg.a.31483" class="linkBehavior">https://doi.org/10.1002/ajmg.a.31483</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_20_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0020"><span class="author">Van Dijk, F. S.</span>, & <span class="author">Sillence, D. O.</span> (<span class="pubYear">2014</span>). <span class="articleTitle">Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment</span>. <i>American Journal of Medical Genetics. Part A</i>,  <span class="vol">164A</span>(<span class="citedIssue">6</span>),  <span class="pageFirst">1470</span>– <span class="pageLast">1481</span>. <a href="https://doi.org/10.1002/ajmg.a.36545" class="linkBehavior">https://doi.org/10.1002/ajmg.a.36545</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_21_1"></ul></li>
                  
                  <li data-bib-id="ajmga63132-bib-0021"><span class="author">Warman, M. L.</span>, <span class="author">Cormier-Daire, V.</span>, <span class="author">Hall, C.</span>, <span class="author">Krakow, D.</span>, <span class="author">Lachman, R.</span>, <span class="author">LeMerrer, M.</span>, <span class="author">Mortier, G.</span>, <span class="author">Mundlos, S.</span>, <span class="author">Nishimura, G.</span>, <span class="author">Rimoin, D. L.</span>, <span class="author">Robertson, S.</span>, <span class="author">Savarirayan, R.</span>, <span class="author">Sillence, D.</span>, <span class="author">Spranger, J.</span>, <span class="author">Unger, S.</span>, <span class="author">Zabel, B.</span>, & <span class="author">Superti-Furga, A.</span> (<span class="pubYear">2011</span>). <span class="articleTitle">Nosology and classification of genetic skeletal disorders: 2010 revision</span>. <i>American Journal of Medical Genetics. Part A</i>,  <span class="vol">155A</span>(<span class="citedIssue">5</span>),  <span class="pageFirst">943</span>– <span class="pageLast">968</span>. <a href="https://doi.org/10.1002/ajmg.a.33909" class="linkBehavior">https://doi.org/10.1002/ajmg.a.33909</a>
                     <ul class="getFTR rlist--inline getFTR__placeholder" data-target="e_1_2_11_22_1"></ul></li>
                  </ul>
            </div>
         </div>
      </section>
   </section>
   <div style="display:none">
      <ul class="custom-style-list noteList"></ul>
   </div>
   <div class="pb-dropzone" data-pb-dropzone="citedBy-dropzone"><section id="cited-by" class="article-section article-section__citedBy cited-by"><div class="accordion article-accordion"><h2><div tabindex="0" role="button" aria-controls="cited-by__content" aria-expanded="false" data-getFTR-enabled="data-getFTR-enabled" data-getFTR-url="/citedBy/links/10.1002/ajmg.a.63132?orderBy=YEAR_ONLINE_PREFERRED&amp;orderType=DESC&amp;linkSource=FULL_TEXT" data-getFTR-count='10' class="accordion__control"><span id="citedby-section" class="section__title">Citing Literature</span><i aria-hidden="true" class="icon-section_arrow_d"></i></div></h2><div id="cited-by__content" data-source="/pb/widgets/citedBy?page=0&amp;widgetId=f6d59956-1f70-4e88-8811-a42ff3d9d1fa&amp;pbContext=%3Bissue%3Aissue%3Adoi%5C%3A10.1002%2Fajmg.a.v191.5%3Bjournal%3Ajournal%3A10968628%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwebsite%3Awebsite%3Apericles%3BrequestedJournal%3Ajournal%3A15524833%3Barticle%3Aarticle%3Adoi%5C%3A10.1002%2Fajmg.a.63132%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="accordion__content cited-by__content"><div class="sciteMetricsDropzone"></div></div></div></section></div>
   </article></div></div><div class="col-lg-4 col-md-4 col-sm-4 hidden-xs hidden-sm hidden-md article-row-right"><div class="publication-cover-info clearfix">



        
        <div class="cover-image-wrapper cover-image__image hasDetails"><a href="/toc/15524833/2023/191/5" title="View Volume 191, Issue 5"><img src="/cms/asset/d4751376-a6e0-426b-b4c6-f4646d6d8072/ajmg.a.v191.5.cover.jpg" alt=""/></a></div><div class="extra-info-wrapper cover-image__details"><p class="volume-issue"><a href="/toc/15524833/2023/191/5" title="View Volume 191, Issue 5"><span>Volume</span><span class="val">191</span>, <span>Issue</span><span class="val">5</span></a></p><p>May 2023</p><p class="page-range"><span>Pages</span><span> 1164-1209</span></p>



        
        
</div>
</div>



        
        



    
        <div class="pb-ad">
            <div id="advert-rail-1" class="advert advert-rail">
			<script>

				googletag.cmd.push 		( function () {
					googletag.display 	( 'advert-rail-1' );
				});

			</script>

			<!-- No JavaScript support is a call to an image -->
			<noscript>
				<a href="/action/clickThrough?id=1011&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fajmg.a.63132&pubId=80516423&placeholderId=1014&productId=101018" target="_blank">
					<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
				</a>
			</noscript>
		</div>
        </div>
        
    

    

    


<div class="tabs__wrapper"><div data-default-tab="related" class="tab tab--slide tab--flex sticko__md tabs--xs dynamic-sticko article__tab  tab--flex  tabs--xs "><ul data-mobile-toggle="slide" role="tablist" class="rlist tab__nav w-slide--list"><li role="presentation" class="tab__nav__item"><a id="pane-pcw-referencescon" href="#pane-pcw-references" data-slide-clone="self" aria-controls="pane-pcw-references" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-references" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn references-tab"><i aria-hidden="true" class="icon-chain"></i><h2>References</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-relatedcon" href="#pane-pcw-related" data-slide-clone="self" aria-controls="pane-pcw-related" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-related" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn related-tab"><i aria-hidden="true" class="icon-related-circles-extend-button"></i><h2>Related</h2></a></li><li role="presentation" class="tab__nav__item"><a id="pane-pcw-detailscon" href="#pane-pcw-details" data-slide-clone="self" aria-controls="pane-pcw-details" role="tab" data-toggle="tab" data-slide-target="#pane-pcw-details" class="tab__nav__item__link article-row-right__tabLinks w-slide__btn details-tab"><i aria-hidden="true" class="icon-Icon_Information"></i><h2>Information</h2></a></li></ul><div role="presentation" class="tab__content"><div id="pane-pcw-references" aria-labelledby="pane-pcw-referencescon" role="tabpanel" class="tab__pane article-row-right__panes empty"></div><div id="pane-pcw-related" aria-labelledby="pane-pcw-relatedcon" role="tabpanel" class="tab__pane article-row-right__panes"></div><div id="pane-pcw-details" aria-labelledby="pane-pcw-detailscon" role="tabpanel" class="tab__pane article-row-right__panes empty"><div class="contentTab"></div></div><div class="tab__spinner"><div class="tab__spinner--box"><img src="/specs/products/acropolis/pericles/releasedAssets/images/spinner-1ffd60b3aabe5b09bc98c48345208fd9.gif" id="spinner" alt=""/></div></div></div></div></div><div class="articleAdvert fixed-element">



        
        



    
        <div class="pb-ad">
            <aside>
	<div id="advert-rail-2" class="advert advert-rail">
		<script>

			googletag.cmd.push 		( function () {
				googletag.display 	( 'advert-rail-2' );
			});

		</script>

		<!-- No JavaScript support is a call to an image -->
		<noscript>
			<a href="/action/clickThrough?id=1012&url=https%3A%2F%2Fpubads.g.doubleclick.net%2Fgampad%2Fjump%3Fiu%3D%24googlePublisherCategory%26amp%3Bsz%3D160x600%7C160x320%7C160x160%7C120x600%26amp%3Btile%3D2%26amp%3Bc%3D%24random&loc=%2Fdoi%2F10.1002%2Fajmg.a.63132&pubId=80516423&placeholderId=1013&productId=101018" target="_blank">
				<img src="https://pubads.g.doubleclick.net/gampad/ad?iu=$googlePublisherCategory&amp;sz=160x600|160x320|160x160|120x600&amp;tile=2&amp;c=$random">
			</a>
		</noscript>
	</div>
</aside>
        </div>
        
    

    

    


</div></div></div></article><script>var articleRef = document.querySelector('.article__body:not(.show-references) .article__references');
if (articleRef) { articleRef.style.display = "none"; }

</script><div id="figure-viewer" data-ux3-wrapper="figure-viewer" data-ux3-transformed-by="figureInit" data-ux3-role="parent" role="dialog" class="figure-viewer"><div class="figure-viewer__reg__top clearfix"><div class="figure-viewer__top__right"><a href="#" data-ux3-role="controller" role="button" class="figure-viewer__ctrl__close"><span class="icon-close_thin"><span class="sr-only">Close Figure Viewer</span></span></a></div><div class="figure-viewer__top__left"><a href="#" role="button" class="figure-viewer__ctrl__return is-hidden"><span class="icon-arrow-left"><span class="sr-only">Return to Figure</span></span></a><button title="zoom out" class="figure-viewer__label__zoom icon-zoom-out zoom-out"></button><span tabindex="1" class="zoomSlider js__zoom-slider ui-slider"><input type="range" class="zoom-range"/></span><button title="zoom in" class="figure-viewer__label__zoom icon-zoom-in zoom-in"></button></div></div><div class="figure-viewer__reg__center"><div class="figure-viewer__cent__left"><div class="figure-viewer__hold__fig"><figure class="holder"></figure></div><a href="#" role="button" class="figure-viewer__ctrl__prev"><span class="icon-arrow_l"><span class="sr-only">Previous Figure</span></span></a><a href="#" role="button" class="figure-viewer__ctrl__next"><span class="icon-arrow_r"><span class="sr-only">Next Figure</span></span></a><div class="figure-viewer__hold__list clearfix container"></div></div><div class="figure-viewer__cent__right"><div class="figure-viewer__title"><a title="Open/Close Caption" href="#" aria-expanded="false" class="figure-viewer__ctrl__caption"><span class="icon-doublearrow"></span><span class="figure-viewer__caption__label">Caption</span></a><span class="figure-viewer__title__text"></span></div><div class="figure-viewer__hold__figcap"></div></div></div></div>




        
        <div style="text-align: right!important;"><a style="font-weight: 300!important; font-size: 90%;" href="/doi/pdf/10.1002/ajmg.a.63132">Download PDF</a></div>
</div>
</div></div></div>

        </section>
    

        </div>
    </div><!--end pagefulltext-->
</main>

        </div>
    











    
    
        <div data-widget-def="pageFooter" data-widget-id="053994f3-7d80-4bb1-97a4-c67fbc4768cd" class="pageFooter">
        



        
        <footer class="page-footer">
    <div data-pb-dropzone="main">
    



        
        <div class="main-footer">



        
        <style>
    .footer-links {
        text-align: center;
    }
    .footer-links h3 {
        font-weight: 300;
    }
    .footer-links a {
        font-weight: 600;
    }
    @media (min-width: 992px) {
        .footer-links {
            text-align: left;
        }
    }
</style>










    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="2753bec1-a79d-4403-827b-6c788ddd6db3" class="footer-sections">
        



        
            <h2 class="sr-only">
                Additional links
            </h2>
        
        <div class="container"><div class="row"><div class=" col-md-3">



        
        <div class="footer-links mb-3">
    <h3>About Wiley Online Library</h3>
    <ul class="rlist">
        <li><a href="https://www.wiley.com/privacy">Privacy Policy</a></li>
        <li><a href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms of Use</a></li>
        <li><a href="https://onlinelibrary.wiley.com/cookies">About Cookies</a></li>
        <li><button class="mange-cookies-btn" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open'); return false;">Manage Cookies</button></li>
        <li><a href="https://onlinelibrary.wiley.com/accessibility">Accessibility</a></li>
        <li><a href="https://onlinelibrary.wiley.com/publishing-policies">Wiley Research DE&amp;I Statement and Publishing Policies</a></li>
        <li><a href="https://onlinelibrary.wiley.com/developing-world-access">Developing World Access</a></li>
    </ul>
</div>
<style>
    .mange-cookies-btn{
        background: none;
        color: inherit;
        border: none;
        padding: 0;
        cursor: pointer;
        font-weight: 600;
    }
    .mange-cookies-btn:hover,
    .mange-cookies-btn:focus,
    .mange-cookies-btn:active {
        text-decoration: none;
        outline: 0;
        background-color: transparent;
    }

    .mange-cookies-btn:focus {
        outline: 5px auto -webkit-focus-ring-color;
    }

    .osano-cm-widget {
        display: none;
    }
</style>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Help & Support</h3>
    <ul class="rlist">
      <li><a href="https://hub.wiley.com/community/support/onlinelibrary">Contact Us</a></li>
      <li><a href="https://www.wiley.com/customer-success/wiley-online-library-training-hub">Training and Support</a></li>
    <li><a href="https://onlinelibrary.wiley.com/dmca-notification-policy">DMCA &amp; Reporting Piracy</a></li>
 
    </ul>
  </div>
</div><div class=" col-md-3">



        
         <div class="footer-links mb-3">
    <h3>Opportunities</h3>
    <ul class="rlist">
      <li><a href="https://onlinelibrary.wiley.com/agents">Subscription Agents</a></li>
      <li><a href="https://onlinelibrary.wiley.com/advertisers">Advertisers & Corporate Partners</a></li>
    </ul>
  </div>
</div><div class=" col-md-3">



        
        <div class="footer-links mb-3">
    <h3>Connect with Wiley</h3>
    <ul class="rlist">
      <li><a href="https://www.wiley.com/network">The Wiley Network</a></li>
      <li><a href="https://newsroom.wiley.com/">Wiley Press Room</a></li>
    </ul>
  </div>
</div></div></div>

        </div>
    











    
    
        <div data-widget-def="ux3-layout-widget" data-widget-id="86584e25-e4db-4118-9550-9b4f5341a4ac" class="copyright-container">
        



        
        <div class="container"><div class="row"><div class=" col-md-12">









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="bfbf6c5d-a650-4662-828f-5275fada9120" class="copyright">
        



        
        <div class="copyright pull-left">Copyright &copy; 1999-2023 <a href="https://www.wiley.com">John Wiley &amp; Sons, Inc</a>. All rights reserved</div>

        </div>
    





        
        <div class="footer-logo pull-right">
        
<a href="https://www.wiley.com" title="Wiley Home Page" aria-label="Wiley"><img alt="Wiley Home Page" src="/pb-assets/tmp-images/footer-logo-wiley-1510029248417.png"></a>

</div>
</div></div></div>

        </div>
    

</div>
    </div>
</footer>

        </div>
    





        
        <!--  -->  <div id="iucr-failure"> <p><i class="icon-notice"></i>The full text of this article hosted at iucr.org is unavailable due to technical difficulties.<a href="#" class="close-iucr-failure"><i class="icon-x"></i></a> </p> </div> 




        
        


















<div class="popup login-popup hidden" role="dialog" tabindex="-1" aria-labelledby="loginPopupHead">



    <div class="content">
        <a href="#" role="button" aria-label="Cancel Login" class="close">
            <i class="icon-tools_close" aria-hidden="true"></i>
        </a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>
        </div>

        <div class="modal__body">
            <div class="ssoLogin">
                
            </div>

            <h2 id="loginPopupHead">Log in to Wiley Online Library</h2>

            































<div class="login-form">
    

    
        
        
    

    
    <form action="/action/doLogin?societyURLCode=" class="bordered" method="post"><input type="hidden" name="id" value="67065c09-4a88-49cd-934c-ac707951d35c" />
        
            <input type="hidden" name="popup" value="true" />
        
        

        
        <input type="hidden" name="loginUri" value="/doi/10.1002/ajmg.a.63132" />
        
            





<input type="hidden" name="redirectUri" value="/doi/10.1002/ajmg.a.63132" />

            
        
        
        
            
            
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                
                
                    <label for="username">Email or Customer ID</label>
                
            
        </div>
        
        
            
            
                <input id="username" class="login" type="text" name="login" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        
        
                    
                        <div class="actions">
                            
                        </div>
                    
                
    </div>


                
                



















    
    <div class="input-group">
        <div class="label">
            <label for="password">Password</label>
        </div>
        
        
            
            
                <input id="password" class="password" type="password" name="password" value="" autocomplete="off" placeholder="Enter your password"autocorrect="off"spellcheck="false"autocapitalize="off"required="true" />
            
        
        <span class="password-eye-icon icon-eye hidden"></span>
        
                
    </div>

                
                    
                        <div class="actions">
                            
                            <a href="/action/requestResetPassword" class="link show-request-reset-password">
                                Forgot password?
                            </a>
                        </div>
                    
                
            
        
        
        <div class="loginExtraBeans-dropZone" data-pb-dropzone="loginExtraBeans">
            
        </div>

        
            
            
                <div class="align-end">
                    
                    
                        
                            
                            <span class="submit ">
                                <input class="button btn submit primary no-margin-bottom accessSubmit" type="submit" name="submitButton" value="Log In" />
                            </span>
                        
                        
                    
                </div></form>
    <div class="societySpecificInstructions">
        
    </div>
</div>

            
                <div class="login-container clearfix form-btn">
                    <a href="/action/registration" class="linkBtn float-left">
                        
                        NEW USER <span aria-hidden="true">></span>
                    </a>
                    
                        <a href="/action/ssostart?redirectUri=%2Fdoi%2F10.1002%2Fajmg.a.63132" class="linkBtn float-right instituation-login">
                            
                            INSTITUTIONAL LOGIN <span aria-hidden="true">></span>
                        </a>
                    
                </div>
            

        </div>
    </div>
</div>




        
        






<div class="popup change-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="changePasswordPopupHead">
    <div class="content">
        <a href="#" class="close cancel" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
        <div class="modal__header">
            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="changePasswordPopupHead">Change Password</h2>
        </div>
        <div class="modal__body">

            <div class="form">

                <form action="/action/changePassword" method="post"><div class="message error"></div>
                    <input type="hidden" name="submit" value="submit" />
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-old">Old Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-old" class="old" type="password" name="old" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                    </div>
                    <div class="input-group">
                        <div class="label">
                            <label for="a589574e-bb98-4c6e-8fed-67365ff05357-new">New Password</label>
                        </div>
                        <input id="a589574e-bb98-4c6e-8fed-67365ff05357-new" class="pass-hint new" type="password" name="new" value="" autocomplete="off" />
                        <span class="password-eye-icon icon-eye hidden"></span>
                        
                            







    


    


    


<div class="password-strength-indicator" data-min="10" data-max="32" data-strength="4">
    <span class="text too-short">Too Short</span>
    <span class="text weak">Weak</span>
    <span class="text medium">Medium</span>
    <span class="text strong">Strong</span>
    <span class="text very-strong">Very Strong</span>
    <span class="text too-long">Too Long</span>
</div>
                        
                    </div>
                    <input class="button primary submit" type="submit" value="Submit" disabled="disabled" /></form>
                <a href="#" class="fakeFormLastElement"></a>
            </div>
            <div class="success-template hidden">
                <h2>Password Changed Successfully</h2>
                <p>Your password has been changed</p>
            </div>
        </div>
    </div>
</div>





        
        





<div class="popup registration-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="createAccountPopupHead">



    <div class="content">
        <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-tools_close"></i></a>
        <div class="modal__header">
            <div class="logoDropZone" data-pb-dropzone="logoDropZone">
                
            </div>

            <h2 id="createAccountPopupHead">Create a new account</h2>
        </div>

        <div class="modal__body">
            <form action="/action/registration" class="registration-form" method="post"><input type="hidden" name="redirectUri" value="/doi/10.1002/ajmg.a.63132" />
                <div class="input-group">
                    <div class="label">
                        <label for="4e647394-f751-4441-baa4-df426bca4b6e.email">Email</label>
                    </div>
                    <input id="4e647394-f751-4441-baa4-df426bca4b6e.email" class="email" type="text" name="email" value="" size="15" />
                </div>
                <div class="submit">
                    <input class="button submit primary" type="submit" value="Register" />
                </div></form>
            <div class="center">
                <a href="/action/showLogin" class="show-login">
                    
                    Returning user
                </a>
            </div>
        </div>
    </div>
</div>




        
        



<div class="popup top-drawer request-reset-password-drawer hidden" role="dialog" tabindex="-1" aria-labelledby="resetPasswordPopupHead">
    <div class="content">
        <div class="modal__header">
            <a href="#" class="cancel close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>

            

<div class="header_logo">
    <img src="/pb-assets/hub-assets/pericles/logo-header-1526603583437.png" alt="">
</div>

            <h2 id="resetPasswordPopupHead">Forgot your password?</h2>
            <p class="sub">Enter your email address below. </p>

        </div>

        <div class="modal__body">

            









<div class="error"></div>


<form action="/action/requestResetPassword" class="request-reset-password-form" method="post"><input type="hidden" name="requestResetPassword" value="true" />
    
        
        
            <div class="input-group">
                






















    
    
        
    <div class="input-group">
        <div class="label">

            
                
                
                    <label for="email">Email</label>
                
            
        </div>
        
        
            
            
                <input id="email" class="email" type="text" name="email" value="" size="15" placeholder="Enter your email"autocorrect="off"spellcheck="false"autocapitalize="off" />
            
        
        
    </div>

            </div>
        
    


    
        
            <div class="password-recaptcha-ajax"></div>
        
        
    

    <div class="message error"></div>

    <div class="form-btn">
        <input class="button btn primary submit" type="submit" name="submit" value="RESET PASSWORD" disabled="disabled" />
    </div></form>
            

            <div class="success-template hidden">

                <p>Please check your email for instructions on resetting your password.
                    If you do not receive an email within 10 minutes, your email address may not be registered,
                    and you may need to create a new Wiley Online Library account.</p>

            </div>
        </div>
    </div>
</div>





        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>




        
        




<div class="popup top-drawer request-username-drawer username-popup hidden"  role="dialog" tabindex="-1" aria-labelledby="requestUsernamePopupHead">
    <a href="#" class="close" role="button" aria-label="close dialog"><i class="icon-close_thin"></i></a>
    <div class="content">
        <h2 id="requestUsernamePopupHead">Request Username</h2>
        <div class="form">
            <p>Can't sign in? Forgot your username?</p>
            <p class="sub">Enter your email address below and we will send you your username</p>
            <div class="message error"></div>
            <form action="/action/requestUsername" method="post"><input type="hidden" name="requestUsername" value="requestUsername" />
                <div class="input-group">
                    <div class="label">
                        <label for="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email">Email</label>
                    </div>
                    <input id="ac834f24-aa07-4ad2-9d13-f77c843f21cb.email" class="email" type="text" name="email" value="" size="15" />
                </div>

                <div class="username-recaptcha-ajax">
                </div>

                <input class="button primary submit" type="submit" name="submit" value="Submit" disabled="disabled" />
                <div class="center">
                    <a href="#" class="cancel">Close</a>
                </div></form>
        </div>
        <div class="success-template hidden note">
            <p>If the address matches an existing account you will receive an email with instructions to retrieve your username</p>
        </div>
    </div>
</div>
        </div>
    </div>








    
    

    
    
    
    
        
            
            

            
                <script type="text/javascript" src="/wro/m6hz~article-metrics-phase2.js"></script>
            
        
    

<script src="/products/acropolis/pericles/releasedAssets/js/build.lazyload.bundle-06a510fc6bc4051f7952.js"></script><script src="/products/acropolis/pericles/releasedAssets/js/main.bundle-3886fa477c52b25f3fe8.js"></script><script type="text/javascript" src="/wro/m6hz~product.js"></script>

<script>var _prum=[['id','59e8fecb3847311aab7b23c6'],['mark','firstbyte',(new Date()).getTime()]];(function(){var s=document.getElementsByTagName('script')[0],p=document.createElement('script');p.async='async';p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();</script>















    <script type="text/javascript">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>





    <script>
        fetch("https://wiley.met.vgwort.de/na/base64-dmd6bS42MDY1MC0xMC4xMDAyLWFqbWcuYS42MzEzMg==", {mode: 'no-cors', referrerPolicy: 'unsafe-url'});
    </script>
<script>
    $(document).ready(function () {
        var start = new Date();
        var doi = $("meta[name='dc.identifier']").attr('content');
        $(window).unload(function () {
            var end = new Date();
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'Duration': end - start,
                    'DOI': doi,
                    'EventType': 'FullTextDuration'
                },
                async: false
            });
        });

        window.onafterprint = function () {
            $.ajax({
                url: '/action/analytics',
                method: 'post',
                data: {
                    'DOI': doi,
                    'EventType': 'FullTextPrint'
                }
            });
        };
    });
</script>

<script>(function(){var js = "window['__CF$cv$params']={r:'7c2652e539a4aacb',m:'N8R0yuR4LHTtwQwFnCiwrxtkO6o2Ar3azTd.6BEzhuI-1683261820-0-AbDRG6G2ZTXxoHNJByBApXq6Hk/XFb7NS49oTOzl4rTK',u:'/cdn-cgi/challenge-platform/h/g'};_cpo=document.createElement('script');_cpo.nonce='',_cpo.src='/cdn-cgi/challenge-platform/scripts/invisible.js',document.getElementsByTagName('head')[0].appendChild(_cpo);";var _0xh = document.createElement('iframe');_0xh.height = 1;_0xh.width = 1;_0xh.style.position = 'absolute';_0xh.style.top = 0;_0xh.style.left = 0;_0xh.style.border = 'none';_0xh.style.visibility = 'hidden';document.body.appendChild(_0xh);function handler() {var _0xi = _0xh.contentDocument || _0xh.contentWindow.document;if (_0xi) {var _0xj = _0xi.createElement('script');_0xj.nonce = '';_0xj.innerHTML = js;_0xi.getElementsByTagName('head')[0].appendChild(_0xj);}}if (document.readyState !== 'loading') {handler();} else if (window.addEventListener) {document.addEventListener('DOMContentLoaded', handler);} else {var prev = document.onreadystatechange || function () {};document.onreadystatechange = function (e) {prev(e);if (document.readyState !== 'loading') {document.onreadystatechange = prev;handler();}};}})();</script><script defer src="https://static.cloudflareinsights.com/beacon.min.js/v52afc6f149f6479b8c77fa569edb01181681764108816" integrity="sha512-jGCTpDpBAYDGNYR5ztKt4BQPGef1P0giN6ZGVUi835kFF88FOmmn8jBQWNgrNd8g/Yu421NdgWhwQoaOPFflDw==" data-cf-beacon='{"rayId":"7c2652e539a4aacb","token":"f3dd54df2ac243bab2129483f57546d1","version":"2023.4.0","si":100}' crossorigin="anonymous"></script>
</body>
</html>
